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ABSTRACT 
 
This work presents a systematic study of macroporous polymer monoliths and 
their use as stationary phases for microscale separation and as supports for 
immobilized trypsin digestion in pipette tip format for bioanalysis. 
Reversed-phase/cation-exchange mixed-mode polymer monolithic 
columns were prepared in situ within fused-silica capillaries via UV-initiated 
free-radical polymerization reaction. Control of the porous properties was 
achieved by varying the ratio of porogenic solvents (e.g. 1,4-butanediol and 1-
propanol), the type of porogenic solvents used and the relative amounts of 
functional monomers and cross-linker. These columns were successfully used for 
the separation of a mixture of selected acidic drugs and -blockers, namely 
ketoprofen, ibuprofen, diclofenac, arterenol and propranolol. Monolithic 
columns with higher amounts of cross-linker were shown to give better 
repeatability. Furthermore, the separation mechanism of the investigated 
compounds was shown to be dual mode hydrophobic/ion-exchange interaction 
of the analytes with the hydrophobic and cation-exchange monolith. All these 
properties demonstrated the potential of these devices for solid-phase extraction 
and sample enrichment purposes in miniaturized formats.  
 Based on the success of the previous work a trypsin-immobilized 
monolithic polymer with pipette-tip format was also investigated to explore the 
utility of using a tip-based protein digestion methodology in a bioanalytical 
setting. The excellent performance of immobilized enzymatic polypropylene 
pipette (IMEPP) tips was characterized using MicrOTOF-Q quadrupole time-of-
flight MS and triple quadrupole LC-MS/MS systems. Very high sequence 
coverages of over 90% were achieved for the digestion of proteins ranging from 
x 
 
low molecular weight to high molecular weight proteins with short contact times 
prior to MS analysis, which is comparable to 24 h digestion in solution. In 
addition, quantitative analysis of target proteins spiked in rat plasma was 
demonstrated for the first time with relatively good linearity over a wide range 
from 40-1000 ng/mL. The developed IMEPP tips exhibit high plasma loading 
capacity up to 40 L of plasma that can be used to yield the highest efficiency for 
digestion. The IMEPP tip approach is thus rapid, reliable, and robust suggesting 
the potential of this approach to improve sample throughput for pharmaceutical 
and pharmacokinetic studies, leading to faster and safer discovery of new drugs 
to treat diseases. 
The trypsin immobilized polymer monolith was prepared in situ in 
syringe-compatible glass tube and evaluated for the digestion of protein. 
Preliminary results showed that the enzyme on the immobilized bed exhibited 
high proteolytic performance in this special format. The present glass tube 
bioreactor provides a promising platform for the full automation, on-line 
coupling to detection systems, short sample preparation times and high-
throughput protein digestion. 
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C h a p t e r  1  
Introduction & Literature Review 
1.1 Introduction 
Reversed-phase high performance liquid chromatography (RPLC) has become 
one of the most popular analytical techniques over the past 30 years for 
quantitative analysis of a wide range of pharmaceutical compounds [1,2]. It has 
been used in a variety of fields, including quality control of drugs, 
pharmacokinetic studies, and the determination of environmental pollutants or 
food additives [1]. The latest paradigms in the process of drug discovery require 
smaller quantities of analytes to be separated in an increasingly large number of 
samples [3] and in a drug discovery setting, the demand for high quality 
bioanalytical assays has grown over recent years. The increase in the number and 
potency of new chemical entities and the associated decrease in sample size, have 
in turn driven down the limits of quantification required for many bioanalytical 
methods. A bioanalytical method now has to be rapid, automated, sensitive, 
selective, robust and applicable to large numbers of samples in order to be 
considered useful. 
Quantitative bioanalysis is an important tool in the process of drug 
discovery, especially pertaining to important in vitro and in vivo studies. The data 
generated from bioanalytical methods are pivotal in making decisions around 
compound progression through the drug discovery process. The need to develop 
new bioanalytical methods to support the drug discovery process presents a 
continual challenge to the bioanalyst. For example, thousands of samples from in 
vitro screens need to be analyzed on a daily basis. Alternatively, quantifying pg/mL 
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levels of drug-related components in plasma from clinical studies, using a 
validated complex bioanalytical method, may be required. More considered 
approaches to both the extraction technique and chromatographic separation have 
also been successfully adopted for clinical applications. 
To further improve the efficiency of the drug discovery process, bioanalysts 
have been expected to generate analytical data in a far more efficient manner. 
Because of this, the development of more selective extraction techniques and the 
optimization of fast chromatographic conditions have come to prominence. Other 
advances in analytical chemistry, such as new column chemistries, high-pressure 
separations and hyphenated techniques such as liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) are common in the development of new 
bioanalytical methods. LC-MS/MS is the analytical platform used most commonly 
for bioanalysis, as triple quadrupole mass spectrometers offer the required 
specificity and sensitivity of detection. LC–MS/MS is ideally suited for 
pharmaceutical compounds, owing to the typical compound physicochemical 
properties and molecular weight. In addition, LC–MS/MS is specific enough to 
allow very rapid chromatographic separations to be performed; it can accept small 
volume samples in a micro-titre plate format, and it can also be used to monitor 
multiple analytes in the same complex sample (such as a plasma extract). LC-
MS/MS has become the most widely used analytical platform for quantifying 
drugs and their metabolites at low concentration levels in biological matrices [4]. 
For rapid LC–MS/MS bioanalysis, most laboratories use short analytical columns 
(3–10 cm), with relatively high flow-rates (e.g. 1 mL/min), small particles (5 μm or 
less) and fast gradients (10% -90% organic modifier) to achieve full analysis in less 
than 5 min per sample [5]. Single ion monitoring MS and multiple reaction 
monitoring MS/MS techniques provide great detection power. Since its 
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establishment in the early 1990s, LC-MS/MS has revolutionized the development 
of assays for new therapeutic agents in biomatrices [4,6,7], replacing more 
traditional high performance liquid chromatography (HPLC) detection techniques, 
such as ultra-violet or fluorescence. 
The development of new analytical methodologies for high-throughput 
bioanalysis has focused on the better utilization of the significant capital 
investment made in LC-MS/MS instrumentation and automation. Advances in on-
line and off-line sample preparation (e.g. sorbent chemistry, micro-plate formats, 
turbulent flow chromatography and column switching) and further advances in 
HPLC technology, which lead to enhancements in speed, sensitivity, and 
resolution (e.g. ultra-high pressure, capillary- and nano- HPLC ) [8-17], have also 
been implemented.  
Sample preparation is a key step in quantitative bioanalysis and can often be 
a bottleneck in the process of developing a robust and efficient bioanalytical 
methodology [4,18]. The sample preparation stage is often the most labor-
intensive, time-consuming and error-prone process in a bioanalytical method [4]. 
This can be attributed to the complex nature of macromolecular compounds, such 
as proteins and non-volatile endogenous substances, that have to be removed from 
a biological sample and separated from the analytes to eliminate matrix 
interferences prior to the LC-MS/MS analyses [19]. Sample preparation can also 
serve to pre-concentrate the sample while removing the endogenous matrix 
interferences at the same time. This leads to an increase in sensitivity and an ability 
to subsequently use faster, less well resolved chromatographic separations. Sample 
preparation is typically achieved by liquid-liquid extraction [20], solid-phase 
extraction (SPE) [13,21], protein precipitation [22], and on-line methods with HPLC 
[23]. In addition, as the number of samples increases, there has been a trend to 
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develop different formats of sample preparation devices, more selective sorbents 
for sample clean-up and enrichment, as well as fully automated analytical 
techniques [24,25]. The introduction of automated sample pre-treatment 
approaches has greatly increased the efficiency of the bioanalysis process [26]. 
Automated SPE in a 96-well plate format is now an established technique for 
sample clean up for biological samples [10]. 
One way to overcome some of the challenges associated with using fast 
LC/MS/MS is the use of monolithic phases. These have a number of potential 
advantages over more conventional silica-based particulate materials, as outlined 
in Table 1.1. Polymer monoliths can be adapted to most bioanalytical situations, 
such as larger scale sample preparation and small-scale capillary- or nano- HPLC 
separations, and therefore their use for bioanalysis has increased over recent years. 
These materials have some interesting properties when compared with the more 
traditional particulate materials, such as their high permeability for liquids and 
biological samples, thus making them ideal for SPE. The relative ease of synthesis, 
high control of shape, porosity and selectivity give the bioanalyst many options in 
the choice of bioanalytical applications and formats for monolithic phases. 
Additionally, the option of operating at high or low flow-rates, stability at high pH 
as compared to similar silica-based materials and low column pressure drop, can 
yield flexibility and speed for HPLC separations. These phases can be prepared in 
situ within narrow capillaries and applied to micro-scale separations and even 
further miniaturized for micro-fabricated applications. In summary, monolithic 
phases can be used in a variety of formats and can be prepared in a range of 
formats including HPLC columns, SPE plates, pipette tips or even synthesized in 
narrow capillaries for nano-flow chromatography. 
Organic polymeric monoliths can take two structurally different forms: (i)  
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Table 1.1: Advantages, disadvantages of using monoliths as compared to 
alternative phases for bioanalytical applications. 
 
Monolithic phases 
Other phases  
(i.e. packed particles) 
Advantages 
Low cost, relative ease of in situ preparation (e.g. 
thermal initiation, redox reagents, UV and 
gamma radiation). 
Mechanically robust, no void volumes formed 
with conventional LC flow-rates. 
Can control the porous properties by varying the 
compositions of monomers and porogens for the 
separations of large and small-molecules. 
High hydraulic permeability and the dominance 
of the convection over the diffusion mechanism 
of mass-exchange under dynamic conditions that 
allow the separation to be carried out at 
extremely high flow-rates. 
Flexible synthesis means that monoliths can be 
modified with almost any functionality, 
including ion-exchange, affinity, chiral, mixed-
mode, restricted access, hydrophobic and 
hydrophilic to tailor the stationary phases for 
different analytes. 
Can be molded into any shape (capillary, 
column, micropipette tips, microfluidic channel 
on a chip). 
Relatively biocompatible, due to open porous 
structure. Could be used for SPE column for over 
200 times for the analysis of human plasma 
without loss of efficiency. 
Can withstand more extreme conditions (i.e. pH 
working range from 2 to10). 
High surface area. 
Higher column 
efficiencies. 
Small particle sizes 
and high operating 
pressures.  
Diverse column 
chemistries and 
HPLC column 
dimensions.  
Validated 
applications/assays. 
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Disadvantages Lower surface area, lower binding capacity. 
 
Lower column efficiencies and HPLC column-to-
column repeatability. 
 
 
 
 
 
 
 
 
 
Narrow column chemistries and column 
dimensions commercially available. 
 
 
Limited use in routine analysis due to the 
limitation of commercial suppliers. 
 
Higher backpressure 
(slow diffusional mass 
transfer). 
For extraction, sorption 
materials, such as 
beads requires extra 
instruments to generate 
high-pressure for the 
sample solution to pass 
through the media. The 
intrinsic problem of all 
particulate media is 
their inability to 
completely fill the 
available space. The 
channeling between 
particles reduces 
extraction efficiencies 
and can adversely 
affect flow 
characteristics. 
Fabrication of packed 
capillary columns 
requires a tremendous 
amount of skill because 
of small i.d. particles 
used. 
Need for frits, 
undesired interactions 
of the frits with some 
analytes can make the 
utilization of packed 
capillary columns very 
problematic. 
Narrow pH stability 
range. 
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homogeneous gels and (ii) rigid porous polymers. Homogeneous gels can be 
applied as visually transparent or opalescent separation media and in principle 
they represent an almost ideal chromatographic support because of their high 
porosity and the fact that the eddy diffusion is negligible. An example of a 
homogeneous gel is the low cross-linked polyacrylamide (PAA), which is a soft 
and highly swollen material. On the other hand, rigid porous polymeric monoliths 
consist of a single piece of highly cross-linked macroporous polymer with 
interconnected pores and greater structural rigidity separations with low column 
backpressure and fast mass transfer kinetics [1-3].  
Recently, Guiochon [27], Smith and Jiang [28] and Potter and Hilder [29] 
have reviewed some general aspects of monolithic materials and their applications. 
In this chapter the focus is on recent developments in the use of monoliths (with 
particular emphasis on polymer monoliths) in the applied area of bioanalysis. The 
synthesis of polymer monoliths is discussed, followed by the use of monoliths for 
bioanalysis by HPLC and for SPE. Finally, some future directions are indicated. 
1.2 Synthesis of organic polymer monoliths for bioanalysis 
Despite the widespread progress in monolith synthesis, the preparation of 
monoliths may often remain a trial-and-error procedure. Furthermore, scale-up of 
the synthesis to larger diameter formats above typical analytical dimensions 
remains a challenge due to the high exothermic level of the polymerization 
reaction which becomes paramount in the case of large-volume monoliths. This can 
result in significant radial temperature gradients, leading to a non-uniform pore 
structure. Danquah and Forde [30] employed a novel synthetic technique using a 
heat expulsion mechanism to prepare a large methacrylate monolith (40 mL) with a 
homogeneous radial pore structure along its thickness. This large monolith was 
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used for the rapid purification of pDNA from clarified bacteria lysate using 
elevated flow-rates under moderate pressure drops. The same authors reported the 
preparation of macroporous methacrylate monolithic material with controlled pore 
structure using an unstirred mould through precise control of the polymerization 
kinetics and parameters. The results revealed that the control of the kinetics of the 
overall process through changes in reaction time, temperature and overall 
composition, such as cross-linker and initiator contents, allowed the fine tuning of 
the macroporous structure [31]. In contrast to this work, Chen et al. [32] directly 
prepared a supermacroporous monolithic cryogel by in situ cryo-copolymerization 
in a stainless steel cartridge using methacrylic acid as functional monomer and 
polyethylene glycol diacrylate as cross-linker. The resulting highly cross-linked 
(90%, molar ratio) cryogel had more uniform super macropores as compared to the 
poly(acrylamide)-based cryogels. The viability of this cryogel as a medium was 
demonstrated through the separations of lysozyme from chicken egg white and 
water-soluble nanoparticles from crude reaction solution. 
A weak ion-exchange grafted methacrylate monolith was prepared by 
Frankovic et al. [3] by grafting the methacrylate monolith with glycidyl 
methacrylate and subsequently modifying the epoxy groups with diethylamine. A 
comparison of the binding capacity for the non-grafted and grafted monolith was 
performed using β-lactoglobulin, bovine serum albumin (BSA), thyroglobulin, and 
plasmid DNA (pDNA). The results revealed that the grafted monolith exhibited 2 
to 3.5-fold higher capacities (as compared to non-grafted monoliths). Furthermore, 
the maximum pDNA binding capacity was reached using 0.1 M NaCl in the 
loading buffer and no degradation of the supercoiled pDNA form was detected. 
The grafted monolith exhibited lower efficiency than the non-grafted version, 
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however baseline separation of pDNA from RNA and other impurities was 
achieved from a real sample.  
Monolithic materials have been prepared for small drug molecule 
bioanalysis ranging from high-throughput separations in combinatorial chemistry 
through to validated clinical assays. For example, Aoki et al. have described a new 
approach to prepare polymer monoliths with morphology tailored for HPLC 
application to small solutes such as drug candidates [33]. Polymer monoliths based 
on 1,3-glycerol dimethacrylate (GDMA) were prepared by in situ photo-initiated 
free radical polymerization (UV-irradiation at 365 nm). The photo-polymerization 
was carried out with a mono-disperse ultra-high molecular weight polystyrene 
solution in chlorobenzene uniquely formulated as a porogen. The poly-GDMA 
monoliths were prepared in bulk, rod and capillary formats and these showed a 
bicontinuous network-like structure featured by their fine skeletal thickness 
approaching sub-m size. This monolithic structure was considered to be a time-
evolved morphology frozen by UV-irradiation via visco-elastic phase separation 
induced by the porogenic polystyrene solution. The UV-initiated poly-GDMA 
capillary monolith demonstrated a sharp elution profile affording higher column 
efficiency and permeability as compared to the thermally prepared capillary of the 
same pore size. This investigation showed that poly-GDMA monoliths with a well-
defined bicontinuous structure could be prepared reproducibly by photo-initiated 
radical polymerization via visco-elastic phase separation using the unique porogen.  
Roohi et al. [34] reported an interesting alternative to reversed-phase (RP) 
monolithic columns using a convenient coupling route of a thermo-responsive 
polymer to hydrophilic silica monoliths. Poly(N-isopropylacrylamide) was 
polymerized in solution via a reversible addition fragmentation chain transfer 
(RAFT) polymerization technique and coupled then in situ onto an amino-modified 
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silica monolithic column. These columns were compared with reversed-phase C18 
monolithic columns in the separation of steroids under isocratic conditions using 
an aqueous mobile phase. The separation was optimized by changing the 
temperature rather than by changing the mobile phase composition. Another rapid 
method for profiling steroids with a wide range of polarity has been developed by 
Colosi et al. [35]. Utilizing HPLC equipped with MS detection and a monolithic LC 
column, steroids were detected and quantified using testosterone-d3 as the internal 
standard. The method was compared to two similar methods using a traditional 
particulate column in terms of number of steroids eluted, peak area repeatability, 
limits of detection and overall analysis time. The monolithic method eluted the 
steroids in a 20 min analysis time, whereas the particulate methods required up to 
45 min [35]. 
Levkin et al. [36] prepared poly(lauryl methacrylate-co-ethylene glycol 
dimethacrylate) and poly(styrene-co-divinylbenzene) stationary phases in 
monolithic format using thermally initiated free radical polymerization within 
polyimide chips featuring channels having a cross-section of 200 m 200 m and 
a length of 6.8 cm. These chips were then used for the separation of a mixture of 
proteins including RNase A, myoglobin, cytochrome, and ovalbumin, as well as 
peptides. Both the monolithic phases based on methacrylate and on styrene 
chemistries enabled the rapid baseline separation of most of the test mixtures. The 
best performance was achieved with the styrenic monolith leading to fast baseline 
separation of all four proteins in less than 2.5 min. The in situ monolith preparation 
process afforded microfluidic devices exhibiting good batch-to-batch and injection-
to-injection repeatability [36]. Furthermore, Zhao et al. [37] developed a capillary 
chromatographic technique for the separation and detection of proteins, taking 
advantage of the specific affinity of aptamers and the porous property of the 
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monolith. A biotinylated DNA aptamer targeting cytochrome c was successfully 
immobilized on a streptavidin-modified polymer monolithic capillary column. The 
aptamer, having a G-quartet structure, could bind to both cytochrome c and 
thrombin, enabling the separation of these proteins from each other and from the 
unretained proteins. Elution of strongly bound proteins was achieved by 
increasing the ionic strength of the mobile phase. The following proteins were 
tested using the aptamer affinity monolithic columns: human IgG, Hb, transferrin, 
human serum albumin, cytochrome c, and thrombin. The benefit of porous 
properties of the affinity monolithic column was demonstrated by the selective 
capture and pre-concentration of thrombin at low ionic strength and the 
subsequent rapid elution at high ionic strength. The combination of the polymer 
monolithic column and the aptamer affinities makes the aptamer-modified 
monolithic columns useful for protein detection and separation. 
Sinner et al. [38] prepared monolithic capillary columns via ring-opening 
metathesis polymerization (ROMP) using norborn-2-ene (NBE) and 1,4,4a,5,8,8a-
hexahydro-1, 4, 5, 8-exo,endo-dimethanonaphthalene (DMN-H6) as monomers. The 
monolithic polymer was copolymerized with Grubbs-type initiator 
RuCl2(PCy3)2(CHPh) and a suitable porogenic system within the confines of fused 
silica capillaries of different inner diameters (i.d.). Capillary monoliths of 200 m 
i.d. showed good performance in terms of retention times, with relative standard 
deviations (RSD) of 1.9% for proteins and 2.2% for peptides. However, the 
separately synthesized capillary monoliths revealed pronounced variation in back 
pressure with RSD values of up to 31%. These variations were considerably 
reduced by the cooling of the capillaries during polymerization. Using this 
optimized preparation procedure capillary monoliths of 100 and 50 m i.d. were 
synthesized and the effects of scaling down the column i.d. on the morphology and 
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on the repeatability of the polymerization process were investigated. The 
applicability of ROMP-derived capillary monoliths to a separation problem 
common in medical research was assessed. A 200 m i.d. monolithic column 
demonstrated excellent separation behavior for insulin and various insulin 
analogs, showing equivalent separation performance to Vydac C4 and Zorbax C3-
based stationary phases. Moreover, the high permeability of monoliths enabled 
chromatographic separations at higher flow-rates, leading to shortened analysis 
times. For the analysis of insulin in human biofluid samples, enhanced sensitivity 
was achieved using a 50 µm i.d. ROMP-derived monolith [38]. 
Wieder et al. [39] prepared hydrophobic organosilane-based monolithic 
capillary columns by thermally initiated free radical polymerization within the 
confines of 200 µm i.d. fused silica capillaries. A novel cross-linker, bis(p-
vinylbenzyl)dimethylsilane (BVBDMS), was copolymerized with p-methylstyrene 
(MS) in the presence of 2-propanol and toluene, using ’azoisobutyronitrile 
(AIBN) as initiator. Monolithic capillary columns, differing in the total monomer, 
microporogen content and nature (2-propanol versus toluene, THF or CH2Cl2) 
were fabricated and the chromatographic efficiency of each monolith for the 
separation of proteins, peptides and oligonucleotides, was evaluated. The pressure 
drop versus flow-rate measurements showed the prepared poly(p-methylstyrene-
co- bis(p-vinylbenzyl)dimethylsilane) (MS/BVBDMS) monoliths to be mechanically 
stable and swelling propensity factors of 0.78–1.10 indicated high cross-linking 
homogeneity [39].  
For the separation of peptides with gradient-elution liquid chromatography, 
Pruim et al. [1] prepared a poly(butyl methacrylate-co-ethylene glycol 
dimethacrylate) (BMA-co-EDMA) monolithic capillary column. The conditional 
peak capacity was used as a metric for the performance of this column, which was 
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compared with a capillary column packed with C18-modified silica particles. The 
retention of the peptides was found to be less on the BMA-co-EDMA column than 
on the particulate C18 column. To obtain the same retention in isocratic elution an 
acetonitrile concentration approximately 15% (v/v) lower was used in the mobile 
phase. The retention window in gradient elution was correspondingly smaller with 
the BMA-co-EDMA column. The relationship between peak width and retention 
under gradient conditions was studied in detail. It was found that in shallow 
gradients, with gradient times of 30 min and more, the peak widths of the least 
retained compounds strongly increased with the BMA-co-EDMA column. This was 
attributed to the fact that these compounds were eluted with an unfavorably high 
retention factor. With shallow gradients the peak capacity of the BMA-co-EDMA 
column (≈90) was clearly lower than that of a conventional packed column (≈150). 
On the other hand, with steep gradients, when the components were eluted with a 
low effective retention factor, the performance of the BMA-co-EDMA column was 
relatively good. With a gradient time of 15 min similar peak widths and thus 
similar peak capacities (≈75) were found for the packed and the monolithic 
columns. Two strategies were investigated to obtain higher peak capacities with 
methacrylate monolithic columns. The use of lauryl methacrylate (LMA) instead of 
BMA gave an increase in retention and narrower peaks for early eluted peptides. 
The peak capacity of the LMA column was ≈125 in a 60 min gradient. Another 
approach used a longer BMA-co-EDMA column which resulted in a peak capacity 
of ≈135 in 60 min. 
1.3 Monolithic phases for bioanalysis using HPLC 
The wide variety of applications of silica monolithic phases for HPLC has been 
summarized by Unger et al. [10], including high-throughput analysis of drugs and 
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metabolites [11-15,40], separation of complex biological samples (e.g. biofluid 
samples, proteins and peptides) [16,17,19-21,24,41] and separation of biological 
samples in more complex multi-dimensional HPLC [22,23,25,42]. High-throughput 
bioanalysis in a drug discovery setting has promoted the change from simple 
isocratic elution towards relatively higher flow-rates and fast gradient elution. Fast 
generic methodology with ballistic gradients, high flow-rates and shorter columns 
(typically of length 10-50 mm and internal diameters 2.1-4.6 mm) packed with 3-5 
m silica-based phases were used in early applications of high-throughput LC-
MS/MS assays to dramatically reduce the chromatographic run times in 
bioanalysis and ADME (absorption, distribution, metabolism, and excretion) 
screening [43,44]. Ultra-fast, high-pressure chromatographic LC-MS/MS 
approaches with short columns and sub-2 µm particle sizes have been reported for 
quantitative bioanalysis [45-47]. The corresponding increase in column back 
pressure and smaller sample injection volumes using this approach with biological 
samples can be avoided using flow-porous monolithic columns. Separation using 
an eluent flow-rate gradient can be performed on monolithic columns due to their 
structure and unique hydrodynamic characteristics [48]. The use of monolithic 
silica columns for screening applications and discovery bioanalysis by fast gradient 
LC-MS/MS, is now well established [49-52].  
Monolithic silica and polymer columns have been commercialized by 
Merck (Darmstadt, Germany) and by Dionex (Sunnyvale, USA) under the brand 
names of ChromolithTM (silica) and ProSwiftTM respectively. Several reviews have 
also described the use of a gradient approach for ultra-fast bioanalysis, with run 
times ranging from less than 10 min for certain separations down to 30 s or less for 
more high-throughput applications [53-55]. Tzanavaras and Themelis [56] 
performed high-throughput assay of acyclovir and its major impurity guanine 
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using the ChromolithTM (100 mm x 4.6mm i.d., Merck) column and a flow-gradient 
approach in HPLC system [56]. Papp et al. [52] presented a rapid and sensitive 
method for quantitation of montelukast in sheep plasma using LC-MS/MS. The 
method used a Chromolith RP column (25 mm x 4.6 mm i.d., Merck) with the 
gradient concentration of acetonitrile (30-95% acetonitrile  in 1 min, 95% for the 
next 0.2 min and re-equilibration to 30% over 0.3 min) and a simple one-step 
protein precipitation sample preparation step, which has a limit of quantification of 
0.36 ng/mL. A total run time of 1.5 min was achieved with the precision below 5% 
and an overall relative standard deviation of 8%. In summary, the use of short 
monolithic columns with fast gradient approaches parallels the increased 
prominence of bioanalysis and sample numbers to be analyzed in a drug discovery 
setting. 
Monolithic HPLC has been successfully implemented to improve the 
efficiency and resolution for bioanalytical HPLC assays. In particular, monolithic 
phase HPLC separations have been established for fast reversed-phase gradient 
HPLC, with an initial divert to waste period allowing for more selective separation 
and reduction of ion suppression phenomena with MS detection. A simplified 
work-flow for this type of assay is indicated in Figure 1-1. This very fast gradient 
HPLC system allows direct analysis of biological samples that have undergone 
minimal sample pre-treatment (e.g. protein precipitation using acetonitrile). The 
initial divert to waste period reduces the introduction of polar components, non-
volatile salts, soluble proteins and other endogenous material to the MS. 
Employment of a fast gradient achieves some separation of the analytes from the 
remaining endogenous material and gives sharper eluting peaks. Therefore, these 
fast gradient systems generally exhibit reduced ionization suppression effects as 
compared to those previously employed using isocratic HPLC conditions (with a  
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Figure 1-1: Typical assay work-flow for a small molecule drug in plasma in an on-line configuration using a monolithic 
HPLC column. 
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high percentage organic mobile phase composition) [52]. The fast gradient systems 
are simple to set up, requiring only a binary HPLC pump and a single switching 
valve. A schematic diagram for this type of set-up is indicated in Figure 1-2. 
Miniaturization of these HPLC column separations has recently been developed, 
giving MS sensitivity as well as solvent and sample consumption advantages, and 
narrow-bore and capillary columns are being employed routinely in bioanalytical 
laboratories. 
 Miniaturization based on decreasing the i.d. of the chromatographic column 
has driven the development of HPLC column formats from narrow-bore (2.1 mm < 
i.d. < 4 mm) to nano-bore (25 m < i.d. < 100 m) or even smaller columns (open 
tubular liquid chromatography < 25 m) for nano analysis of biological molecules. 
Four factors have promoted the trend to develop smaller LC columns. The recent 
developments in capillary-LC have been aimed to enhance the separation 
efficiency characteristics of capillary techniques, particularly where many analytes 
need to be separated. The second factor is the overwhelming growth of LC-MS/MS 
in drug discovery and development; this has in turn spurred the need to interface 
the MS source more optimally with the column flow-rates to yield more efficient 
ionization and sensitivity. The third factor is the requirement of capillary-LC 
columns to analyze smaller-sized bioanalytical samples with less mobile phase 
consumption. Finally, the development of the chromatographic hardware, in 
particular, pumps capable of reproducibly delivering flow-rates in the nL/min, has 
greatly enhanced the practical implementation of miniaturized systems.
 Monolithic capillary columns were initially developed for capillary 
electrochromatography (CEC) and stimulated the introduction of this format for 
HPLC separations [57]. Capillary-HPLC monolithic columns provide an alternative 
approach to conventional phases in the analyses of protein molecules, because of  
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Figure 1-2: Diagram showing the divert valve set-up for a monolithic gradient 
HPLC system, for direct injection of biofluids (e.g. protein precipitated plasma 
or diluted urine). Position A is held in high aqueous conditions with the HPLC 
eluent being directed to waste, thereby removing polar interferences and non-
volatile salts. After this hold period the valve is switched to position B to direct 
the eluent into the mass spectrometer and a fast gradient is performed to elute 
the analytes. This process is fully automated and is able to eliminate the need 
for a separate SPE procedure.          
 
 
 
Chapter 1 
19 
 
one-step fabrication process and faster analysis times [58]. Most of the publications to 
date have focused on the synthesis and characterization of monolithic materials for 
capillary- or nano-LC with internal diameters of approximately 25-320 m [58-
64]. Urban and Jandera [26] reviewed the syntheticpolymethacrylate-based 
monoliths in capillary-LC and their applications. Numerous highly important 
applications of micro-LC are in the field of analyses of low- and high-molecular 
weight biologically active solutes, typically for protein and peptides [64-66]. 
Zhang et al. [67] recently developed a LC-MS platform, known as the extended 
range proteomic analysis (ERPA) for comprehensive protein characterization at 
ultra-trace level. Large peptides with or without post-translational modifications 
were finely separated with high resolution using nano-bore (20 and 50 m i.d.) 
polystyrene divinylbenzene (PS-DVB) monolithic columns. High sequence 
coverage (>95%) analysis for -casein and epidermal growth factor receptor at 
low-molecular levels were achieved using the nano-bore polymer monolithic 
column. This methodology has immense potential for the characterization of 
biologically important proteins at trace level and the facilitation of biomarker 
discovery [61]. The living functionalities of monoliths that allow grafting of 
surfaces with functional polymer chains open up a new approach to capillary 
column technologies and chemistries [57]. However, there are relatively few 
publications that focus on the synthesis and fabrication of polymer monoliths for 
the bioanalysis of small molecules using nano-bore HPLC columns. 
Most monolithic columns are shorter in lengths, so as to achieve faster 
separation and to ensure the consistency of the monolithic morphology throughout 
the column. Hosoya et al. [68] prepared novel wired chip devices for -HPLC 
analyses where the monolithic capillary column is 95 cm length. The latter was 
prepared using a tri-functional epoxy monomer, tris(2,3-epoxypropyl)isocyanurate 
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with a diamine, 4-[(4-aminocyclohexyl) methyl] cyclohexylamine. The prepared 
column was evaluated by observing the sectional structure of the column with a 
scanning electron microscope and also by -HPLC. The repeatability in the 
preparation of the long capillary columns was extensively examined for 
applications of novel wired chip devices. Furthermore, the wired chip device 
column showed that its high performance was maintained even after chip 
preparation [68]. 
1.4 Monoliths for sample preparation using solid phase extraction 
Solid phase extraction (SPE) has become one of the most popular sample 
preparation strategies for the extraction and pre-concentration of small-molecule 
drugs in biological samples [69,70]. SPE can offer the benefits of a selective clean-
up, lower detection limits, high accuracy and precision, amenability to 
automation and also extended column lifetimes [71]. SPE also offers a large 
choice of sorbent phases and formats, allowing flexibility with respect to assay 
development, miniaturization and sample throughput. 
SPE sorbents are commonly based on chemically bonded phases of silica, 
cross-linked polymers or graphitized carbon, with bonded silica-based materials 
especially dominating the field [72,73]. Particles of the SPE phase can be packed in 
a cartridge, micro-plate or column [73]. However, there are some inherent 
limitations of silica-based materials, which include the presence of polar silanol 
groups, low surface area and narrow pH stability range. Furthermore, an intrinsic 
problem of all particulate media is their inability to completely fill the available 
space, with flow-channeling between particles leading to reduced extraction 
efficiencies and adverse flow characteristics [71,74]. This has led to the 
development of alternative SPE formats, such as disk type materials with 
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embedded small sorbent particles [74] or micro-sized disks with bonded phases 
[75]. By using the disk approach, better extraction recovery can be obtained due to 
the superior flow control between samples [71,74,76]. The extraction disks used for 
SPE are normally prepared by punching from larger sheets of material, but the 
limitation of this approach is that it often results in low sample loading capacity 
[77].  
In situ preparation of SPE materials with larger surface area and capacity 
can be easily achieved with the use of monolithic materials [15,74]. The unique 
properties of monoliths, in particular their high permeability for liquid biological 
samples, operation at high flow-rates without loss of efficiency [78,79], low cost, 
pH stability and ease of preparation, as well as adjustable shape, porosity and 
selectivity, allow them to meet the requirements of modern miniaturized SPE 
materials designed specifically for automated  operation [7,71].  
Many different options exist for the off-line and on-line coupling of SPE to 
HPLC. The most common approach is the off-line configuration, although it can be 
a time-consuming process to set up this methodology in an automated fashion, 
unless specific robotic interfaces are used. In addition, technical difficulties may 
arise when dealing with smaller sample volumes, and pre-concentration methods 
and complex elution protocols are also often required. In on-line approaches [80-
82], the sample preparation step is embedded into the chromatographic system 
and manual intervention is minimized, thereby increasing efficiency and sample 
throughput [83]. Both silica- and polymer-based monolithic sorbents have 
significant advantages over packed particles for SPE and hence monolithic phases 
are becoming more popular as sorbent materials for SPE. Several reviews have 
addressed the applications of silica- and polymer-based monoliths for bioanalytical 
sample preparation [27,45,74,83].  
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1.4.1 Off-line sample preparation by SPE 
Off-line SPE can be optimized independently from the ensuing HPLC separation 
and can be easily automated [84]. For this reason, off-line SPE has been 
frequently performed using a range of commercial disposable cartridges or disks 
[69,85]. SPE techniques in 96-well format are widely adopted in automated 
higher throughput quantitative bioanalysis and hence are also well-suited for 
LC-MS/MS applications [85,86]. The associated liquid transfer steps, including 
preparation of calibration standards and quality control samples as well as the 
addition of the internal standard are usually performed using robotic liquid 
handling systems [83,87]. The principles and application details of automated 96-
well SPE have been documented in a number of publications [88,89], and a 
simplified work-flow for this type of assay is shown in Figure 1-3. In addition, 
several related small volume 96- and 384-well SPE devices have been described 
and these provide the benefits of lower solvent requirements, minimal 
desorption volumes and decreased void volume [84,90-92]. Combinations of a 
number of techniques (e.g. protein precipitation followed by SPE) and more 
intricate extraction protocols have also been developed to achieve high purity of 
the sample extract as well as high sample throughput [93]. 
Monolithic materials have recently been introduced in the field of SPE and 
have potentially great impact in some bioanalytical applications [82]. SPE using 
monolithic silica gel cast into a pipette tip was reported by Miyazaki et al. [94] for 
the purification of biological samples. The surface of monolithic silica can be 
chemically modified readily to provide selective extraction of analytes with 
specific characteristics (e.g. hydrophilic, hydrophobic, phosphorylated form, etc.)  
Polymer monoliths in SPE can be prepared in situ in a wide range of formats, 
including capillary, micropipette tips, and microfluidic channels and can offer
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Figure 1-3: Typical assay work-flow for a small molecule drug in plasma in an off-line configuration with automated 
SPE. 
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exciting possibilities for micro-SPE [18,29,84,94]. Using this approach a wide 
range of surface functionalities can be accessed either through co-polymerization 
of suitable functional monomers, simple direct chemical modification of the base 
polymer or by photografting [95] or coating a suitable monolithic scaffold with 
functionalized nanoparticles [96,97]. The approach of coating with nanoparticles 
is particularly attractive as suitable nanoparticles can be synthesized with almost 
any functionality, including ion-exchange, affinity, chiral, mixed-mode, restricted 
access, hydrophobic and hydrophilic, and the same scaffold can be used for a 
wide range of nanoparticles with different chemistries. 
There are numerous reports describing off-line SPE using polymer 
monoliths, with subsequent coupling to HPLC for bioanalysis [98-101]. Altun et 
al. and Abdel-Rehim et al. [18,102-104] introduced a sample preparation 
technique using a set of polypropylene tips containing a plug of an in situ 
polymerized methacrylate-based monolithic sorbent for use with 96-well plates. 
These sorbents have been used successfully for the extraction and quantification 
of -blockers [104] and anaesthetics [103] from human plasma by LC-MS/MS. 
This novel design permitted 96 samples be extracted in approximately 2 min, 
with only microlitre volumes of solvent being required for elution. In addition, 
the unique properties of monolithic materials facilitate a low pressure drop, thus, 
reducing the risk of blockages due to plasma samples even at higher flow rates. 
Moreover, they also provide high analyte binding efficiency and yield good 
recoveries as a result.  
This approach can be further extended to include immobilized enzymes 
for sample digestion. Ota et al. [105] described a novel silica monolith within a 
pipette tip, where trypsin was successfully immobilized via an aminopropyl 
group. The trypsin-immobilized monolith was used for rapid digestion of 
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reduced and alkylated proteins with only minimal manual operations prior to 
chromatographic analysis, and was evaluated for high-throughput trypsin 
proteolysis of bio-substances in proteomics [105]. 
1.4.2 On-line sample preparation SPE 
In an HPLC system for bioanalytical applications, monolithic columns can serve 
either as an on-line extraction cartridge or analytical column, or combinations of 
this in a column switching or multi-dimensional set-up. Performing the SPE 
process as part of the HPLC system has recently gained popularity as an 
automated bioanalytical technique. The major advantage of this approach is that 
it can incorporate the sample preparation, analyte enrichment, HPLC separation 
and MS detection steps into a single system. In-line SPE is based on direct 
injection of crude biological samples, with little pre-treatment (e.g. dilution with 
internal standard), onto an LC-MS/MS system that incorporates switching valves 
and multi-column configurations [85]. In its simplest form, bioanalysis using 
column switching methods involves two columns, the first being used for sample 
clean up (SPE) and the second for chromatographic separation [45]. Various 
column dimensions can be configured for the fast analysis of drugs and their 
metabolites in biological matrices at the ng/mL level or lower. There are minimal 
sample preparation steps required; except for sample aliquoting, internal 
standard addition and centrifugation [106,107]. These on-line SPE systems can 
also be used in 96-well plate format in conjunction with a robotic liquid handling 
system to provide complete automation. The pre-treated samples are then 
injected directly onto the LC-MS/MS system auto-samplers with temperature 
control capability to prevent evaporation and sample instability issues [107]. This 
can provide a more environmental friendly analytical method which reduces the 
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operator’s exposure to hazardous solvents, aerosols and toxins from the samples 
and sample preparation process [108].  
Several generic approaches have recently been developed for on-line 
sample extraction coupled to LC-MS/MS [109]. These extraction phases include 
restricted access media (RAM) [110,111], large-size particle disposable cartridges 
and monolithic phases [88]. Zang et al. [82] described a novel on-line SPE 
approach integrated with a monolithic HPLC column and triple quadrupole 
tandem mass spectrometry for direct plasma analysis to simultaneously monitor 
an eight-analyte test mixture in plasma. A simple column-switching 
configuration that required only one six-port switching valve and one HPLC 
pumping system allowed both isocratic and gradient separations for on-line SPE 
LC-MS/MS. By using the monolithic column, the total analysis time was 
significantly shortened while high chromatographic separation efficiency was 
still maintained. This method provided the benefits of minimum sample 
preparation, simplified hardware configuration, increased sample throughput, 
efficient chromatographic capability, and a robust bioanalytical LC-MS/MS 
system. 
An alternative on-line sample preparation based on turbulent flow 
chromatography (TFC) has been well-documented in recent years. A unique 
characteristic of this on-line sample preparation approach is the use of narrow-bore 
LC column (typically 1 mm x 50 mm) packed with large irregular shaped particles 
(typically 30-50 m) as the stationary phase and relatively high flow-rates. The 
large particles permit the use of extremely high linear velocities in the ranges of 3-5 
mL/min. The combination of the high flow-rate and large particle sizes promotes 
the rapid passage of the large biomolecules of the biological sample matrix with 
the simultaneous retention of the small-molecule analytes of interest. This setup 
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facilitates the sample extraction procedure without significant increases in column 
pressure or blockages. Monolithic phases have been successfully employed in TFC 
using high-flow on-line extraction. For example, Xu et al. described the use of a 
short monolithic silica column for the bioanalysis of plasma and urine [112,113]. 
The performance of this extraction method was compared with that of an 
automated liquid-liquid procedure; with both of the methods being found to give 
similar performance.  
Commercially available automated SPE systems, such as Symbiosis™, offer 
the advantages of both off-line and on-line SPE. These SPE systems have 
disposable cartridges contained in a 96-cartridge cassette and the use of  multiple 
cartridge trays permits more than 1000 samples to be run [81]. The Symbiosis™ 
system was described by Alnouti et al. [81] using both conventional C18 and 
monolithic columns (ChromolithTM) for high-throughput direct analysis of 
pharmaceutical compounds in plasma. The combination of on-line SPE with 
monolithic columns enabled the development of high-throughput methods with 2 
min total analysis time without compromising the data quality. Alternatively, these 
systems can also be operated in an off-line mode either for method development or 
routine SPE where the final elution sample is not compatible with the LC set-up 
(i.e. the requirement for evaporation, buffer reconstitution followed by 
chromatographic analysis). A multi-dimensional SPE mode allows the use of two 
different extraction mechanisms on two separate cartridges in one sample run, 
resulting in a more selective sample clean-up. 
1.5 Conclusions and future possibilities 
Monolithic materials provide both well-documented advantages and limitations. 
Future bioanalytical interest in these materials could lie in further adaptations of 
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the surface chemistry to select the right phases for isolation of specific analytes for 
SPE, or to improve separations in HPLC. Once the phases are optimized for a 
particular assay, other formats and scalability could be tested, with a view to 
achieving miniaturize and high-throughput analyses. Pipette tip based formats 
offer some exciting possibilities, especially when multi-purpose devices are used. 
For example, enzyme digestion and selective SPE can be combined into a single 
pipette tip using sequential layers of specific-purpose monolithic materials. 
Furthermore, mixed mode adsorbents that combine ion-exchange and reversed-
phase characteristics for instance, can also provide some attractive options.  
 The use of electrospray nano-flow interfaces with LC-MS/MS platforms has 
become far more prevalent, particularly in the peptide and biomarker 
quantification arena. Difficulties in constructing suitable small-scale analytical 
columns and preparative on-line clean-up columns have been encountered. The 
latter can comprise specific immunoaffinity extraction columns, which can be 
difficult to setup and integrate into a HPLC system. Most importantly, it can take a 
relatively long time to identify and isolate suitable antibody reagents to prepare 
the column. Small-scale monolithic columns could provide an alternative 
approach, due to their flexibility and ease of preparation. 
 Capillary- and nano- LC formats are attractive both from the mass 
sensitivity and environmental perspective. The trend in bioanalysis is leaning 
strongly in this direction as samples are decreasing in size with the increased usage 
of micro-sampling techniques, such as dried blood spot analysis. In this respect, 
monoliths are likely to find increasing usage in areas such as isolating small 
volumes for micro-sampling, tailored stationary phases and microchip-
based/micro-fabricated formats. 
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1.6 Project aims 
As presented in the literature review, monolithic materials, especially organic 
polymer monoliths have been widely used for the separation and sample pre-
treatment process in bioanalysis. Organic polymer monoliths also possess 
significant potential to be developed in different formats and functionalities, which 
suggests their versatile applicability to all types of bioanalytical problems.  
Taking into consideration the possibilities for future developments in this 
field as identified in the literature review above, this project aims to explore ways 
in which monoliths can be designed for use in high throughput absorption, 
distribution, metabolism and elimination (ADME) assays. The focus in all of this 
work will be on methods to miniaturize this analysis. The specific aims of the 
project are to: 
 Investigate and synthesize of a range of functional polymer monoliths both 
in bulk and in situ within capillaries and characterize the stationary phase 
properties, such as porosity, morphology and ion-exchange functionality. 
 Test the suitability of the monolithic phases and optimize the selective 
separation process of a set of target analytes of importance to ADME assays 
using a capillary LC system. 
 Synthesize the optimized macroporous polymer monoliths in pipette tip 
formats and explore the possibility of using trypsin immobilized enzyme 
polypropylene pipette (IMEPP) tips for high throughput analyses. 
 Characterize and implement the developed IMEPP tips in a real 
bioanalytical setting, i.e. for qualitative and quantitative analysis of target 
proteins in biological matrix. 
 Synthesize these enzyme reactors in a range of different formats for 
different bioanalytical settings. 
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C h a p t e r  2  
Experimental 
This section describes the instrumentation, chemicals and procedures used 
throughout this research, unless otherwise specified in a particular chapter.   
2.1 Instrumentation 
For the preparation of the monolith phases in situ within capillary and pipette tips, 
an OAI deep UV illumination system (Model LS30/5, San Jose, CA, USA) fitted 
with a 500W HgXe-lamp was used for UV exposure. For calibration, the irradiation 
power was adjusted to 20.0 mW/cm2, using an OAI model 206 intensity meter with 
a 260 nm probe head. The Teflon® -coated UV transparent fused-silica capillary (75 
m I.D. x 375 µm O.D.) was obtained from Polymicro Technologies Inc. (Phoenix, 
AZ, USA). Finntip-200 pipette tips consisting of homopolymeric isotactic 
polypropylene (PP) were purchased from Pathtech Pty Ltd (Victoria, Australia). 
Scanning electron microscopy (SEM) was performed on a DSM 962 
scanning electron microscope (Zeiss, LEO) equipped with a DX-4 X-ray detection 
system by EDAX. The SEM provides secondary and backscattered electron 
imaging of biological, geological and other specimens yielding surface information. 
SEM operated in low and high vacuum mode using accelerating voltages of 15, 20 
and 25 kV.  
The HPLC system used throughout this study was a Dionex Corporation 
UltiMate®  3000 capillary LC system featuring an integrated flow-splitter connected 
to a continuously monitored flow meter and control valve, which maintained 
constant flow in the range of 0.1 to 10.0 L/min. It comprised a binary pump, a 
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vacuum degasser, a column thermostat, an autosampler and a photodiode-array 
UV detector. Chromeleon®  Chromatography Management System version 6.80 
was used for the system control, data acquisition and processing. OriginLab 8.0 
software (Northampton, MA, USA) was also used for data analysis and graphing.  
Direct infusion ESI-MS experiments were performed using a quadrupole 
time-of-flight MS, Bruker MicrOTOF-Q MS controlled by a MicrOTOF-Q Control 
software from Bruker Daltonics (Bremen, Germany).  The liquid sample was 
delivered via a KD Scientific (Holliston, MA, USA) syringe pump.  The pump was 
set at 180 µL/hr and an appropriate syringe from Hamilton (Reno, Nevada, USA) 
was employed.  Acquisition time was at least 2 min for each sample using the tune 
wide LC method of the software.  
For LC-MS separations, an Agilent 1200 Series LC system (Santa Clara, CA, 
USA) consisting of a binary pump, a vacuum degasser, an autosampler, a 
thermostatted column (30 °C) (Agilent Technologies, Palo Alto, CA) was coupled 
to a Bruker micrOTOF-Q operating at a resolution of 10000 in the positive ion 
mode. Argon was used as a nebulizing gas (1.5 bar) and nitrogen as a drying gas 
(8.0 L/min, 200 °C). The capillary voltage was set to +4.0 kV. The reversed-phase 
(RP) analytical column was a Dionex Acclaim®  PolarAdvantge C16 (2.1 x 100 mm, 
3 µm) coupled with binary RP solvents comprising (A) water and (B) acetonitrile, 
both containing 0.1% formic acid. The data were collected and handled with the 
Bruker Compass DataAnalysis 4.0 software.  
Multiple reaction monitoring (MRM) transition development and 
optimization were performed on an AB SCIEX Triple Quadrupole™ 5500 mass 
spectrometer (Foster City, CA, USA) coupled to an Agilent 1100 binary HPLC 
pump. An external Valco valve (10 or 6 port valves can be used) in “back flush 
mode” was employed to control the column switching for both the loading and 
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eluting gradient. A CTC PAL autosampler (Zwingen, Switzerland) fitted with a 
250 µL syringe and 250 µL sample loop (for larger volume injection) was employed 
for sample introduction. The system was controlled using Analyst version 1.5.1 
which was also used for data acquisition and processing. An Onyx monolithic RP 
C18 guard column (Torrance, CA, USA) and a Waters Xbidge BEH130 C18 column 
(2.1 x 100 mm, 3.5 µm) (Milford, MA, USA) were used as pre-column and 
analytical column in addition to the RP solvents were (A) 5% acetonitrile/ 95% 
water and (B) 95% acetonitrile/ 5% water, both containing 0.1% formic acid. 
Chromatography was carried out using a fast gradient; following a 2.5 min sample 
loading, peptides were eluted over a 22 min gradient from 0-45% “B”. The column 
was washed with 95% “B” for 1 min and re-equilibrated at initial conditions for 3 
min prior to the next injection.  
2.2 Reagents 
Unless specified otherwise, the chemicals used were of analytical grade and are 
listed in Table 2.1 to 2.6.  
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
40 
 
Table 2.1: Chemicals used as buffers 
Buffer Formula Supplier 
Acetic acid CH3COOH BDH Chemicals 
Formic acid HCOOH Sigma-Aldrich 
Trifluoacetic acid CF3COOH Sigma-Aldrich 
Disodium hydrogen phosphate Na2HPO4 Merck 
Ammonium acetate CH3CO2NH4 Sigma-Aldrich 
Ammonium bicarbonate CH3COONa BDH Chemicals 
Tris(hydroxymethyl)aminomethane 
hydrochloride 
NH2C(CH2OH)3 
· HCl 
Sigma-Aldrich 
Sodium dihydrogen phosphate NaH2PO4 Sigma-Aldrich 
Hydrochloric acid HCl Sigma-Aldrich 
Sodium hydroxide (99.99% and 
99.0%) 
NaOH Sigma-Aldrich 
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Table 2.2: Chemicals used as analytes 
Analyte Formula pKa  Supplier 
Arterenol, 
hydrochloride 
(HO)2C6H3CH(OH)C
H2NH2 · HCl 
8.55 Sigma-Aldrich 
Propranolol 
hydrochloride 
C16H21NO2 · HCl 9.5 Sigma-Aldrich 
Ketoprofen,  C16H14O3 5.94 Sigma-Aldrich 
Diclofenac C14H10Cl2NO2 4 Sigma-Aldrich 
Ibuprofen C13H18O2 4.4 Sigma-Aldrich 
Pindolol C14H20N2O2 9.04 Sigma-Aldrich 
Acebutolol C18H28N2O4 9.2 Sigma-Aldrich 
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Table 2.3:  Chemicals used for methacrylate polymerization 
Chemical Formula Supplier 
-methacryloxypropyl-
trimethoxysilane (-MAPS) 
C10H20O5Si Sigma-Aldrich 
1,4-butanediol HO(CH2)4OH Sigma-Aldrich 
1-propanol CH3(CH2)2OH Sigma-Aldrich 
2,2-dimethoxy-2-
phenylacetophenone 
(DMAP) 
C6H5COC(OCH3)2C6H5 Sigma-Aldrich 
Methanol CH3OH Sigma-Aldrich 
Cyclohexanol C6H12O Merck 
Decanol C10H22O Sigma-Aldrich 
Dodecanol C12H26O Sigma-Aldrich 
Basic alumina activity 
grade I, Type WB-2 
Al2O3 Sigma-Aldrich 
Butyl methacrylate (BMA) H2C=C(CH3)CO2-(CH2)3CH3 Sigma-Aldrich 
3-Sulfopropyl methacrylate 
(SPMA) 
H2C=C(CH3)CO2(CH2)3SO3K Sigma-Aldrich 
Ethylene glycol 
dimethacrylate (EDMA) 
[H2C=C(CH3)CO2CH2]2 Sigma-Aldrich 
Methyl methacrylate CH2=C(CH3)COOCH3 Sigma-Aldrich 
2-Hydroxyethyl 
methacrylate (HEMA) 
H2C=C(CH3)COOCH2CH2OH Sigma-Aldrich 
Azobisisobutyronitrile 
(AIBN) 
(CH3)2C(CN)N=NC(CH3)2CN Sigma-Aldrich 
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Table 2.4:  Protein samples used for studies 
Protein Molecular Weight (Da) Source Supplier 
Trypsin 23800 Bovine 
pancreas 
Sigma-Aldrich 
Melittin 2846.5 Bee venom Sigma-Aldrich 
Calcitonin gene 
related peptide 
3806.3 Rat Sigma-Aldrich 
Cytochrome c 11701.5 Equine heart Sigma-Aldrich 
Myoglobin 16951.4 Equine heart Sigma-Aldrich 
Transferrin 77050 Human Sigma-Aldrich 
Serum albumin 66000 Bovine Sigma-Aldrich 
Polyclonal IgG 150000 Human Sigma-Aldrich 
    
    
 
Table 2.5:  Organic solvents used in this work 
Chemical Formula Supplier 
Acetone (CH3)2CO BDH Chemicals 
Acetonitrile CH3CN Merck 
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Table 2.6: Other chemicals used in this work 
Chemicals Formula Supplier 
Urea NH2CONH2 Sigma-Aldrich 
Guanidine hydrochloride (GdnHCl) CH5N3 · HCl Sigma-Aldrich 
Iodoacetamide (IAA) ICH2CONH2 Sigma-Aldrich 
DL-Dithiothreitol (DTT) HSCH2CH(OH)CH(OH)C
H2SH 
Sigma-Aldrich 
Methoxy polyethylene glycol 550 
methacrylate (PEGMA) 
H2C=C(CH3)CO2(CH2CH
2O)nCH3 
Sartomer 
Tris(2-carboxyethyk)phosphine 
hydrochloride (TCEP) 
C9H15O6P · HCl Sigma-Aldrich 
4,4-Dimethyl-2-vinyl-2-oxazolin-5-
one (VAL) 
C7H9NO2 Tokyo Chemical 
Industry Co. 
Benzophenone (C6H5)2CO Sigma-Aldrich 
Copper(II) sulfate pentahydrate CuSO4.5H2O Sigma-Aldrich 
Potassium chloride KCl Sigma-Aldrich 
Ethanolamine NH2CH2CH2OH Sigma-Aldrich 
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2.3 Procedures 
2.3.1 Buffer and standard preparation  
Buffers, analyte and protein standards were prepared with water purified by a 
Milli-Q water purification apparatus (Millipore, Bedford, MA, U.S.A.). All buffers 
were degassed using vacuum sonication and filtered with a Millex-HA 0.45 μm 
disc filter (Millipore). Monomers were purified prior to use by passage through a 
bed of basic alumina (Brockman activity I, 60-325 mesh), followed by distillation 
under reduced pressure. Distilled monomers were stored at -20 °C in the freezer. 
2.3.2 Sample injection 
For the HPLC separations, samples were injected on to the monolithic column via 
the HPLC autosampler. The capillary HPLC column temperature was maintained 
at 40 °C. The mobile phases A and B consisted of 0.1% TFA in water (v/v) and 0.1% 
TFA in acetonitrile (v/v), respectively. For all samples, the injected volume was 1 
L. Preliminary UV analyses were performed at several different wavelengths for 
each drug sample, so as to select the optimum wavelength for all the drug analytes 
and utilize a single wavelength UV detector optimally. 
For the LC-MS separations, samples were injected on to the column via the 
Agilent 1200 Series autosampler.  
For the Agilent 1100/ AB SCIEX Triple Quadrupole™ 5500 mass 
spectrometer, samples were introduced by CTC PAL auto sampler fitted with a 250 
µL syringe and 250 µL sample loop. 
2.3.3 Surface modification in fused-silica capillaries 
In order to anchor the monolithic structure to the capillary wall by covalent 
bonding, the fused-silica capillaries were surface-modified using the procedure of 
Schaller et al. [1]. The Teflon® -coated UV transparent fused-silica capillaries were 
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rinsed using a Harvard syringe pump (Harvard Apparatus, Holliston, MA, USA) 
and a 250 L gas-tight syringe (Hamilton Company, Reno, NE, USA) with acetone 
and water, activated with 0.2 mol/L NaOH for 30 min, washed with water, then 
with 0.2 mol/L HCl for 20 min, rinsed with water and ethanol. A 20% (w/w) 
solution of -methacryloxypropyl-trimethoxysilane (-MAPS) in 95% ethanol 
adjusted to pH 5 using acetic acid was pumped through the capillaries at a flow-
rate of 15 L/hr for 1 h. The capillary was then washed with acetone and dried with 
a stream of air and left at room temperature for 24 h. 
2.3.4 Synthesis of polymer monoliths in capillaries 
The monomers (butyl methacrylate and sulfopropyl methacrylate), cross-linker 
(ethylene glycol dimethacrylate), porogens (1,4-butanediol and 1-propanol) were 
mixed with the UV initiator 2,2-dimethoxy-2-phenylacetophenone (DMAP) to give 
a clear, organic solvent mixture. This mixture was sonicated for 10 min and 
subsequently degassed with nitrogen for 5-10 min prior to UV-initiated 
polymerization. The overall ratio of monomer to porogen was held constant. Only 
the relative composition of the porogenic solvents was varied to give a controlled 
porous structure. A small portion of polymerization mixture was pumped into a 
fused-silica capillary which had previously been derivatized with -MAPS.  The 
ends of the capillary were plugged with rubber septa. The capillary containing the 
polymerization mixture was irradiated under constant UV irradiation for 10 min 
using the OAI deep UV illumination system described in Section 2.1. The resultant 
monolithic column was flushed with methanol for 5 h at 1200 kPa, followed by 
water using a syringe pump, prior to the HPLC separations.  
2.3.5 Measurement of ion-exchange capacity 
The ion-exchange capacity of the monolithic stationary phases synthesized in situ 
in the capillary was determined by copper adsorption/desorption using the liquid 
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chromatography system (Dionex). The capillary columns were first loaded with 
potassium using 0.2 mM potassium chloride solution. Excess chloride was flushed 
from the column using MilliQ water at a rate of 0.2 μL/min for a period of 30 min. 
The capillary was disconnected from the pump and the system was flushed with 
0.1 mM copper(II) sulfate pentahydrate (CuSO4.5H2O) solution for a period of 30 
min using a flow-rate of 2 µL/min. The capillary column was reconnected to the 
system and 0.1 mM copper solution was pumped through the capillary at a rate of 
0.2 µL/min. The absorbance of the eluent was monitored at 235 nm until 
breakthrough was observed and the absorbance reached a stable value. The 
process was further repeated twice. 
2.3.6 Porosimetry 
Porosimetry measurements were performed by mercury intrusion (Micrometrics 
Pore Sizer 9310, Norcross, Georgia, USA), using a 3 cc glass penetrometer designed 
for powder analysis. Characterization measurements were conducted on 0.1 g of 
polymer material placed into the penetrometer head, before securely fastening the 
lid with a nut and screw cap. Pressure measurements were made from levels 
between 0.5 psi and 30,000 psi (2,000 bars), yielding pore size distributions in the 
range of 0.003 to 360 µm.  
2.3.7 Surface modification in polypropylene pipette tips 
Finntip pipette tips (Finntip-200) consisting of homopolymeric isotactic 
polypropylene (PP) [3] were used in this study. The surface modification in pipette 
tip was done by using both single- and two-step photografting according to the 
procedure described previously [3] (Figure 2-1). The photoinitiator benzophenone 
was used to generate radicals at the surface of PP by hydrogen abstraction (Figure 
2-1). For single-step photografting, a stock solution containing methyl methacrylate 
(MMA) (0.485 g) and ethylene glycol dimethacrylate (EDMA) (0.485 g) with a ratio 
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Figure 2-1: Schematic diagram of the single- and two-step photografting procedures. 
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(1:1) (% w/w) was prepared. From this stock solution, a modification mixture 
containing MMA:EDMA:BP (benzophenone) (3% w/w) (0.03 g) was prepared. 
Before use, the stock solution was vortexed and purged with nitrogen for 10 min to 
remove oxygen. The Finntip pipette tips were then filled with 60 µL modification 
mixture and sealed with parafilm [Figure 2-2 (a)]. The filled pipette tips (with 
tapered end sealed with parafilm) were irradiated on both sides of the tips under 
UV light for 12 min (or 10.5 min if EDA was used). Once the reaction was 
complete, the pipette tip was washed with methanol and acetone, before drying in 
a vacuum oven at room temperature for 10 min. For the two-step surface 
modification procedure, BP was first grafted to the surface of PP tips by filling the 
tips with 3% (w/w) BP solution in methanol and sealed with parafilm. The filled tip 
was irradiated under UV for 12 min. After photgrafting BP, the tip was rinsed with 
methanol and dried. Next, the tip was filled with the monomer mixture (MMA and 
EDMA) and irradiated under UV. Upon completion of the reaction, the pipette tip 
was washed with methanol and acetone, and was then dried in a vacuum oven at 
room temperature for 10 min.   
Polypropylene tip Surface modification mixture:
(1:1  methyl methacrylate: ethylene 
glycol dimethacrylate + 3% 
benzophenone)
Free 
double 
bonds
UV
(a) (b)
 
Figure 2-2: Schematic diagram of the photoinduced surface modification and 
preparation of a monolith in an empty pipette tip. (a) Tip is filled with a BP 
solution in methacrylate and irradiated with UV source; (b) a grafted 
compatibilizing polymer layer containing free double bond is created at the 
surface.  
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2.3.8 Preparation of porous polymer monoliths in PP tips 
A polymerization mixture consisting of 16% (w/w) BMA, 24% (w/w) EDMA, 12% 
(w/w) 1,4-butanediol, 42% (w/w) 1-propanol  and 1% (w/w) DMAP (with respect to 
monomers) was prepared and purged with nitrogen for 10 min. The surface-
modified pipette tip was filled with 20 µL of the homogenous polymerization 
mixture, and irradiated using an OAI deep UV illumination system. The 
polymerization was allowed to proceed first for 40 min with the sharp end of the 
tip down, and then for 25 min with the sharp end up (Figure 2-3), resulting in a 1 
cm monolith support in situ polypropylene pipette tip. After photopolymerization, 
the pipette tip with polymer monolith was then washed with methanol for 1 h 
using the vacuum filtration apparatus (Figure 2-4), to allow the solvents to flow 
through the porous monolith. The pore size of the monolith was ~ 2.8 µm, as 
measured by mercury intrusion porosimetry [4]. 
2.3.9 Digestion protocol for immobilized enzyme polypropylene 
pipette (IMEPP) tip and MonoTip® Trypsin 
The pipetting procedure of the IMEPP tip was done by attaching silicone tube to a 
curved tip syringe (Monojet 412, Figure 2-5). The IMEPP tip was equilibrated by 
aspirating and dispensing the digestion buffer for 10 cycles. The protein sample 
solution was heated in a dry bath incubator at 37 C prior to the digestion by 
IMEPP tip. Then, protein sample was aspirated and dispensed (20 cycles). The 
pipette tip was removed from the syringe and soaked with the sample solution for 
30 min. The tip was removed and reconnected to the syringe to dispense the 
remaining digestion solution at the tip end. After the digestion procedure was 
complete, the solution with peptides was protonated by adding formic acid in 
order to achieve a final concentration of 0.1%. The same digestion procedure was 
used for the MonoTip®  Trypsin except that an autopipette was used instead of the
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Figure 2-3: Schematic diagram showing in situ preparation of polymer monoliths in polypropylene pipette tip. 
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Figure 2-4: A vacuum filtration apparatus was assembled using a filter flask with 
a side arm which permits making a connection to vacuum pump. The top 
opening of the suction flask accommodates a two-hole rubber stopper which in 
turn supports a glass tube specifically used for suction operation for pipette tips. 
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Figure 2-5: Silicone tube attached to curve syringe (Monojet 412) for pipetting 
IMEPP tip. 
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curved tip syringe. 
2.3.10 Scanning electron microscopy 
The monolithic capillary was cut into 1 cm fragments that were mounted 
perpendicularly to a 12 mm pin-type aluminium stub using epoxy resin.  High-
resolution images were obtained by coating the capillary with gold or platinum 
(nominally 40 nm thick). In order to take cross-sectional SEM images of the pipette 
tips, samples approximately 3 mm in length were cut from the tip with a razor 
blade and mounted on an aluminum stub. This was coated with a thin layer of 
platinum using an EIKO IB5 high-resolution platinum coater. 
2.4 Calculations 
2.4.1 Permeability based on Darcy’s Law 
The flow of solution through a porous medium is directly proportional to the 
pressure drop over a given distance. Using this relationship, the permeability B0, 
which represents the resistance to mobile phase flow through the monolithic 
column can be calculated by pumping five different solvents through the column 
at different linear flow-rates according to [4] where B0 is the column permeability, υ 
is the linear velocity (m/min), L is the column length (m), η is the dynamic solvent 
viscosity (Pa·s) and ΔP is the column back pressure (Pa). 


L
B0                                                       
2.4.2 Retention factors 
Retention factors were calculated using the following expression:  
0
0
t
tt
k R

  
Chapter 2 
 
55 
 
where Rt  is the elution time of the analyte and 0t  the elution time of the flow 
marker.   
2.4.3 Sequence coverage 
Sequence coverages were calculated using the following expression: 
%100
2
1
.. 
P
P
CS  
where P1 is the number of peptides identified, P2 is the expected number of 
peptides after protein digestion. Sequence coverages of over 80% are very useful 
and important for proteomic studies.    
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C h a p t e r  3  
Mixed-Mode Porous Polymer Monoliths for 
Separation of Small Molecule Pharmaceuticals 
3.1 Introduction 
The increasing cost of drug discovery and development places a significant burden 
on the drug candidate evaluation process. It has been estimated that discovering 
and bringing one new drug to the market takes an average of 14 years of research 
and clinical development efforts, and costs around 2 billion US dollars. Of ten 
thousand or more drugs tested in early drug discovery, only one may eventually 
lead to a drug available to the market. Therefore, high-throughput adsorption, 
distribution, metabolism and excretion (ADME) assays for compound drug 
development properties are extremely important in this process [1].  
In recent years, monolithic supports as stationary phases in HPLC have 
gained significant interest in pharmaceutical analysis, in particular for small 
molecules as well as protein and peptide separations in gradient and isocratic 
modes [2-4]. The most prevalent hyphenated techniques, liquid chromatography 
coupled to tandem mass spectrometry, have become critical tools in 
pharmacokinetics and metabolism studies at various drug development stages [5]. 
Tandem mass spectrometry based methods provide unique analytical sensitivity, 
selectivity and speed for monitoring one specific target compound in biological 
samples. This has reduced the need for high resolution power in LC analysis. 
Despite only acceptable resolution being required in the sample analysis, certain 
sample preparation steps are needed to remove endogenous interference species 
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from the matrix prior to the HPLC-MS/MS assay for small molecules. This 
prevents the HPLC column from clogging in reversed-phase (RP) chromatography 
and to avoid ion source contamination in the mass spectrometer [5].  In addition, 
the use of capillary columns with a nanospray interface gives better compatibility 
and sensitivity with mass spectrometry. Other advantages of the capillary column 
format include the small consumption of both sample and solvents and providing 
fast assays and short method development timelines [6]. Therefore, an increasing 
number of researchers are focusing on improving the capacity, selectivity and 
repeatability of columns in miniaturized formats [7-9].  
Monolithic materials can be divided into two main categories, namely silica-
based (inorganic) and rigid polymer (organic) based monoliths. The silica-based 
monoliths can be prepared by a sol-gel method [10] and the rigid polymer-based 
monoliths are generally made by in situ polymerization of monomers, cross-linkers 
and porogens [11]. Polymer-based monoliths have been widely used as matrices 
for sample preparation and separation since being first introduced by Hjerten et al. 
[12] and following further innovations by Svec and Fréchet [13]. Although there 
are some concerns of using polymer-based monoliths for sample preparation, such 
as low surface area and the relatively poor chromatographic performance for small 
molecules [6,14,15], the advantages of these materials clearly outweigh the silica-
based monoliths in terms of the pH stability and a wealth of surface chemistries 
available [14]. Monolithic materials also offer particular advantages for high-
throughput ADME assays due to high permeability (i.e. high flow-rates can be 
used) and excellent column stability [9,16]. 
Mixed-mode strong cation-exchange (SCX) and reversed-phase (RP) 
materials are the most often used modes of chromatography for the extraction and 
separation of different types of compounds of pharmaceutical interest [17]. These 
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approaches have been used for over 80% of the separation of target analytes in 
pharmaceutical analysis [18]. Several approaches have been reported to synthesize 
strong SCX polymer monoliths containing sulfonic acid groups, including 
adsorption [19], post-modification [20], and copolymerization [21]. Recently, 
monolithic columns with mixed-mode of strong anion-exchange (SAX) and 
hydrophilic (HI) or RP interactions have also been reported by several groups 
[20,22,23]. The mixed-mode monolithic columns with SAX interaction were used to 
counter undesirable electrostatic adsorption between positively charged basic 
compounds and the stationary phases [24,25]. These columns can be prepared 
using a monolithic matrix containing active groups followed by their 
functionalization with versatile surface chemistries [20,26]. However, the post-
functionalization strategy with multiple steps can be time-consuming and precise 
control over the number of ionizable functionalities can be difficult to achieve. An 
alternative approach to obtain ion-exchange functionality monolithic columns is 
the direct incorporation of ion-exchange functional monomers into continuous 
polymer matrices by the co-polymerization of suitable monomers and cross-linkers. 
For example, Lin et al. [22] reported a novel a mixed-mode SAX-HI stationary 
phase for the separation of polar-charged nucleotides and neutral compounds. 
Jiang et al. [17] fabricated a SCX-RP monolithic columns for the separation of basic 
compounds using micro-HPLC. Both works have demonstrated the fast 
preparation procedures of mixed-mode functionality monolithic columns and it is 
easy to control the average concentration of functional groups in the monolith, 
thus, more repeatable and manufacturable. 
Despite the enormous significance for users, only a few studies relating to 
the repeatability and stability of polymer-based monolithic columns are found in 
the literature [9,27]. Geiser et al. [9] used three standard proteins – ribonuclease A, 
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cytochrome c and myglobin to investigate the stability and repeatability of 
poly(BMA-co-EDMA) capillary columns. They found excellent repeatability of 
retention times for the reparation of three proteins as evidenced by percent relative 
standard deviation (%RSD) values of less than 1.5%. The stability of retention times 
was also monitored and no significant shifts in either retention times or 
backpressure were observed after more than 2200 protein separations. Recently, Li 
et al.  [28] reported a highly cross-linked network resulting from single crosslinking 
monomers that improved column-to-column repeatability, better mechanical 
stability and higher surface area of polymeric monoliths [14]. However, this 
polymer monolith prepared by a single monomer does not make it easily possible 
to provide mixed-mode functionality. To date, there are also only a few studies on 
the stability and repeatability of mixed-mode SCX-RP functionalities polymer-
based monolithic columns for capillary LC [17,22]. Further effort is therefore 
needed to develop novel stationary phases with negatively charged and RP 
functionalities for highly efficient separation of polar analytes. In this regard, we 
report on the characterization, repeatability and stability of a mixed-mode SCX-RP 
polymeric monolithic stationary phase prepared by the copolymerization of a 
functional monomer, namely 3-Sulfopropyl methacrylate (SPMA) with BMA and 
EDMA within the confines of 75 µm i.d. fused-silica capillaries. The impact of 
different polymerization parameters (monomer content, porogenic solvent and 
cross-linker) on the porous properties, and hence on the separation selectivity for 
some acidic drugs and -blockers, was studied.   
3.2 Experimental 
The general experimental details are described in Chapter 2.  Detailed conditions 
are elaborated in each of the figure captions. 
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3.2.1 Preparation of porous polymer monoliths in fused-silica 
capillaries 
The surface modification in fused-silica capillaries was done using the procedure of 
Schaller et al. [29]. The short (~10-15 cm in length) surface-modified capillary was 
filled by capillary action with the degassed polymerization mixture consisting of 
monomers, porogens together with 1% (w/w) DMAP (with respect to monomers). 
Several SPMA monoliths that consist of similar composition and percentages of 
monomers but differ in the composition of porogens were prepared (S1-S7), as 
described in Table 3.1. In addition, monoliths (S1M-S3M) consisting of a greater 
amount of cross-linker (EDMA) than the functional monomer (BMA) were 
prepared, as shown in Table 3.2. The short columns filled with the polymerization 
mixture were placed under the light source and irradiated with UV light for 10 min 
at a distance of 30 cm. The unreacted porogens were removed from the short 
monolithic columns by pumping the columns with methanol using a syringe pump 
at a flow-rate of 100 µL/hr for 4 h before being conditioned with water and mobile 
phase, both for 1 h at 30 µL/hr.  
3.2.2 Bulk monolith preparation 
Bulk polymers were prepared using a sandwich container (Figure 3-1) for 
characterization studies. The sandwich container is made of stainless steel and has 
a diameter of 6.35 cm. It consists of two halves; a base with a thickness of 1 cm and 
an upper rim which is 0.45 cm thick. The central part of the base is made of 
polypropylene and there is a shallow cavity which has a diameter of 3.5 cm and a 
depth of 2 mm. For the monolith formation, the polymerization mixture was 
injected into this shallow cavity, and a piece of quartz plate of 4.6 cm in diameter 
and 2 mm in thickness was placed in between the two halves of the container. The 
two halves were fastened together with three screws that are at 120 degrees from  
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Table 3.1: Effect of variation of the percentage of porogenic solvents on the pore 
size of the studied monoliths (S1-S7) prepared from a polymerization mixture 
consisting of 0.4% (w/w) SPMA, 23.6% (w/w) BMA and 16% (w/w) EDMA that 
constitute 40% (w/w) of the polymerization mixture with respect to 60% (w/w) 
porogenic solvents. 
 
Polymer 
 
1,4-butanediol 
[% (w/w)] 
1-propanol 
[% (w/w)] 
Water 
[% (w/w)] 
Pore size 
[µm] 
S1 30 60 10 2.70 
S2 20 70 10 2.20 
S3 10 80 10 0.14 
S0 0 90 10 NA 
S4 90 0 10 NA 
S5 80 10 10 NA 
S6 70 20 10 1.06 
S7 60 30 10 1.36 
 
NA – Polymer does not form for measurement. 
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Table 3.2: Effect of variation of the percentage of porogenic solvents and alcohol 
chain length on the pore size of the studied monoliths (SMeth-SL) prepared 
from a polymerization mixture consisting of 0.4% (w/w) SPMA, 23.6% (w/w) 
BMA and 16% (w/w) EDMA that constitute 40% (w/w) of the polymerization 
mixture with respect to 60% (w/w) porogenic solvents (percentage shown in 
table). 
 
Polymer* 
 
1,4-butanediol 
[% (w/w)] 
Alcohol 
[% (w/w)] 
Water 
[% (w/w)] 
Pore size 
[µm] 
S1Meth 30 60 10 1.23 
S2Meth 20 70 10 1.68 
S3Meth 10 80 10 2.24 
S1C 30 60 10 1.71 
S2C 20 70 10 0.97 
S3C 10 80 10 0.07 
S1D 30 60 10 1.90 
S2D 20 70 10 NA 
S3D 10 80 10 NA 
S1L 30 60 10 2.07 
S2L 20 70 10 NA 
S3L 10 80 10 NA 
 
NA – Polymer does not form for measurement. 
*Meth: methanol (C1) 
C: cyclohexanol (C6) 
D: decanol (C10) 
L: dodecanol (C12) 
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one another. The polymerization mixture was inserted via a syringe fitted with a 25 
gauge syringe needle in the sandwich container. With the solution in place and the 
two halves of the sandwich container secured, the container was then irradiated 
under UV for 20 min. For characterization of the porous properties, the polymer 
material was removed from the sandwich container and the material was extracted 
with methanol using Soxhlet apparatus for 12 h, before being vacuum-dried at 60 
°C for a further 12 h. These materials were later used for the determination of pore 
size distribution and pore volume. 
3.2.3 Standard solutions and sample preparation 
Drug samples arterenol, propranolol and ketoprofen, diclofenac and ibuprofen 
were prepared in water and methanol at 1 mg/mL. All were further diluted or 
multicomponent standard mixtures of samples were made using ultra-pure water 
from the Milli-Q Element system (Millipore, Billerica, MA, USA). 
 
 
    
 
Figure 3-1: Sandwich container used for bulk monolith preparation.  
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3.3 Results and discussion 
3.3.1 Preparation of polymer monoliths 
Several prerequisites should be met when designing a macroporous monolithic 
polymer for use in separation media and solid-phase extraction (SPE). Among 
these, material surface chemistry, porosity, pore size distribution and rigidity 
constitute the core of the monolith formation strategy [14]. In the monolithic 
systems studied here, the first two variables depended on the type of monomers 
used. SPMA was used as a functional monomer for its strong cation-exchange 
properties, EDMA was used as a crosslinking monomer and BMA monomer was 
used as a functional monomer with RP properties. Since the other variables are 
closely related to the porous structure of the monolith, these depend on the pore-
forming solvent (porogens). Consequently, the number of variables that were 
used for the control of porous properties in this system was limited to: a) the 
ratio of monomers to pore-forming solvents in the polymerization mixture, b) the 
percentage of different solvents in the pore-forming mixture and c) the ratio of 
cross-linker to functional monomers in the polymerization mixture.  
SPMA-based monolithic fused-silica capillary columns with 75 µm 
internal diameter and varying pore properties were prepared in situ by a UV-
initiated free-radical copolymerization reaction. The mixed-phase monomers 
consisted of sulfopropyl methacrylate SPMA [0.4% (w/w)], butyl methacrylate 
BMA [23.6% (w/w)] and ethylene dimethacrylate EDMA [16% (w/w)], with 1,4-
butanediol, 1-propanol and water as porogenic solvents, and 2,2-dimethoxy-2-
phenylacetophenone (DMAP) as the photo initiator. As the porosity of 
monolithic phases can be varied by making minor alterations to the composition 
of the polymerization mixture, the total monomer concentration in the prepared 
phases was kept constant at 40% (w/w) with respect to the total porogen solvents 
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consisting of 1,4-butandiol, 1-propanol and water at 60% (w/w). Thus, only the 
percentage of solvents in the total porogenic solvent composition, the percentage 
of cross-linker to functional monomers, and their effects on the pore size and 
separation of different compounds were studied. For comparison purposes, the 
alkyl chain of the alcohol in the porogenic solvent was altered in a separate 
experiment. Thus, either methanol (C1), cyclohexanol (C6), decanol (C10) or 
dodecanol (C12) was used to replace the 1-propanol in the aforementioned 
polymerization mixture. 
Three types of polar porogen mixtures that favor early phase separation of 
the polymer were used for the creation of the porous structures. Thus, 1-propanol, 
1,4-butandiol and water that constituted 60% (w/w) of the polymerization mixture 
were tested. Out of the 60% (w/w) of total porogenic solvents, the amount of water 
[10% (w/w)] was fixed while the ratio of 1,4-butanediol to 1-propanol was 
systematically varied in the total porogen solvents in an attempt to prepare the first 
set of capillaries, namely S1 to S7 with different properties (Table 3.1). 
Furthermore, the effect of alkyl chain length in the alcohol porogenic solvent 
mixture on the pore size and separation of the investigated drugs was studied. 
Thus, 1-propanol was replaced with methanol (S1meth-S3Meth), cyclohexanol 
(S1C-S3C), decanol (S1D-S3D) or dodecanol (S1L-S3L) using similar percentages of 
porogenic solvents as reported above (Table 3.2). 
3.3.2 Characterization of SPMA-based polymer monoliths 
3.3.2.1 Mercury intrusion porosimetry  
Monoliths prepared in situ in capillaries do not have sufficient bulk for 
porosimetry measurements. Therefore, polymerization was carried out in a 
sandwich device of larger volume to obtain sufficient amount of monolithic 
polymer so that the mercury intrusion porosimetry measurements on bulk 
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material can be representative of the porous properties [30]. This technique 
revealed the median pore diameters from all the prepared monoliths, with the 
value of the median pore diameter being 2.70 µm and 2.20 µm for S1 and S2, 
respectively. The porogenic solvent composition of S1 and S2 consisted of 1,4-
butandiol, 1-propanol and water, in the ratios of 30:60:10  and 20:70:10 (% 
w/w/w), respectively. On the other hand, the pore diameters of S3, S6 and S7 
were 0.14 µm, 1.06 µm and 1.36 µm, respectively, and their corresponding 
porogenic solvent composition ratios were 10:80:10; 70:20:10; and 60:30:10 (% 
w/w/w), respectively (Table 3.1).  
For S1 and S2, early phase separation was achieved and larger pore size 
was obtained. However, the relatively smaller pore sizes of S3, S6 and S7 were 
probably due to the simultaneous decrease in solubility of both the monomers 
and the polymers in the system which contained a certain percentage of 
porogenic solvents. When the amount of 10% (w/w) 1,4-butanediol in 
combination with 80% (w/w) 1-propanol was used as in S3, 70:20 [1,4-
butanediol:1-propanol, % (w/w)] as in S6, or 60:30 [1,4-butanediol:1-propanol, % 
(w/w)] as in S7, the solubility of both monomers and the polymers decreased 
(Table 3.1). The polymer chains remained soluble in the mixture for a longer 
period prior to phase separation due to the absence of contrasting polarity within 
the separated nuclei and also in the surrounding solution. Monomers were not 
compelled to adsorb preferentially into the nuclei and the polymerization 
proceeded with the formation of nuclei that remained individualized. 
Consequently, a larger number of individual nuclei competed for the remaining 
monomers [31], and this led to a large number of small microglobules that 
aggregated to form macroporous structure with fine individual microglobules 
and small pore sizes (e.g. S3, S6 and S7) (Table 3.1). On the contrary, a decrease in 
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the solubility of the polymer formed in a system containing 30% (w/w) 1,4-
butandiol relative to that of 60% (w/w) 1-propanol, as in S1, led to an early phase 
separation. The separated nuclei, swollen with 1,4-butandiol (a more polar 
solvent than 1-propanol) preferentially extract the monomers from the 
surrounding liquid polymerization containing the less polar 1-propanol since the 
monomers favor the more polar environment. The enlarged nuclei could attract 
and coalesce with the newly precipitated chains and further increase their size, 
thus leading to the formation of large microglobules and larger pores. This 
explanation is in agreement with the previously reported pore formation 
mechanism [31]. The homogenous pore size distribution curve of S1, S2 and S3 
measured by mercury intrusion porosimeter is shown in Figure 3-2. Additionally, 
S0, S4 and S5 with 0:90, 90:0 and 80:10 [1,4-butandiol:1-propanol, % (w/w)] and a 
fixed 10% (w/w) water formed an emulsion in the polymerization mixture due to 
poor solubility of monomers (Table 3.1). 
On the other hand, by varying the alkyl chain in the alcohol porogenic 
solvent from 1-propanol (C3) to methanol (C1), cyclohexanol (C6), decanol (C10) or 
dodecanol (C12), an increase in pore size was also observed from 1.23 µm for 
methanol  (S1Meth) to 2.07 µm for dodecanol (S1L) (Table 3.2). In addition, the 
increase of methanol percentage relative to that of 1,4-butandiol in the porogenic 
solvents led to an increase in the pore sizes of the formed monoliths (Figure 3-3 
and Table 3.2). This is in contrast with S1-S3 where the pore sizes decreased when 
increasing the amount of 1-propanol compared to methanol (Tables 3.1 and 3.2, 
Figure 3-3). No monolithic polymer formed for S2decanol, S3decanol, S2dodecanol 
and S3dodecanol due to solubility problems. Based on these results, monoliths 
prepared with different alcohol alkyl chains were not further considered; only 
monoliths prepared with 1-propanol (S1-S3, S6 and S7) were investigated further.  
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Figure 3-2: Pore size distribution curve of S1, S2 and S3 measured by mercury 
intrusion porosimeter. 
 
 
 
Figure 3-3: Relationship between median pore diameter and amount of alcohol 
porogen. 
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3.3.2.2 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) was initially used to study the effect of 
variation of the weight percentage of the porogenic solvent on the morphology of 
the prepared monoliths. This was achieved by comparing polymers prepared in 
bulk and in capillary. Both showed similar SEM images regardless of the method 
of preparation (Figure 3-4).  
The morphology of the prepared monoliths S1, S2, S6 and S7 showed that 
the copolymerized monolith was composed of a heterogeneous surface of spherical 
units agglomerated into larger clusters interdispersed by large-pore channels, a 
characteristic sign of monolithic structures (Figure 3-4). S3 with 10:80 1,4-butandiol 
to 1-propanol [% (w/w)]  and a fixed 10% (w/w) of water was not permeable when 
a mobile phase of 50:50 acetonitrile:water [% (w/w)] was used. It was observed to 
be a more gel-like monolith rather than having macropores such as exhibited by 
the S1, S2, S6 and S7 monoliths (Figure 3-5). 
 
       
(a)                                                                      (b) 
Figure 3-4: SEM images of S1 prepared (a) in situ in capillary and (b) in bulk 
process.   
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Figure 3-5: SEM images of S1, S2, S3, S6 and S7 prepared by in situ polymerization process showing an obvious feature 
of the effect of 1-propanol on the morphology of SPMA-based monolith prepared in capillary column. 
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3.3.3  Chromatographic characterization of SPMA monolithic  
columns 
3.3.3.1 Separation mechanism 
The main interest in this part of the study was the development of new SCX-RP 
functionality polymer-based monolithic columns that could tolerate relatively large 
injection volumes and exhibit adequate separation performance of small molecules.  
The desired material would also have the capability for upscaling for preparative 
chromatography or downscaling for low resolution chromatography (e.g. rapid 
screening) or sample preparation applications. Therefore, 1 µL of sample volume 
was injected for all the chromatographic evaluations. By mixing SPMA (cation-
exchange functional monomer) and BMA (RP functional monomer) the formation 
of a mixed-mode SCX-RP material resulted. 
3.3.3.1.1  Reversed-phase interaction 
Monolithic columns with RP retention mechanisms have been widely used for the 
analysis of various complex samples [32]. The hydrophobicity of the stationary 
phase determines the selectivity of the separation, and RP retention can be easily 
controlled by adjusting either the percentage of the organic modifier in the mobile 
phase or the hydrophobicity of the surface [33]. In order to confirm a RP separation 
mechanism of the prepared mixed-mode monolith, three acidic drugs (i.e. 
diclofenac, ibuprofen and ketoprofen) were chosen as test compounds in the 
capillary LC mode. At low pH, these drugs existed as neutral analytes and were 
separated based on RP interaction. The logarithm of the retention factor of the 
target analytes was plotted against volume percentage of the organic solvent 
(acetonitrile) in the mobile phase. As shown in Figure 3-6, as the volume of organic 
modifier in the mobile phases was increased, the retention for the investigated  
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Figure 3-6: Plot of logarithm of the retention factor of a set of acidic drugs 
versus logarithm of the organic solvent in the mobile phase acetonitrile:water 
with 0.1% trifluoroacetic acid (TFA) separated on S1 monolithic column. 
Capillary 12 cm x 75 µm i.d. Conditions: flow-rate, 2 µL/min; 1 µL injection 
volume; column temp, 40 °C; detection wavelength, 219 nm. 
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analytes decreased.  The linearity of these plots confirms the RP nature of the 
separation mechanism.  
3.3.3.1.2 Cation-exchange interaction and capacity 
The inclusion of SPMA provides cation-exchange sites in the monolith. The ion-
exchange contribution to the separation mechanism was also investigated. Ion-
exchange interactions between the charged analytes and the stationary phase can 
be influenced by the concentration of the competing ions in the mobile phase used. 
A competing ion (NH4+) was chosen and its concentration was altered, with log 
[ammonium] plotted versus log k (retention factor) (Figure 3-7) for the separation 
of a set of -blockers, namely acebutolol, pindolol and propranolol using 
ammonium acetate buffer (pH 7.5) and acetonitrile (65/35, % v/v) with a total NH4+ 
concentration ranging from 5 mM to 30 mM. The results revealed that when the 
concentration of the competing ion increased, the retention of the investigated 
analytes (positively charged under the above mentioned conditions) decreased 
accordingly. This was due to the competition of ammonium ions (+ve) with the 
analytes (+ve) towards the stationary phase (-ve) which resulted in the reduction of 
the ion-exchange interactions of the analytes (β-blockers) with the negatively 
charged stationary phase.  
The ion-exchange capacity of the S1 monolithic column was determined 
by an adsorption/elution method, as described in Chapter 2. The capacity 
determined for a 75 µm i.d. monolithic column was 1.3 pequiv/cm of column, 
corresponding to a total capacity of 15.6 pequiv for a 12 cm column. The 
stationary phases exhibited relatively low cation-exchange capacity due to the 
prepared monoliths having relatively large pores, decreasing the surface-to-
volume ratio, and the degree of negative charge on the polymer was low due to 
the low concentration of SPMA [0.4% (w/w)] used in the polymerization mixture 
[7].  
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Figure 3-7: Plot of the logarithm of the retention factor for a set of β-blockers 
versus the logarithm of the competing ion concentration in the mobile phase (5 
to 30 mM ammonium acetate-acetonitrile 65:35, v/v), pH adjusted to 7.5 with 
ammonium hydroxide, separated on S1 monolithic column [Capillary 12 cm x 75 
um i.d. (capacity ≈1.3 pequiv/cm)]. Conditions: flow-rate, 0.7 µL/min. Other 
conditions are the same as in Figure 3-6. 
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3.3.3.2 Permeability of SPMA monolithic columns 
An important characteristic of a column in LC is its permeability B0, which 
represents the resistance to mobile phase flow through the column. The 
permeabilities B0 for S1 and S2 monoliths were determined by pumping 30:70 
acetonitrile:water (% v/v) through the column at different flow-rates and calculated 
using Darcy’s Law as illustrated in Section 2.4.1. As can be seen in Figures 3-3 and 
3-8, an increase in the size of both flow-through channels and their permeability 
were evidenced along the 1,4-butandiol and 1-propanol variation range. Good 
linearity between backpressure and the flow-rate for S1 and S2 clearly 
demonstrated that the monoliths had sufficient mechanical stability to withstand 
the pressure of the liquid passing through the column up to 3200 psi (Figure 3-8). 
This also indicates that the prepared monolith did not appear to swell or shrink in 
different flow-rates.  
3.3.3.3 Method development and separation performance of SPMA 
monolithic columns 
Compared to the number of reports of the successful separation of large-
molecular-weight compounds using organic polymer monoliths, only a handful 
have been successful for small molecules due to the lower surface areas and 
generally larger pores in polymer monoliths compared to silica-based monoliths. 
The present SCX-RP polymer-based monoliths are very versatile stationary phases. 
With these phases, analytes with hydrophobic moieties could interact with the 
hydrophobic domain of the stationary phase (RP mechanism), while positively 
charged analytes could be retained by electrostatic interactions with the SCX site in 
the acidic to neutral pH range.  
To further characterize the selectivity of the mixed-mode poly(SPMA-co-
BMA-co-EDMA) monolithic columns under  investigation, a set of acidic drugs 
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Figure 3-8: Permeability measurement of different prepared monoliths in 12 cm x 75 µm i.d. capillary using acetonitrile: 
water 30:70 [% (v/v)]. 
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and -blockers with different pKa values, namely diclofenac (pKa = 4), ibuprofen 
(pKa = 4.4), ketoprofen (pKa = 5.94), arterenol (pKa = 8.55) and propranolol (pKa 
= 9.5), were selected as model compounds for capillary HPLC. In terms of finding 
acceptable separation conditions, two parameters were selected to access the 
separation performance and repeatability: (i) the target analytes were separated 
at acceptable resolution (i.e. all target analytes were baseline separated in the 
chromatograms) and (ii) target analytes were separated under isocratic 
conditions. Isocratic elution was preferred for simple samples (i.e. less than 10 
components) where the retention factor of last peak eluted at less than 5 [34].  
A mobile phase composition of 30:70 acetonitrile:water [% (v/v)] 
containing 0.1% (v/v) trifluoroacetic acid (TFA) (pH 2) was selected based on the 
separation mechanism (SCX-RP) of the prepared monoliths and properties of the 
target analytes. Traditionally, TFA is used in the mobile phases for RP-HPLC 
separations to serve one or more of the following functions: (i) pH control, (ii) 
complexation with oppositely charged ionic groups to enhance RP retention (ion 
pairing), (iii) or the suppression of adverse ionic interactions between basic 
analytes and silanol groups on the silica to minimize peak broadening [35]. The 
presence of TFA as a very strong eluting additive might have affected the elution 
of the analytes. However, in a separate experiment, weaker acids, namely formic 
acid and acetic acids, were used as additives [0.1% (w/w)] in the mobile phase 
composition consisting of acetonitrile: water 30:70 (% v/v) for the separation of 
the investigated compounds. The best analytical performance was obtained when 
TFA was used as an additive in the mobile phase composition.  
S1 monolithic column exhibited acceptable separation performance for the 
baseline separation of five pharmaceutical drugs (Figure 3-9). At pH 2 (pH of the 
used mobile phase), these β-blockers were positively charged while the acidic 
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Figure 3-9: Separation of some acidic drugs and β-blockers using SPMA monolithic columns (12 cm x 75 µm i.d.) 
Conditions: flow-rate, 0.5 µL/min; Peaks: 1, Arterenol; 2, ketoprofen; 3, ibuprofen; 4, diclofenac; 5, propranolol. Other 
conditions are the same as in Figure 3-6.  
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drugs were neutral. In terms of properties of the investigated acidic drugs, they 
appeared to be hydrophobic in nature and their hydrophobicity increased from 
ketoprofen, ibuprofen, to the strongly retained diclofenac. In addition, an 
electrostatic attraction between the functional sulfopropyl anion of the monolith 
and the positively charged β-blockers was expected. Therefore, a mixed-mode 
(i.e. SCX-RP) mechanism was involved in the separation of β-blockers. Figure 3-
10 shows a fast separation on the S1 monolithic column using high flow-rate (2 
µL/min) and column temperature (80 °C). The target analytes were eluted within 
10 min without significantly increased backpressure.  On the contrary, S2, S6 and 
S7 showed poor separation of the studied compounds using the above 
mentioned mobile phase composition (Figure 3-9). The surface chemistry, 
concentration of sulfonic acid groups on the polymer surface as well as the size and 
distribution of pores played a key role in affecting the separation performance. 
3.3.3.4 Repeatability of SPMA monolithic columns 
Repeatability is extremely important for a developed monolithic material 
designed for the separation and sample preparation purposes. The repeatability 
of the monolithic columns S1 and S2 was assessed through the %RSD of the 
retention times of the five analytes mentioned above. The repeatability of the 
column preparation process was tested on three levels: (i) intra-batch (run-to-run 
and day-to-day) and (ii) inter-batch (batch-to-batch). The run-to-run and day to 
day reproducibilities of a given monolith were evaluated from ten and six 
injections, respectively, of the test analytes using the same column. Meanwhile, 
the column-to-column repeatability was calculated from results obtained with six 
different columns prepared from different polymerization mixtures with the 
same composition. Acceptable RSD values for intra-batch and inter-batch are 
2.5% and 15%, respectively, as reported in the literature [9,36,37].  
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Figure 3-10: Separation of some acidic drugs and β-blockers using S1 monolithic 
column (12 cm x 75 µm i.d.). Conditions: mobile phase, acetonitrile/water (20:80, 
v/v) with 0.1% TFA (v/v/v); flow-rate, 2 µL/min; column temperature, 80 °C. 
Other conditions same as in Figure 3-6. 
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The observed run-to-run (n=10) and day-to-day (n=6) RSD values of 
arterenol, ketoprofen, ibuprofen, diclofenac and propranolol on S1 and S2 
columns were very low, ranging from 0.5 to 2.14%, except for arterenol which 
was not repeatable on the S2 column (Table 3.3). Additionally, the column-to-
column (n=6) repeatability for the aforementioned analytes on S1 and S2 columns 
exhibited high RSD values, ranging from 28 to 43% (Table 3.3). Although 
columns S1 and S2 exhibited good permeability (i.e. they can withstand up to 
3200 psi), these results clearly confirmed the non-robustness of the prepared 
monolithic columns S1 and S2 as their performance appeared to vary greatly 
based on the RSD values of column-to-column repeatability of the target analytes 
(Table 3.3 and Figure 3-11).  
3.3.4 Effect of cross-linker on the modified SPMA monoliths(SM) 
3.3.4.1 Combined effects of percentage variations of the cross-linker  
and porogenic solvents on modified SPMA monoliths 
The lack of column-to-column repeatability of the S1 and S2 columns was the 
motivation to alter the amount of cross-linker, which was the second variable in 
the studied monolithic system. A higher amount of cross-linker (EDMA) over 
functional monomers (SPMA and BMA) in the fixed polymerization mixture 
[40% (w/w)] monomers with respect to porogenic solvents [60% (w/w)] may 
result in more robust and repeatable monolithic polymers while maintaining the 
SCX-RP interaction properties. It has been reported that a higher cross-linker 
concentration produced monoliths with improved column-to-column 
repeatability and better mechanical stability [28]. Similar effects were observed in 
the investigated system, when further experimentation was done with the same 
overall monomer percentage but the monomer composition percentages being 
switched between the functional monomer BMA and cross-linker EDMA.    
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Table 3.3: Repeatability of prepared SPMA-based monolithic columns S1 and S2 expressed as relative standard 
deviations (%RSD) of retention time (R.T.) for the separation of acidic drugs and -blockers using mobile phase 30:70 
acetonitrile:water with 0.1% TFA. Other conditions are the same as in Figure 3-9. 
 
NA – Analyte was not observed 
 
 
 
 
 
 
Run-to-run (n=10) Day-to-Day (n=6) Column-to-column (n=6) 
Compound 
Analyte 
Conc. 
(mg/L) 
Retention time (R.T.) Retention time (R.T.) Retention time (R.T.) 
Mean %RSD Mean %RSD Mean %RSD 
S1          S2 S1          S2 S1          S2 S1          S2 S1          S2 S1          S2 
Arterenol 3.50 6.76 NA 1.02 NA 6.76 NA 1.39 NA 6.27 NA 17.72 NA 
Ketoprofen 0.70 7.32 7.10 1.05 0.66 7.32 7.14 1.40 1.26 7.24 7.33 43.30 28.14 
Ibuprofen 1.75 8.51 9.83 1.05 0.48 8.52 9.87 1.40 1.54 9.76 9.70 37.49 28.04 
Diclofenac 2.45 9.50 11.51 0.98 0.87 9.50 11.44 1.27 1.25 11.57 NA 38.40 NA 
Propranolol 3.50 16.55 13.50 0.83 0.74 16.51 13.36 1.35 2.14 NA 11.48 NA 36.50 
Chapter 3 
 
83 
 
0 10 20 30 40
-2
0
2
4
6
8
10
0 10 20 30 40
-2
0
2
4
0 5 10 15 20 25 30 35 40
-2
0
2
4
6
8
0 5 10 15 20 25 30 35 40
-2
0
2
4
A
b
s
o
rb
a
c
e
 (
m
A
U
)
Time (min)
column pressure: 240psi
column pressure: 85psi
S1B
S1 C
S1A
4,5
32
1
5
4
3
2
1
column pressure: 275psi1
2 3
4 5
column pressure: 500psi
S1 D
1
2
3,4 5
S1A
Backpressure: 85psi
S1B
Backpressure: 240psi
S1C
Backpressure: 275psi
S1D
Backpressure: 500psi
 
 
Figure 3-11: Column-to-column repeatability of S1 (12 cm x 75 µm i.d.): separation of acidic drugs and β-blockers on 
different batches of S1 stationary phase. Other conditions are the same as in Figure 3-8. 
Chapter 3 
 
84 
 
Thus, newly modified monoliths i.e. S1M-S3M were prepared using 16% (w/w) 
BUMA, 0.4% (w/w) SPMA, 23.6% (w/w) EDMA [overall 40% (w/w)] compared 
with 23.6% (w/w) BUMA, 0.4% (w/w) SPMA, 16% (w/w) EDMA [overall 40% 
(w/w), as for the previously prepared S1-S7] and 60% (w/w) porogenic solvents 
as used previously for S1-S7 (Table 3.4).  
Considering the effect of 1-propanol on the pore size shown previously in 
the examples S1-S7 (where higher percentage of 1-propanol led to the formation 
of monoliths with smaller pore size), the effect of increasing the amount of cross-
linker over functional monomer might be reduced if the percentage of 1-
propanol relative to that of 1,4-butandiol was varied in the preparation of the 
modified monoliths S1M-S3M. Thus, fixing the amount of water [10% (w/w)], the 
effect of the percentage variation of 1-propanol relative to that of 1,4-butandiol in 
the 60% (w/w) porogenic solvent and 40% (w/w) monomers compositions (16% 
(w/w) BMA, 0.4% (w/w) SPMA, 23.6% (w/w) EDMA) was studied in an attempt 
to prepare a second set of columns, namely S1M-S3M, that were intended to 
exhibit both rigidity and larger pore size. 
3.3.4.2 Mercury intrusion porosimetry of the modified SPMA 
monoliths  
Mercury intrusion porosimetry was used to measure the pore size of the 
modified SM monoliths that were prepared. The results (Table 3.4) show that the 
median pore diameters from all the above prepared columns (S1M-S3M) were 
2.85 µm for S2M, 1.35 µm for S1M and 1.12 µm for S3M with porogenic solvents 
consisting of 1,4-butandiol, 1-propanol and water in the ratios of 20:70:10, 
30:60:10 and 10:80:10 [% (w/w/w)],  respectively. The pore diameters of the 
modified monoliths were not what were expected. In contrast with S1-S7, there 
was a higher amount of cross-linker than functional monomer in the 
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polymerization mixture. As the amount of 1-propanol increased relative to that 
of 1,4-butandiol, the pore size increased from S1M to S2M, although it decreased 
again in S3M (Table 3.4 and Figure 3-12). This indicated that phase separation 
occurred early for systems with 60 and 70% (w/w) of 1-propanol over 1,4-
butandiol and with higher amount of cross-linker over functional monomer. 
3.3.4.3 Scanning electron microscopy of the modified SPMA 
monoliths  
In terms of the morphology of the prepared monoliths, SEM analysis of S1M, S2M 
and S3M showed the copolymerized monolith was composed of a heterogeneous 
surface of spherical units agglomerated into larger clusters interdispersed by large 
pore channels. Therefore, these monoliths (S1M-S3M) showed good permeability 
to solvents and can withstand backpressure of up to 3200 psi (Figure 3-8). It was 
interesting to see that previously the S3 was not permeable, but, it became 
permeable in the S3M form and macropores were observed after the composition 
of the cross-linker and functional monomer were switched (Figures 3-5 and 3-13). 
3.3.4.4 Separation performance, repeatability and stability of 
modified SPMA monolithic columns 
A similar set of acidic drugs and -blockers were tested for their 
chromatographic separation on the studied monoliths (S1M-S3M). All acidic 
drugs and -blockers studied in this investigation were baseline separated within 
25 min using a mobile phase consisting of acetonitrile:water:TFA (34:66:0.1%, 
v/v/v) for S2M and S3M columns [Figures 3-14 (a) and 3-15 (a)]. Fast separations 
using S2M and S3M monolithic columns were performed using high flow-rate (2 
µL/min) and column temperature (80 °C). The target analytes were eluted within 
5 min [Figures 3-14 (b) and 3-15 (b)]. 
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Table 3.4: Effect of variation of the percentage of porogen solvents on the pore 
size of the studied modified SPMA monoliths (S1M-S3M) prepared from a 
polymerization mixture consisting of 0.4% (w/w) SPMA, 16% (w/w) BMA and 
23.6% (w/w) EDMA that constituted 40% (w/w) of the polymerization mixture 
with respect to 60 % (w/w) porogen solvents. 
 
Polymer 1,4-butanediol 1-propanol Water Pore size 
 
[% (w/w)] [% (w/w)] [% (w/w)] [µm] 
S1M 30 60 10 1.35 
S2M 20 70 10 2.85 
S3M 10 80 10 1.12 
 
 
 
 
Figure 3-12: Pore size distribution curve of S1M, S2M and S3M measured by 
mercury intrusion porosimeter. 
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                                (a)                                                                    (b)                                                                       (c) 
Figure 3-13: SEM images of modified SPMA monoliths (a) S1M, (b) S2M and (c) S3M. 
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(b) 
Figure 3-14: Separation of some acidic drugs and β-blockers on S2M monolithic 
column (12 mm x 75 µm i.d.) using either mobile phase composition 
acetonitrile:water:TFA (a) 34:66:0.1% v/v/v;  flow-rate, 0.5 µL/min; column 
temperature, 40 °C or (b) 30:70:0.1% v/v/v; 2µL/min; 80 °C. Other conditions are 
the same as in Figure 3-9. 
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(b) 
Figure 3-15: Separation of some acidic drugs and β-blockers on S3M monolithic 
column (12 mm x 75 µm i.d.) using either mobile phase composition 
acetonitrile:water:TFA (a) 34:66:0.1% v/v/v; flow-rate, 0.5 µL/min; column 
temperature, 40 °C or (b) 30:70:0.1% v/v/v; 2 µL/min; 80 °C. Other conditions are 
the same as in Figure 3-9. 
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Stability of a column and repeatability of retention times during 
separations are critical in the evaluation of chromatographic properties. Several 
batches (A-D) of S2M and S3M columns were prepared from separate 
polymerization mixtures under similar conditions and the separations of the test 
compounds were evaluated (Figures 3-16 and 3-17). The observed run-to-run 
(n=10) RSD values based on retention times of arterenol, ketoprofen, ibuprofen, 
diclofenac and propranolol on S2M and S3M columns were all within 1.2% 
(Table 3.5). The RSD values for day-to-day (n=6) were higher, ranging from 0.7 to 
2.7% (Table 3.5). Additionally, the column-to-column (n=6) repeatability for the 
aforementioned analytes on S2M exhibited satisfactory RSD values, ranging from 
3 to 11% (Table 3.5).  The column-to-column (n=6) RSD values of S3M were also 
at acceptable level with all values < 15% except for propranolol (16%) (Table 3.5). 
The stability of the prepared S2M was impressive and acceptable separation 
performance of all the analytes was obtained for up to 450 injection cycles at 
80 °C (Figure 3-17). Stable retention times of tested compounds featuring a RSD 
less than 3.5% were observed, even after 450 separations for the S2M monolithic 
column prepared via photopolymerization. These results clearly confirmed the 
robustness of the prepared monolithic column S2M as the separation 
performance did not appear to deteriorate with time, temperature, number of 
injections or column-to-column conditions (Figure 3-18). 
3.4 Conclusions 
Mixed-mode SPMA-based monolithic columns for HPLC separation of some acidic 
drugs and -blockers were prepared. The influence of porogenic solvent 
composition and cross-linker on morphological, porogenic and separation 
properties of monoliths has been investigated. The possibility of fine-tuning of 
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Figure 3-16: Column-to-column repeatability of S2M: separation of acidic drugs and β-blockers on different batches of 
S2M stationary phase using mobile phase composition acetonitrile:water:TFA (34:66:0.1%, v/v/v). Other conditions are 
the same as in Figure 3-8. 
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Figure 3-17: Column-to-column repeatability of S3M: separation of acidic drugs and β-blockers on different batches of 
S3M stationary phase using mobile phase composition acetonitrile:water:TFA (34:66:0.1%, v/v/v). Other conditions are 
the same as in Figure 3-9. 
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Table 3.5: Repeatability of prepared SPMA-based modified monolithic columns S2M and S3M expressed as relative 
standard deviations (%RSD) of retention time (R.T.) for the separation of acidic drugs and -blockers. Other conditions 
are the same as in Figure 3-16. 
 
 
 
 
 
 
 
Run-to-run (n=10) Day-to-Day (n=6) Column-to-column (n=6) 
Compounds 
Analyte 
Conc. 
(mg/L) 
Retention time (R.T.) Retention time (R.T.) Retention time (R.T.) 
Mean %RSD Mean %RSD Mean %RSD 
S2M          S3M S2M          S3M S2M          S3M S2M          S3M S2M          S3M S2M          S3M 
Arterenol 3.50 5.92 6.56 0.72 0.82 5.92 6.52 0.74 0.87 6.01 7.16 3.45 6.19 
Ketoprofen 0.70 7.39 8.42 0.76 0.88 7.38 8.36 1.10 0.89 7.66 9.30 4.90 2.96 
Ibuprofen 1.75 9.17 10.71 0.84 0.95 9.16 10.66 1.14 1.38 9.97 12.09 5.08 5.44 
Diclofenac 2.45 11.30 13.31 0.92 0.98 11.29 13.27 1.38 1.95 12.73 15.31 5.03 8.85 
Propranolol 3.50 13.61 16.92 0.82 1.17 13.60 16.64 1.49 2.72 15.95 21.58 11.05 15.97 
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Figure 3-18: Study of the stability of S2M column after 450 injection cycles of a mixture of acidic drugs and -blockers. 
Conditions:  mobile phase, acetonitrile:water (30:70, v/v) with 0.1% TFA; flow-rate, 2 µL/min; 1 µL injection volume; 
column temp, 80 °C. 
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porosity and separation properties of monoliths was explored by changing the 1-
propanol to 1,4-butanediol ratio to allow for the optimization of the HPLC 
performance of the columns. In general, at a given porogenic solvent composition, 
a SPMA-based monolith with a greater amount of cross-linker gave better 
repeatability values in separation behavior, even at high temperature (up to 80 °C). 
Furthermore, the separation mechanism of the investigated compounds appeared 
to be based on a mixed-mode hydrophobic/ion-exchange interaction of the analytes 
with the SCX-RP monolith. The influence of ion-exchange interaction on the 
retention between the -blockers and the stationary phase could be manipulated 
by changing the concentration of the competing ion (5-30 mM NH4+) of the mobile 
phase used.  All these properties are promising for a broader application of mixed-
mode porous polymer monoliths in low resolution chromatography and sample 
preparation for pharmaceutical analysis. The simplicity of the in situ preparation 
process also makes the monolithic columns excellent candidates for use in 
miniaturized devices, such as microfluidic chips and pipette tips. 
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C h a p t e r  4  
Development of a Trypsin-Immobilized 
Monolithic Polymer with Pipette-Tip Format 
for Protein Digestion 
4.1 Introduction                                                              
There have been significant improvements in the analytical methodologies and 
techniques pertaining to proteomic studies in the past decades. Several strategies 
have emerged as efficient and indispensable techniques for the bottom-up 
approach of protein analysis, which involves separation, identification, and 
characterization of proteins in the field of functional proteomics [1,2]. Two-
dimensional electrophoresis (2-DE) is one of the most powerful methods for the 
separation of proteins, followed by off-line digestion and further identification by 
MS/MS [3]. Alternatively, the hyphenation of multidimensional HPLC with 
MS/MS is used for the separation and identification of all the digested proteins 
extracted from a biological sample [4]. However, sample preparation often poses a 
constraint to rapid bioanalysis. The traditional protocol for protein digestion is 
accomplished by enzymatic hydrolysis in free solution for at least several hours. 
This method presents a number of drawbacks, such as proteolytic enzyme 
autodigestion, low efficiency, extended incubation time, insufficient sample 
loading capacity for direct analysis of plasma, and manual sample manipulation 
steps. These limit the advancement of high throughput protein identification 
technology [5]. To obtain rapid, sensitive and high-throughput protein digestion, 
research efforts have focused on the immobilization of enzymes. 
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Research dealing with immobilization of trypsin can be dated back to the 
late 1970s [6]. Immobilized enzymes have found applications in a wide variety of 
areas. In addition, the application of bioreactors containing immobilized enzymes 
is also growing as an integral part of quality control (QC) and quality assurance 
(QA) for products in biotechnology, chemical synthesis, and the pharmaceutical 
industry [7]. These enzyme reactors enable rapid screening of enzyme inhibitor 
candidates as well as detailed characterization of binding interactions and reaction 
mechanism [8,9]. Over the past few decades, various strategies enabling enzyme 
immobilization have been designed and developed. Enzymes can be covalently 
bound, trapped, or physically adsorbed onto various supports, such as particles 
[10], membranes [11], the inner walls of fused-silica capillaries,[12] magnetic 
particles[13] and monolithic materials [14]. It is also now well-known that the 
properties of the support such as pore size, porosity, chemistry, and mechanical 
strength will affect the characteristics of the immobilized enzymes [15]. That is, the 
activity and the applicability of the resulting bioreactor are greatly affected by the 
selection of the support matrix.  
Currently, monoliths have been widely used as matrices for sample 
preparation and separation. The micrometer-sized pores of the monoliths provide 
a low-pressure drop for the proteins to flow convectively through the interstices 
and interact with the enzyme-immobilized surfaces via short diffusion distances, 
which may enhance the digestion efficiency. A review of the advantages of using 
monoliths over using alternative phases for bioanalytical applications has been 
reported elsewhere [16]. In addition, the wide variety of applications of silica and 
organic polymer monolithic phases in the preparation of immobilized enzyme 
reactors of different formats has been reported. A number of bioreactors prepared 
by inorganic silica monoliths in 4.6 mm i.d. column have been studied by 
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Temporini et al. for the on-line digestion and characterization of proteins [17,18].  A 
solid-phase digestion tool of immobilized-trypsin on monolithic silica gel in a 
pipette tip has been developed [19]. Organic polymer monoliths used as supports 
for enzyme immobilization have been prepared in different formats, such as in situ 
in the channel of microfluidic devices [14], monolithic disks [20] and columns of 
different i.d. [7,21]. Specifically, organic polymer monoliths have gained much 
attention over silica-based monoliths as supports for enzyme immobilization due 
to properties such as high chemical stability over a wide pH range, good 
biocompatibility, ease of preparation in different formats and ease of modification 
with various functional groups [5].  
A further advantage of polymer monoliths is that they can be readily 
modified, for example using UV light. Irradiation with UV light through a 
photomask allows precise patterning of the area subjected to surface modification 
and enables the precise placement of specific functionalities within selected areas of 
a single monolith for use in a variety of applications [22,23]. This process permits 
the introduction of multiple sites with various functionalities located next to each 
other or at predetermined locations in a single monolith [24].  Recently, 2-vinyl-
4,4,-dimethyazlactone (VAL) has been used for copolymerization with ethylene 
glycol dimethacrylate (EDMA) to obtain a reactive monolithic support for the 
immobilization of enzymes [25,26]. Krenkova et al. [7] described the preparation of 
enzymatic microreactors containing trypsin and endoproteinase LysC immobilized 
on a porous polymer monolith for the characterization and identification of 
proteins, such as cytochrome c, bovine plasma albumin, and high-molecular 
weight human immunoglobulin G. Subsequently, a reactor with immobilized 
peptide-N-glycosidase F on a porous polymer monolith in a capillary was also 
developed for the fast and efficient release of N-linked glycans from 
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immunoglobulin G molecules [7]. The monolith was first hydrophilized via 
photografting of poly(ethylene glycol) methacrylate (PEGMA) followed by 
photografting of VAL. This multistep photografting process was used to reduce 
non-specific adsorption of proteins and to obtain a support containing reactive 
azlactone functionalities so as to enable the preparation of highly active 
immobilized enzymes [7,26]. With the use of this system, a much shorter reaction 
time and a lower reaction temperature were achieved for the protein digestion.  
In this chapter, a novel trypsin-immobilized organic polymer monolith 
based on a pipette tip format is described for the analysis of proteins. A robust and 
reproducible monolith formulation reported previously in Chapter 3 was used as 
the support for the enzyme immobilization. The tips were prepared using a porous 
polymer monolith, followed by photografting the pore surface of the monolith 
with VAL inside the pipette tip. An unstable enzyme, trypsin, was successfully 
immobilized covalently in the azlactone-functionalized area. The functionalized 
monolith was characterized, followed by evaluation of its efficiency in the rapid 
digestion of proteins.  
4.2 Experimental 
The general experimental details are described in Chapter 2.  Detailed conditions 
are elaborated in each of the figure captions. 
4.2.1 Fluorescent assay of protein absorption 
4.2.1.1 Photografting of poly(ethylene glycol) methacrylate (PEGMA)  
A two-step modification reaction was used for the hydrophilization of the 
monolithic support to prevent the non-specific adsorption of proteins to the 
monolith surface [26]. Briefly, the monolith in the pipette tip was flushed with a 
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deaerated 5% (w/w) benzophenone (BP) solution in methanol for 30 min using a 
vacuum filtration apparatus. It was then exposed to UV irradiation for 4 min with 
rotation. The tip was fitted on a rotating stirrer and was rotated at the slowest 
speed possible (~50 rpm). After photografting BP, the monolith was flushed with 
methanol for 30 min to remove the unbound initiator. Next, a deaerated 0.1 M 
solution of PEGMA monomer in water was pumped through the monolith for 30 
min and the monolith was exposed to UV irradiation for 4 min with rotation. The 
monolith was then rinsed with water for 60 min to remove the unreacted PEGMA 
monomer. 
4.2.1.2 Preparing stock solution of protein and fluorescein 
isothiocyanate (FITC) 
A stock solution of protein was prepared by directly dissolving commercially 
available bovine serum albumin (BSA, Sigma Aldrich) in MilliQ water. In order 
to prepare 1x10-4 M of BSA (MW 66430), 132.9 mg of BSA was dissolved in 20 mL 
of water using a magnetic stirrer at approximately 25 °C. Then, it was diluted to 
1x10-5 M with water. To prepare 10-3 M of FITC (Sigma Aldrich) solution, 19.5 mg 
of FITC was dissolved in 50 mL of high purity (>99.8%) acetone and diluted to 
5x10-5 M with acetone.   
4.2.1.3 Labeling reaction of protein with fluorescein isothiocyanate 
(FITC-BSA) 
In order to prepare a fluorescently-labeled BSA solution with the concentration 
of 5x10-6 M, 20 mL of BSA solution (1x10-5 M) and 20 mL FITC (5x10-5 M) were 
mixed (five moles of FITC were coupled to one mole of albumin) in dry 50 mL 
plastic tubes. Then the mixtures were wrapped with aluminum foil and kept in 
the drawer overnight to perform the labeling reaction (at ~20-25 °C temperature 
controlled environment). 
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4.2.1.4 Fluorescent assay of protein adsorption on the pipette tips 
The extent of protein adsorption on unmodified and PEGMA-photografted 
monolith in situ pipette tips was evaluated using a fluorescence assay developed 
previously [27]. Briefly, the pipette tips were flushed with a 5x10-6 M (~0.33 
mg/mL) solution of fluorescein-labeled BSA for 1 h. The pipette tips were then 
rinsed with water for 30 min to remove excess BSA. After BSA exposure, the 
cross-section of the tip was then observed using a microscope with a blue LED 
array illuminating the microscope for fluorescent imaging as shown in Figure 4-1. 
Monolith tips with and without PEGMA-photografting were used for screening 
non-specific protein adsorption. Successful prevention of protein adsorption was 
indicated by the low fluorescence intensity observed. By contrast, high 
fluorescence intensity indicated substantial absorption of the fluorescent protein 
and poor performance of the monolith surface.  
 
     
 
Figure 4-1: The set-up of a microscope with blue LED array illuminating the 
microscope for fluorescent imaging. 
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4.2.2 Photografting of 2-vinyl-4,4-dimethylazlactone (VAL) 
A mixture consisting of 25% (w/w) VAL and 0.22% (w/w) BP dissolved in 75:25 (% 
w/w) tert-butyl alcohol:water was pumped through the monolith for 30 min and 
exposed to UV irradiation for 30 min on both sides of the tips (Figure 4-2). After 
grafting vinyl azlactone, the monolith was washed with acetone for 1 h to remove 
excess reagents. 
4.2.3 Immobilization of trypsin on grafted support 
Trypsin (1, 2, 5, 10 and 15 mg/mL) was dissolved separately in 50 mM phosphate 
buffer, pH 7.2, containing 0.25 mg/mL benzamidine. Benzamidine was added to 
avoid undesirable autodigestion and the enzyme solution was pipetted for 15 to 20 
cycles. After the immobilization reaction, the monoliths were rinsed with 1 M 
ethanolamine in 50 mM phosphate buffer, pH 7.2 to quench all unreacted azlactone 
functionalities. Finally, the monolithic reactor was washed and stored with 50 mM 
ammonium acetate solution pH 6.7 at 4 C.   
The amount of immobilized trypsin on the azlactone monolith in the pipette 
tips was determined by the modified method described previously [28]. After the 
immobilization process, the tip was rinsed with 20 μL of the same buffer to remove 
the unreacted trypsin on the surface of monolith. This eluent was collected and 
combined with the eluent from the immobilization and diluted to 2 mL and the 
absorbance was measured at 280 nm. The concentration was calculated by the 
difference of the amount of trypsin before and after immobilization using the 
calibration curve established (slope = 0.0014 abs/µgmL-1). 
4.2.4 Sample preparation for protein digestion 
The sample preparation for protein digestion was performed according to the 
procedure described previously [7]. The digestion of proteins using immobilized 
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Figure 4-2: Schematic diagram of the photopatterning process. (a) vinylazlactone (VAL) is photopatterned onto the 
monolith surface and activates the surface for protein immobilization. (b) azlactone functionality reacts with amines of 
proteins to form a covalent amide bond between the protein and the polymer monolith surface.  
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enzyme polypropylene pipette (IMEPP) tips is illustrated in Figure 4-3. Briefly, 
cytochrome c was dissolved in 50 mM ammonium acetate, pH 8.75 containing 20% 
acetonitrile to a concentration of 0.5 mg/mL. 100 µL of the protein sample was 
incubated in a dry-bath incubator for 5 min at 37 C before being pipetted with 
IMEPP tips using the protocol described in Section 2.3.9. For protein digestion with 
soluble enzyme, trypsin was added at a substrate-to-enzyme ratio of 50:1 (w/w) for 
protein digestion and the solution was incubated at 37 C for 24 h. The proteolysis 
was terminated by decreasing the pH with the addition of formic acid to a final 
concentration of 0.1% (1 µL of 10% formic acid in water).  The resultant peptide 
fragments from the digestion of IMEPP tips or liquid phase digestion were 
collected in microvials and analyzed using direct infusion MS. The mass spectra of 
all samples were then compared against a protein digestion database (protein 
prospector, http:// prospector.ucsf.edu/) to identify the digest and determine the 
sequence coverage (Figure 4-3).   
4.3 Results and discussion 
4.3.1 Surface modification of the polypropylene (PP) tips 
The modification of the surface of PP was first demonstrated by Stachowiak et al., 
who covalently attached the porous monolithic polymer to the tip wall in order to 
transfer the technique to the microfluidic chips [22,29]. Following this, Altun et al. 
have used the grafting modification to create reactive groups and they improved 
the wetting ability of the inner surfaces of PP tips in order to prepare monolithic 
pipette tips for SPE purposes in high throughput bioanalysis [29,30]. In the present 
work, the inner surface of PP tips was modified via grafting of monomer, followed 
by the preparation of a porous poly (butyl methacrylate-co-ethylene glycol 
dimethacrylate) monolith. The porous polymer monolith in situ PP tips can act as a  
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Figure 4-3: Schematic diagram for the protein digestions using trypsin-immobilized monolith tip.  
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support for enzyme immobilization in protein digestion. In this study, we also 
investigated a two-step photografting approach that involved covalent attachment 
of monomer to the PP surface (method described in section 2.3.7). Figure 4-4 shows 
the SEM images of non-modified PP tips and surface modification of tips by single- 
and two-step photografting using BP as initiator. The SEM images were not 
markedly different except that the surface of the modified tip looked smoother, as 
shown in Figures 4-4 (b) and 4-4 (c).  
Based on the results above, the effects of single- and two-step surface 
modification were further investigated by synthesizing the poly (BMA-co-EDMA) 
in situ PP tip using UV-induced polymerization. Figure 4-5 (a) shows SEM images 
of the monolith inside the PP tips in the absence of surface treatment. A magnified 
image shown in Figure 4-5 (a) bottom indicates a large void between the PP wall of 
the tip and the monolith. After washing the monolith with methanol and drying it 
in the vacuum oven, the monolith was loosened and could slip out of the tip. By 
contrast, a surface grafted with monomer enabled a better attachment of the 
monolith either by single-step or two-step photografting methods, as shown in 
Figures 4-5 (b) and 4-5 (c). This can be confirmed by the presence of a thin layer of 
polymer gel observed from the magnified images taken between the PP wall and 
monolith [Figures 4-5 (b)] which can also correspond to the smoother surfaces of 
tip walls for single or two-step photografting. Both of the photografting methods 
showed excellent covalent binding of the monolith to the PP surface and good 
mechanical stability. When a high pressure was applied, the monolith attached 
well to the surface without slipping out.  
In addition, the differences between using EDA (ethylene diacrylate) and 
EDMA for the surface modification of PP tips were compared. Previous works 
suggested that EDA offers the benefits of shorter exposure time which 
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                                             (a)                                                      (b)                                                        (c) 
Figure 4-4: SEM images of PP tips (above) and the magnified part (bottom): (a) no surface modification (b) single-step 
photografting and (c) two-step photografting. 
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         (a)                                                                (b)                                                         (c) 
Figure 4-5: SEM images of porous polymer monoliths prepared in PP tips (above) and the magnified part (bottom): (a) no 
surface modification (b) single-step photografting with MMA/EDMA 1:1 with BP [3% (w/w)] and (c) two-step 
photografting.
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achieve a stronger surface treatment of the PP surface. However in this work, 
surface modification with EDA achieved only partial attachment of the monolith to 
the PP wall. These results are in agreement with findings reported by Stachowiak 
et al. who stated that using EDMA for surface modification achieved the best result, 
with no visible void between the PP wall and monolith [22]. Therefore, a single-
step photografting with EDMA was used to simplify the preparation of monoliths 
in tips.   
4.3.2 Fluorescence assay of protein adsorption 
The hydrophilic polymer PEGMA has been widely used for modifying the surfaces 
of monoliths to reduce non-specific protein interactions and to permit repeated use 
of the reactor [7,26,31]. BSA is well-known to be a “sticky” protein and is 
commonly used to estimate protein adsorption onto enzyme-immobilized 
monolithic supports [32]. The fluorescence assay of BSA can be used to mimic the 
conditions for enzyme immobilization onto the monolith to obtain an enzyme 
reactor in pipette tip format [27]. Figure 4-6 shows the fluorescence images of a 
pipette tip with and without PEGMA-grafted after being flushed with fluorescein-
labeled BSA and rinsed with water. The non-PEGMA-grafted tip was highly 
susceptible to absorption of the fluorescently-labeled protein. The monolith 
photografted with PEGMA [Figure 4-6 (b)] exhibited lower fluorescent intensity 
than the monolith which had not been photografted [Figure 4-6 (a)]. Despite the 
fact that this method was developed to impart hydrophilic functionalization onto 
monoliths in small i.d. capillaries (75 µm), these images clearly demonstrated the 
successful upscaling of the reaction to larger i.d. PP tips. When monolith 
containing FITC-BSA was washed with 20% acetonitrile in water, most of the BSA 
was removed, with much lower fluorescence intensity monolith observed [Figure 
4-6 (c)]. The longer photografting time (from 4 min to 8 min) for PEGMA resulted 
in a thicker layer of PEGMA being formed on the monolith, which caused high 
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           (a)                                                                  (b)                                                             (c) 
Figure 4-6: Fluorescence cross-section images of pipette tips.  Fluorescein-labeled BSA was pumped through the polymer 
monolith tips (a) without and (b) PEGMA-grafted region after washed with water and (c) 20:80 (% v/v) acetonitrile:water.
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backpressure. Therefore, 4 min photografting was deemed to be the optimum 
irradiation time. 
4.3.3 Enzyme immobilization using azlactone functionalities  
The application of azlactone monoliths in enzyme immobilization has been widely 
used in the past 10 years for the fabrication of enzymatic microreactors. The aim of 
this chapter was to develop an inexpensive single-use IMEEP tip, so the issue of 
non-specific adsorption is less of a problem in this work. Thus, we used the non-
PEGMA-grafted monolithic PP tips for subsequent studies. 
As a starting point, the protocols described previously [26] were used to 
prepare the azlactone monolith [i.e. 15% (w/w) VAL, 2 min photografting and 5 
mg/mL of trypsin for immobilization]. The first demonstration of proteolytic 
activity for the IMEPP tip was carried out by pipetting 100 µL 0.5 mg/mL of 
cytochrome c for 10 cycles. However, no noteworthy enzyme activity was 
observed for the cytochrome c digestion using the IMEPP tip [Figure 4-7 (b)], as 
compared to the cytochrome c solution digested using the non-VAL-grafted 
monolithic PP tip [Figure 4-7 (a)]. This might be due to the fact that the UV source 
used for functionalization could not penetrate the large i.d. of the monolith 
fabricated in situ inside the PP tips, since the PP materials have a much lower UV 
transmission compared to the UV transparent fused-silica capillaries with smaller 
i.d.. Another possibility for the lack of enzyme activity might be an insufficient 
amount of VAL grafted onto the surface of monolith, resulting in a low capacity of 
enzyme immobilized on the polymer surface.  
As demonstrated by Krenkova et al. [7], the concentration of VAL at 25% 
(w/w) or above in the monolith support clogged the column. Here, 25% (w/w) VAL 
was used in the photografting mixture, with 10 min of UV irradiation. The result 
shows that reasonable backpressure could be maintained to allow solution to pass 
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through the PP tips after photografting with the relatively high concentration of 
VAL. Cytochrome c was again used to demonstrate the proteolytic activity of the 
IMEPP tip grafted with higher concentration of VAL. Figure 4-7 (c) indicates that 
the IMEPP exhibited very high activity for the complete digestion of cytochrome c 
with 100% of sequence coverage achieved within few minutes. 
The maximum concentration of VAL and photografting time that could be 
used to maximize the enzyme loading capacity of the IMEPP tip were also 
determined. Firstly, the photografting time was increased from 10 min to 30 min 
while maintaining the permeability of the monolith. However, when the 
concentration of VAL was increased from 25% (w/w) to 30% (w/w), permeability 
through the IMEPP tip was no longer observed. Therefore, 25% (w/w) VAL in the 
photografting mixture and 30 min photografting time were used for the following 
studies. Table 4.1 shows a comparison of the performance of the IMEPP tips with 
different numbers of pipetting cycles for the digestion of cytochrome c at 0.1 
mg/mL. This table shows that the highly efficient IMEPP tip developed here could 
give sequence coverage of 89% even with 1 pipetting cycle (or 10 s) of digestion of 
low-molecular weight proteins, such as cytochrome c. 
4.3.4 Effects of trypsin concentration for immobilization on 
monolithic support 
A batch of three IMEPP tips immobilized with different concentrations of trypsin 
was prepared (2530a, b, c, d and e). Using the UV spectrometric method, the 
amount of immobilized trypsin on the azlactone monolith was found to be 
different when different concentrations of trypsin solution were employed (Table 
4.2). The maximum bound amount of trypsin was limited to about 140 µg which 
was  
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Figure 4-7: ESI-TOF mass spectra obtained from cytochrome c digestion using 
pipette tips (a) without VAL photografting; (b) photografting under UV light at 
an exposure time of 2 min with 15% (w/w) VAL in photografting mixture; (c) 
exposure time of 30 min with 25% (w/w) VAL in photografting mixture. 
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Table 4.1: Comparison of digestion performances of the IMEPP tip with 
different numbers of pipetting cycles for the digestion of cytochrome c. 
Label 2530 2530 2530 2530 
pipette cycles 1 5 10 15 
Identified peptide 
number 
87/105 99/105 100/105 105/105 
Sequence coverage (%) 89 94 95 100 
 
 
Table 4.2: Amount of bound trypsin and performance of the IMEPP tips 
immobilized with different concentrations of trypsin. 
 Label 2530a 2530b 2530c 2530d 2530e 
Trypsin conc. immobilization 
(mg/mL) 
1 2 5 10 15 
Reacted amount (Trypsin µg) 214 406 1031 1809 2821 
Bound amount (Trypsin µg) 18 71 138 142 135 
Identified peptide number 54/105 95/105 100/105 102/105 99/105 
Sequence coverage (%) 51 90 95 97 94 
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obtained using a concentration of 10 mg/mL trypsin in solution. Any trypsin 
concentration greater than 10 mg/mL makes it difficult to pass through the 
monolith because of the high backpressure stemming from the high viscosity 
solution. However, the amount of immobilized enzyme on the monolith in the 
present work was four times higher than that previously used in a capillary format 
[28]. Thus, it might result in much higher digestion capacity. 
With regard to enzyme immobilization, it is always desirable to increase the 
amount of enzyme on the support in order to enhance the enzyme:substrate ratio 
and thus increase the protein digestion reaction rate. Two critical factors have been 
suggested for the optimization of trypsin bioreactor performance: accessibility to 
the active site related to enzyme:substrate ratio, and response intensity (i.e. 
sensitivity) related to the total amount of active sites [33]. As shown in Table 4.2, 
when the amount of trypsin used for immobilization increased, the bound amount 
of trypsin as well as the sequence coverage likewise increased. However, when the 
immobilization maximum had been reached, using 10 mg/mL of trypsin, all the 
available binding sites had been occupied. When 15 mg/mL of trypsin solution was 
used for immobilization, the sequence coverage slightly decreased. This might 
either be due to the high enzymatic density on the solid support which hindered 
the access of substrate to the active site, or perhaps the higher enzyme loading 
induced an aggregation and/or denaturation of the enzyme prior to or after 
immobilization, which led to a slight decrease in the enzyme activity [33]. Based on 
these results, a trypsin concentration of 10 mg/mL for immobilization was selected 
for studies of protein digestion.  
In summary, a single-step surface modification method with EDMA, post 
modification of monolith support with 25% (w/w) VAL concentration and exposed 
under UV for 30 min, enzyme immobilization using 10 mg/mL of trypsin and 50 
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mM ammonium acetate solution in 20:80 acetonitrile:water, pH 8.75, were used in 
all our experiments. 
4.4 Conclusions 
In this work, a novel trypsin-immobilized polypropylene pipette tip based on an 
organic polymer monolith was developed. UV-initiated photografting provided a 
simple and versatile approach for PP surface modification that produced better 
attachment of the polymer monolith. Further post-modification on the pore surface 
of the monolith created reactive azlactone functionalities which afforded an 
excellent support for the immobilization of trypsin. In addition, the high surface 
area to volume ratio, as well as a high degree of interconnected channels produced 
in photopolymerized monoliths, provided rapid mass transfer for proteolytic 
digestor applications. The preliminary results obtained are very promising in view 
of the very high sequence coverage coupled with very short digestion time 
achieved for cytochrome c. It is likely that this developed IMEPP tip can be used 
for the digestion of protein samples of different sizes. This makes the developed 
immobilized enzyme reactor based on pipette tip format very suitable for high-
throughput sample preparation required to accelerate the process of protein 
mapping, drug discovery and drug development. Further studies were to be 
focused on detailed characterization of this enzyme reactor in comparison with 
commercially available tryptic digest tips and traditional liquid phase digestion. In 
addition, the developed IMEPP tips were to be used for fast sample preparation of 
biological samples of pharmaceutical interest for both qualitative and quantitative 
bioanalysis.  
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C h a p t e r  5  
Characterization and Application of a Trypsin-
Immobilized Monolithic Polymer with Pipette-
Tip Format for Bioanalysis using LC-MS/MS 
5.1 Introduction 
In recent years, there has been a significant change in direction in the 
pharmaceutical industry and many new drugs are based on biological molecules, 
such as proteins and peptides. In testing the efficacy and safety of these new types 
of drugs, it is necessary to measure the medication levels in blood or plasma and 
the first step in this process is an enzymatic digestion step. Traditional enzyme 
digestion protocols present a number of drawbacks, such as long incubation time 
and also enzyme autodigestion which results in undesirable formation of 
additional peptides, leading to possible ionization suppression in the MS analysis 
and interference in the interpretation of the data [1]. Recent major research efforts 
have focused on the use of reactive monoliths directly polymerized in different 
formats (e.g. capillaries, microchips, columns, pipette tips, syringe needle and 
disks), acting as supports for trypsin immobilization. Such immobilized enzyme 
techniques have been used in the digestion of proteins, which are followed by MS 
determination of the peptides [2-6] and were introduced in Chapter 4 of this thesis. 
These applications clearly highlight the potential of enzyme immobilization 
technology for fast and efficient sample preparation. However, previous work was 
all based on qualitative studies of proteins in standard buffer as a proof of concept 
of these enzyme reactors. A limited number of proteomic studies have been 
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reported for rapid proteolytic digestion and protein identification in serum 
samples [3,7]. Conversely, quantitative analyses of proteins are more applicable 
and important to the bioanalytical setting of the pharmaceutical industry. One of 
the most difficult analytical challenges in the drug discovery process is preparing 
samples for reliable quantification of proteins in a fast and efficient manner. These 
proteins are potential biomarkers of disease in biological matrices.  
Tip-based methods reap numerous advantages in terms of speed, efficiency, 
sample clean-up and enrichment with subsequent coupling to LC-MS/MS for high-
throughput bioanalysis. Altun et al. [8] and Abdel-Rehim et al. [9] introduced a 
sample preparation technique using a set of polypropylene tips containing a plug 
of an in situ polymerized methacrylate-based monolithic sorbent for use with a 96-
tip robotic device. These sorbents have been used successfully for the extraction 
and quantification of -blockers and anaesthetics from human plasma by LC–
MS/MS. A novel trypsin-immobilized organic polymer monolith based on a pipette 
tip format has been developed and described in Chapter 4 for the digestion of 
proteins. The developed IMEPP tips exhibited high hydrolytic activity for the 
digestion of cytochrome c, which resulted in very high sequence coverage of over 
90% with a short contact time prior to MS analysis. 
The aim of this chapter is to explore the utility of tip-based protein digestion 
methodologies in a bioanalytical setting. Additionally, this chapter will compare 
and contrast the potential advantages of this technology with traditional liquid 
phase digestion and commercially available tryptic digest tips, such as MonoTip®  
Trypsin. The developed IMEPP tips were characterized using a MicrOTOF-Q 
quadrupole time-of-flight MS and LC-MS/MS system including an AB SCIEX 
Triple Quadrupole™ 5500 mass spectrometer, followed by an evaluation of its 
efficiency in rapid digestion of proteins by running a number of pipetting cycles. In 
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addition, digestion of proteins spiked in rat plasma was performed for the first 
time using enzyme immobilization technology for both qualitative and 
quantitative analysis. This method has great potential for high-throughput sample 
preparation, enabling a fast quantitative profiling of biological molecules for drug 
discovery and development in pharmaceutical industries.  
5.2 Experimental 
The general experimental details are described in Chapter 2.  Detailed conditions 
are elaborated in each of the figure captions. 
5.2.1 Sample preparation for qualitative analysis 
5.2.1.1 Protein digestion in standard buffer  
The sample preparation for protein digestion was performed according to the 
procedure of Krenkova et al. [10]. Briefly, protein [BSA (bovine serum albumin) or 
hIgG (polyclonal human immunoglobulin G)] was dissolved in 100 mM 
ammonium bicarbonate, pH 8.2, containing 8 M urea to obtain a solution with a 
concentration of 5 mg/mL. The protein was then reduced and alkylated. 1 mL of 5 
mg/mL protein was added to 100 µL of 45 mM dl-dithiothreitol (DTT) at 60 C for 
40 min. After the temperature of the sample solution was reduced to room 
temperature, the proteins were alkylated with 100 µL of 100 mM iodoacetamide 
(IAA) for 30 min at room temperature. Before digestion, the reduced and alkylated 
protein solution was diluted to 0.5 mg/mL using 50 mM ammonium acetate, pH 
8.75 containing 20% acetonitrile. Melittin (0.005 mg/mL, rat calcitonin gene-related 
peptide (CGRP) (0.005 mg/mL), cytochrome c (0.1 mg/mL) and myoglobin (0.1 
mg/mL) without any previous treatment were dissolved in 50 mM ammonium 
acetate, pH 8.75 containing 20% acetonitrile. For protein digestion with soluble 
enzyme, denatured protein was diluted with water to achieve a final urea 
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concentration of 2 M and protein concentration of 1.25 mg/mL (for BSA). Trypsin 
was added to 200 µL of protein solution at a substrate-to-enzyme ratio of 50:1 
(w/w) for protein digestion and the solution was incubated at 37 °C for 24 h. The 
proteolysis was terminated by a pH decrease after the addition of formic acid to a 
final concentration of 0.1% (1 µL of 10% formic acid in water).  For the digestion of 
proteins using IMEPP tips, the protein was dissolved in a solution consisting of 50 
mM ammonium acetate, pH 8.75, containing 20% acetonitrile, and 20 pipetting 
cycles were used. The peptide fragments from the digestion were collected in 
microvials and analyzed using the direct infusion and LC-MS methods. The mass 
spectra of all samples were then compared against the protein digestion database 
to determine the sequence coverage.   
5.2.1.2 Protein digestion in rat plasma  
Rat plasma samples were spiked with target proteins (melittin, rat CGRP, 
cytochrome c, myoglobin, BSA and IgG) individually to achieve the same 
concentration as described above. Then, 1 µL of plasma spiked with target protein 
was made up to a total volume of 100 µL using 50 mM ammonium acetate buffer 
with 20% acetonitrile for IMEPP tip digestion. The peptides from the digestion 
were collected in microvials and analyzed using the direct infusion and LC-MS 
methods. The peptide fragments were identified using a database search of Protein 
Prospector tool.  
5.2.2 Protein identification and multiple reaction monitoring (MRM)  
design 
5.2.2.1 Sample preparation for MRM development 
Different proteins, including melittin, rat CGRP, cytochrome c, myoglobin, 
transferrin, BSA and hIgG per 20-µL aliquot of 10 mg/mL were prepared using 
digestion buffer (100 mM Tris-HCl/ 10 mM CaCl2/ 20% acetonitrile). Each of the 
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proteins was digested individually for the development of MRM methods. For 
smaller-sized proteins such as melittin, rat CGRP, cytochrome c and myoglobin, 
each of the 20 µL aliquot protein samples was diluted with 450 µL of digestion 
buffer, 10 µg of trypsin added and the sample were incubated at 37 C for 24 h on 
an Eppendorf heating block. For larger-sized proteins that needed to be chemically 
treated, such as transferrin, BSA and hIgG, the 20 µL aliquot protein samples were 
diluted with 25 µL of 6 M guanidine hydrochloride (GdnHCl). Samples were 
reduced by adding 15 µL of 7 mM TCEP, followed by 45-min incubation at 56 °C 
on an Eppendorf heating block. Alkylation of cysteine residues was carried out by 
adding 15 µL of 13 mM iodoacetamide and incubating the sample for 1 h at 37 C. 
Alkylated protein samples were diluted with 450 µL of digestion buffer, 10 µg of 
trypsin added and the solutions were incubated at 37 C overnight. Each of the 
digested proteins was further diluted 1:80 with the digestion buffer. 75 µL of 
protein samples (100 µL for myoglobin) were injected and analyzed by the LC-
MS/MS system. 
5.2.2.2 Peptide MRM development 
A scheme describing the work flow for the method development of test proteins 
and peptides in plasma is shown in Figure 5-1. Peptide fragment masses were 
selected from in silico digest of each target protein using the ExPASy tool available 
from the website http://au.expasy.org/proteomics. The “Tools” option of the 
website was chosen, followed by the selection of “PeptideMass” function. For 
smaller-sized proteins (e.g. melittin, rat CGRP, cytochrome c and myoglobin) that 
were not reduced and alkylated, the amino acid sequence of each protein was 
inserted in the field. Trypsin was chosen as the enzyme for the database search, 
with no missed cleavages being allowed. For larger-sized proteins that were 
chemically reduced and alkylated, the option “cysteines treated with 
Chapter 5 
 
126 
 
iodoacetamide” was chosen. The possible surrogate peptides resulted from the 
digestion of each protein were displayed. Due to the possibility of chosen surrogate 
peptide in the target standard protein being present in other target proteins or 
sample matrix (in this case, rat plasma), each surrogate peptide was checked via 
BLASTP searches to ensure that each selected proteotypic peptide corresponded to 
a single gene product only.  
Due to the limitation in mass range of the API5500 (up to 1000 mAU for the 
linear ion trap and 1250 for MRM quantitative mode), the multiply charged parent 
ions (mainly +2 & +3) were utilized for peptides larger than 1000 Da. An enhanced 
product ion (EPI) scan was then utilized, for up to five parent ions simultaneously. 
The EPI scan enabled the identification of the product ions with highest intensity 
and suitable collision energy to construct a quantitative (MRM) method.  
 
 
 
Figure 5-1: Schematic for the method development of test proteins and peptides 
in rat plasma.  
 
 
5.2.3 Characterization of performance of IMEPP tips 
5.2.3.1 Plasma loading experiment for IMEPP tips  
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The rat plasma sample was spiked with a mixture of four target proteins 
(i.e. melittin, rat CGRP, cytochrome c and myoglobin) to achieve a final 
concentration of 100 µg/mL for each protein. Different amount of rat plasma 
ranging from 1 – 60 µL (1, 2.5, 5, 10, 20, 40, 60 µL) were made up to a total volume  
of 170 µL with the digestion buffer and digested using IMEPP tips. The digestion 
protocols used for commercially available tryptic digest MonoTip®  Trypsin and 
IMEPP tips were described previously in Section 2.3.9. For liquid phase digestion, 
trypsin (10 µg) was added to each sample solution and the solution was incubated 
at 37 C for 24 h. The proteolysis was terminated by a pH decrease after the 
addition of formic acid to a final concentration of 0.1% (1 µL of 10% formic acid in 
water). The resultant peptide solutions were made up to a total volume of 200 µL 
using mobile phase A (5% acetonitrile/ 95% water with 0.1% formic acid) and were 
injected onto an AB SCIEX Triple Quadrupole™ 5500 mass spectrometer using the 
multiple reaction monitoring (MRM) mode. Extracted ion chromatograms (EIC) 
corresponding to tryptic digested peptides of target proteins were recorded and 
areas of the eluting peaks were computed.   
5.2.3.2 Time course assay 
Rat plasma spiked with four target proteins (100 µg/mL for each protein) was used 
in this assay. A 10 µL sample of the plasma was diluted with 160 µL of digestion 
buffer. The protein sample solution was digested using IMEPP tips and MonoTip®  
Trypsin for a duration of 30 min. Different digestion durations of 30 min, 1 h, 4 h 
and 24 h were set up for liquid phase digestion of the protein sample, while 
keeping the amount of trypsin (10 µg) constant. The digested samples were diluted 
1:20 using the digestion buffer and analyzed with the LC-MS/MS system. 
5.2.3.3 Sample clean-up and enrichment functionality assay 
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The rat plasma spiked with four target proteins (100 µg/mL for each protein) was 
again used in this assay. A 10 µL sample of the plasma was diluted with 160 µL of 
digestion buffer, one with and one without 20% acetonitrile. Then, the plasma 
samples were digested with IMEPP tip and MonoTip®  Trypsin. The digestion tips 
using 100% aqueous buffer were eluted with 50 µL of 100% acetonitrile containing 
0.1% formic acid. Sample solutions digested in digestion buffer with and without 
20% acetonitrile as well as the eluted samples from the aqueous-digestion-tips 
were analyzed using the LC-MS/MS system. 
5.2.3.4 Volume test 
The rat plasma (10 µL) spiked with four target proteins (100 µg/mL for each 
protein) was diluted with 60 µL and 160 µL of digestion buffer. Then, plasma 
samples with different total volumes (70 µL and 170 µL) were digested with 
IMEPP tips and analyzed using the LC-MS/MS system. 
5.2.4 Sample preparation for quantitative analysis in rat plasma 
For quantitative analysis, the rat plasma sample was spiked with a mixture of 
four target proteins (i.e. melittin, rat CGRP, cytochrome c and myoglobin) to 
achieve final concentrations of 1.5625, 3.125, 6.25, 12.5, 25 and 50 µg/mL for each 
protein in plasma. To each protein mixture with different concentration, 10 µL of 
plasma was added to 60 µL of buffer (100 mM Tris-HCl/ 10 mM CaCl2/ 20% 
acetonitrile) and the sample digested using IMEPP tips. The digested sample 
solutions were back-diluted to a volume of 200 µL using mobile phase A (5% 
acetonitrile/ 95% water with 0.1% formic acid).  
For larger-sized proteins that need to be chemically treated, such as 
transferrin, BSA and hIgG, the rat plasma samples were spiked with a mixture of 
three target proteins to achieve final concentrations of 1.5625, 3.125, 6.25, 12.5, 25 
and 50 µg/mL for each protein in plasma. The high-molecular weight proteins 
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spiked in plasma (10 µL) were diluted with 15 µL of Tris-HCl, pH 8.8 containing 
10 mM of CaCl2 and 20% acetonitrile, and were further diluted with 25 µL of 6 M 
(GdnHCl). Samples were reduced and alkylated. Alkylated protein samples were 
desalinated with 420 µL of the same buffer. Aliquots of 100 µL of the reduced 
and alkylated protein solutions were pipetted with 20 cycles of pipetting 
procedure and the tip was soaked in the sample solution for 30 min. The 
resultant peptide solutions were diluted with 100 µL buffer and analyzed by the 
AB SCIEX Triple Quadrupole™ 5500 mass spectrometer using the MRM mode. 
A calibration curve was constructed based on the peak areas recorded against the 
concentration of proteins spiked in rat plasma. 
5.3 Results and discussion 
5.3.1 Application of IMEPP tips to the digestion of model proteins 
spiked in standard buffer and rat plasma  
The high complexity of plasma makes the digestion of proteins using the 
immobilized enzyme method very challenging. Tens of thousands of proteins are 
present in plasma and are dispersed over an extremely wide concentration range. 
Several different proteins have often been used in model test systems that include a 
proteolytic digestion step. In this study, six proteins with molecular masses 
ranging from 2.8 kDa to 150 kDa were used as the model proteins. Under 
optimized conditions, the excellent proteolytic activity of the IMEPP tips on these 
proteins was demonstrated in Chapter 4. Due to the low target substrate levels that 
are present in plasma, trypsin autolysis becomes a significant competing reaction 
which reduces substrate conversion, and the reaction is substrate-limited. In 
addition, the non-specific adsorption of proteins may also block the active sites on 
the IMEPP tips and decrease the tryptic digest activity. The newly developed 
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method, involving the immobilization of enzyme on a large through-pore organic 
polymer monolith support using higher enzyme concentration, enhanced the 
hydrolysis rate and enabling rapid diffusion, should promote efficient digestion of 
low concentration substrates. This is the first time a rapid digestion of proteins 
spiked in plasma using the IMEPP tips developed has been performed. 
The high efficiency digestion of the small protein rat CGRP using the IMEPP 
tip is shown in Figure 5-2. The large protein peak was missing after the digestion. 
The IMEPP tip also showed very high proteolytic activity even when it was used to 
digest the protein spiked in rat plasma sample (Figure 5-2). No significant 
difference was found between the digestion using soluble trypsin and IMEPP tips 
(Figure 5-2).  Figure 5-3 shows base peak chromatograms (BPC) of cytochrome c 
digest prepared using 24 h digestion with soluble trypsin, with 15 pipetting cycles 
(~ 6 min) for digestion of cytochrome c in digestion buffer and rat plasma using 
IMEPP tips at a concentration of 0.1 mg/mL (Figure 5-3). No marked difference 
between the digestions using soluble trypsin, IMEPP tip and digestion in rat 
plasma using IMEPP tip was observed (Figure 5-3). However, some cytochrome c 
remained undigested when in-solution digestion was used (Figure 5-3). By 
contrast, the IMEPP tip exhibited excellent performance, with complete digestion 
of cytochrome c and much faster digestion in comparison with the conventional in-
solution digestion (Figure 5-3). It is also worth mentioning that the liquid phase 
digestion of protein spiked in rat plasma would result in undesirable formation of 
additional peptides due to enzyme autodigestion, which may lead to ionization 
suppression or interference in the interpretation of data (Figures 5-2 and 5-3). 
Meanwhile, it has been demonstrated that using tip-based protein digestion, the 
problem of enzyme autodigestion was eliminated (Figures 5-2 and 5-3). 
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Figure 5-2: Chromatograms of a tryptic digest of rat CGRP (0.005 mg/mL) using the IMEPP tip and soluble trypsin in 
both standard buffer and rat plasma. Conditions: HPLC column, Dionex Acclaim® PolarAdvantge C16 (2.1 x 100 mm, 3 
µm); temperature, 30 °C; flow-rate, 0.2 mL/min; injection volume, 5 µL; mobile phases: A, 0.1% formic acid in water; B, 
0.1% formic acid in acetonitrile; a linear gradient of B% from 20% to 55% in 35 min.  
Chapter 5 
 
132 
 
 
Figure 5-3: Chromatograms of a tryptic digest of cytochrome c (0.1 mg/mL) using the IMEPP tip and soluble trypsin in 
both standard buffer and rat plasma. Conditions are the same as described in Figure 5-2.  
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Cytochrome c and other protein standards were chosen because they are 
inexpensive, stable and easy to prepare due to the lack of cysteines which 
simplifies the digestion protocols. Therefore, any specific treatment prior to 
digestion was not necessary when small proteins such as rat CGRP or cytochrome 
c were used. On the other hand, the three-dimensional protein structure of large 
proteins, such as BSA, was stabilized by chemical interactions such as disulfide 
bonding, and RP or hydrophilic interactions between the polypeptide chains. In the 
case of digesting BSA with the IMEPP tip, pre-treatments such as chemical and 
thermal were required. Without any specific pre-treatment prior to digestion, the 
IMEPP tip would be unable to catalyze digestion, since the active site of the trypsin 
did not come into contact with the peptide chain within shorter digestion times [4]. 
Therefore, the process of chemical reduction and alkylation are generally 
employed to enhance exposure sites of the protein which were previously 
inaccessible for proteolysis [11]. In this study, the salts present in the protein 
solution after this treatment were diluted 10 times so that the proteolytic activity of 
the immobilized enzyme would not be compromised. Figure 5-4 shows the LC-MS 
separation of the digestion of denatured BSA with the IMEPP tip. The digested 
peptide was obtained with 15 pipetting cycles at 37 C. The peptide profile 
digested with the developed tip was the same as that processed with the 
conventional method. 
The individual digests of the proteins in standard buffer and those that were 
spiked in rat plasma are shown in Figures 5-5 and 5-6. The digestion was both very 
fast and efficient and no real difference was observed between mass spectra 
obtained from the in-solution digestion (not shown) and the digestion using 
IMEPP tips for the digestion of rat CGRP, cytochrome c and BSA. In addition, the 
IMEPP tips were also used for the digestion of standard proteins, melittin and 
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Figure 5-4: Chromatograms of a tryptic digest of BSA (0.5 mg/mL) using the IMEPP tip and soluble trypsin in both 
standard buffer and rat plasma. Conditions are the same as described in Figure 5-2 except a linear gradient of B% from 
10% to 50% B in 35 min. 
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Figure 5-5: ESI-TOF MS spectra of peptides obtained by digestion of six proteins using IMEPP tips. Conditions: direct 
infusion flow-rate, 180 µL/hr; acquisition time, 2 min; capillary voltage, 4.5 kV; end plate offset, 500 V; nebulizer, 0.3 
bar; drying gas, 4 L/min; temperature, 180 °C. Asterisks define peaks of positively identified peptides after protein 
digestion. 
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Figure 5-6: ESI-TOF MS spectra of peptides obtained by digestion of four proteins spiked in rat plasma using IMEPP 
tips. Conditions are the same as described in Figure 5-5. 
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myoglobin, by direct infusion ESI-TOF MS method (Figure 5-5). The mass spectra 
of all samples were then compared against the protein digestion database (protein 
prospector, http:// prospector.ucsf.edu/) to identify the digest and determine the 
sequence coverage. Asterisks were not included in the digestion of hIgG in Figure 
5-6 because this protein contains six different components. It would be difficult to 
differentiate the peptides resulting from the digestion of these components using 
asterisks. Table 5.1 summarizes the results of highest sequence coverage obtained 
for each digested protein. An ideal coverage of 100% was achieved for the low-
molecular mass peptide rat CGRP using soluble enzyme and the IMEPP tip. In 
addition, the sequence coverages of the proteins digested using IMEPP tips were 
above 88% in standard buffer and also above 84% for proteins spiked in rat plasma 
(Table 5.1).    
A myoglobin trypsin digest always results in relatively few peptides and 
exhibits large protein peaks at high concentration (0.5 mg/mL), as shown in Figure 
5-7 (a). This is because myoglobin contains a heme group which is hard to digest. 
The early studies of Russell et al. showed that enzymatic digestion in mixed 
organic-aqueous solvent systems were highly efficient in terms of both the rate of 
digestion and amino acid sequence coverage  [12]. They reported that trypsin 
maintained proteolytic activity in a variety of solvents (e.g. methanol, acetone, 2-
propanol and acetonitrile) using up to 80% organic solvent [12]. Several authors 
have also confirmed that the activity of immobilized trypsin is not affected by 
organic solvents, with the usage of up to 100% acetonitrile [13,14]. Gordon and 
David also reported an optimum of 45% acetonitrile used to achieve the highest 
sequence coverage of the digestion [14]. Therefore, a digestion buffer containing 
45% or 80% acetonitrile in 50 mM ammonium acetate, pH 8.75 was used for 
myoglobin digestion in order to improve the digestion efficiency. Surprisingly, the 
Chapter 5 
 
138 
 
Table 5.1: Results of sequence coverage for the digestion of proteins and spiked samples using IMEPP tips. 
Protein MW (Da)
Concentration 
(mg/mL)
Sequence Coverage (%)
Soluble 
trypsin
IMEPP
IMEPP (Spiked 
sample)
Melittin 2848 0.005 100 100 100
Rat CGRP 3806 0.005 100 100 100
Cytochrome c 11702 0.01 97 95 87
myoglobin 16951 0.1 95 89 66
BSA 69294 0.5 92 88 84
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Figure 5-7: ESI-TOF MS spectra of peptides obtained by digestion of myoglobin 
(0.5 mg/mL) using IMEPP tips in (a) 20% acetonitrile (sequence coverage: 97%), 
(b) 45% acetonitrile (sequence coverage: 88%) in digestion buffer.   
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sequence coverage obtained from the digestion of myoglobin using 45% 
acetonitrile was lower than using 20% acetonitrile [Figure 5-7 (b)]. 
Several reports have suggested that using high organic solvents might  
increase the proteolytic activity of the trypsin, since increasing the amount of  
organic solvent also increases the solubility of the substrate, which changes the 
conformation of substrate or enzyme itself, providing more accessible active sites 
for the substrate [12]. One thing that is known with certainty is that increasing the 
amount of acetonitrile also increases the eluting strength of the solution, enabling it 
to release more digested peptides from the monolith support and thus allowing 
more digested fragments to be detected. A similar value of sequence coverage was 
obtained despite using 45% acetonitrile in the digestion buffer for BSA digestion. 
Using 80% acetornitrile in the digestion buffer was also tried for the digestion of 
BSA. However, a higher percentage of acetonitrile resulted in the precipitation of 
the protein which blocked the IMEPP tip. Furthermore, it is important to note that 
the lowest concentration of acetonitrile in the digestion buffer is always preferable 
to facilitate the subsequent gradient separation of peptides in reversed-phase 
chromatography (e.g. LC-MS). Therefore, 20% acetonitrile was employed for the 
digestion of high-molecular weight protein. 
The efficiency of the trypsin-immobilized organic polymer pipette tip was 
also evaluated with high-molecular weight proteins, such as human polyclonal 
IgG. The rapid growth of antibody drugs and drug candidates in the 
biopharmaceutical industry has created a demand for automated proteolytic 
digestion to assist in pharmaceutical stability studies, to identity assays and to 
facilitate quality control of these therapeutic proteins [15]. Therefore, efficient and 
rapid digestion is necessary for studying this extensive and complex protein. This 
protein contains four types of heavy chains (Igg-1, Igg-2, Igg-3 and Igg-4) and two 
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Figure 5-8: Chromatograms of a tryptic digest of hIgG (0.5 mg/mL) using the IMEPP tip and soluble trypsin in both 
standard buffer and rat plasma. Conditions are the same as described in Figure 5-4. 
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types of light chains (Igg-kappa and Igg-lambda). Again, this high-molecular 
weight protein has to be reduced and alkylated prior to the in-solution and IMEPP 
tip digestion. The peptide chromatogram of the digestions is shown in Figure 5-8. 
The mass spectra of the digests of hIgG using soluble trypsin and the IMEPP tip in 
both standard buffer and rat plasma are shown in Figures 5-5 and 5-6. Results 
characterizing the digestion of hIgG chains obtained using both soluble trypsin and 
the IMEPP tip are summarized in Table 5.2. Similar values of sequence coverage 
were observed for both the trypsin-immobilized pipette tip and use of the soluble 
enzyme. However, lower sequence coverage was observed for the digestion of 
protein spiked in rat plasma. This might be due to the high protein components 
which were present in rat plasma, blocking the majority of active sites on the 
trypsin-immobilized monolith support, thereby resulting in a loss of activity of the 
IMEPP tip during the digestion of heavy chains (i.e. Igg-1) [16]. However, this 
method works well for the light chains (i.e. Igg-kappa and Igg-lambda), yielding 
sequence coverage similar to that of the in-solution digestion, albeit with an 
additional advantage of very short digestion time (~ 6 min). In summary, these 
results suggest that the developed trypsin-immobilized monolithic polymer tips 
can be used for fast and efficient digestion of both low- and high-molecular weight 
proteins, thus indicating that this tip can be used for proteome studies. 
5.3.2 Design of MRM assays for target proteins 
The application of MRM to peptide analysis has created a new breakthrough for 
protein analysis in complex biological matrices. Due to the multiple fragment steps 
in MRM, higher selectivity is achieved. In this chapter, MRM methods were 
developed in order to identify the peptides after protein digestion, which can be 
used to interpret the digestion efficiency. Specifically, a range of different assays 
were developed including plasma loading capacity, time course assay, sample  
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Table 5.2: Comparison of sequence coverage identification of hIgG using soluble trypsin, IMEPP tips and IMEPP tips for 
spiked samples. 
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clean-up and effect of digestion volume for the evaluation of the digestion 
efficiency of the developed IMEPP tips in comparison with commercially available 
tryptic digest tips and liquid phase digestion. 
To develop a targeted analysis method, proteotypic peptides from each 
protein were selected for detailed analysis and MRM transition design. The 
molecular weight of cytochrome c is 11701.55 Da; its singly charged molecular ion 
could not be observed by the LC-MS/MS because it is above the mass detection 
range of the instrument. Therefore, surrogate peptides obtained from the tryptic 
digest of this protein had to be used to represent the amount of the protein present 
in the sample matrix. An example of in silico digest of cytochrome c from the 
equine heart is given in Figure 5-9. The surrogate peptides at different charged 
states were calculated using the in-house Peptide Mass Calculator. The entire 
surrogate peptides were BLAST searched against the sample matrix (in this case, 
rat plasma) to look for uniqueness in these surrogate peptides. For each protein, 
two or more proteotypic peptides were selected for further analysis. Care was 
taken where possible to ensure the selected peptides did not contain cysteine or 
methionine residues and were between 8 and 15 amino acids in length [17]. From 
Figure 5-10, it can be observed that the surrogate peptide with amino acid 
sequence EETLMEYLENPK only existed in equine heart cytochrome c and not in 
any rat genome sequences. This therefore can potentially be used as a surrogate 
peptide for quantification of equine heart cytochrome c in rat plasma. 
The unique surrogate peptides of cytochrome c were selected as the first 
precursor ions in the product ion scan mode. The precursor ions were set into the 
EPI mode (normally up to five ions) in order to identify the most intense fragment 
ions with suitable collision energy to construct a quantitative (MRM) method 
(Figure 5-11). For each peptide, two or more transitions were selected from the  
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Figure 5-9: A typical result of in silico digest of cytochrome c.  
 
 
 
 
 
 
Figure 5-10: BLAST search result of horse heart cytochrome c against rat genome. 
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Figure 5-11: EPI experiment spectra from cytochrome c. 
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remaining transitions based on the most intense y ions in the MS/MS spectra, with 
preference given to product ions with m/z values above the precursor ion to 
increase MRM specificity.  In this case, the major fragment ions produced from the 
doubly-charged ion (m/z = 748.35) are m/z = 892.5, 763.4 and 600.3 (Figure 5-12). 
The fragment ions were checked using “MS-product” in the protein prospector to 
ensure that they were from the precursor ion. Table 5.3 shows that the fragment 
ions m/z = 892.5, 763.4 and 600.3 corresponded to y7, y6, and y5 ions of the 
surrogate peptide. To decrease the MS duty cycle while ensuring a high number of 
MS/MS scans over peak, only the most intense MRM transition for each peptide 
was kept in the final method, and the MS/MS conditions for these MRMs were 
optimized. Therefore, the most intense fragment m/z 892.5 was selected as the 
transition for one of the surrogate peptides for the quantification of cytochrome c 
for different assays and quantitative analysis (Figure 5-12). The same procedure 
was carried out for all the standard proteins (melittin, rat CGRP, myoglobin, BSA, 
transferrin, hIgG). Details of the conditions used for the analysis of each peptide, 
including optimized transition parameters and collision energies for targeted 
proteins are shown in Tables 5.4 and 5.5. In total, the list indexes eight proteins, 
with a total number of 22 surrogate peptides. Figure 5-13 shows a typical LC-
MS/MS chromatogram with MRM transitions of protein mixture (melittin, rat 
CGRP, cytochrome c and myoglobin). 
5.3.3 Characterization of the digestion performances of IMEPP tips in 
Pfizer UK 
To evaluate the digestion performances of IMEPP tips, the following assays were 
considered in particular: the plasma loading capacity, digestion efficiency over 
different durations, sample enrichment functionality and the optimum sample 
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Figure 5-12: MRM methods workflow by selecting the most intense fragment 
ions from the product ion of cytochrome c. (A) shows the single product ion m/z 
748.35 from the EPI experiment spectra. (B) shows the MS/MS fragment ions of 
the selected product ion. 
A 
B 
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Table 5.3: Theoretical peak table generated from the surrogate peptide m/z 748.35 of cytochrome c. 
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Table 5.4: Details of surrogate peptides, Q1, Q3 mass and specific collision energy for each target protein. 
 
Protein   MRM transitions  
Protein Peptide Sequence Peptide mass Charge state Q1 Q3 Collision Energy 
Melittin VLTTGLPALISWIK 1511.9 2+ 756.8 927.7 30 
       
Rat CGRP DNFVPTNVGSEAF 1396.6 2+ 698.8 476.3 20 
       
Myoglobin GLSDGEWQQVLNVWGK 1815.9 2+ 908.4 390.3 40 
 VEADIAGHGQEVLIR 1606.9 2+ 803.9 814.5 45 
 HGTVVLTALGGILK 1378.8 2+ 689.8 885.5 40 
 LFTGHPETLEK 1271.7 2+ 636.3 716.3 40 
 HPGDFGADAQGAMTK 1501.7 2+ 751.8 742.8 37 
       
Cytochrome c EETLMEYLENPK 1495.7 2+ 748.3 892.4 30 
 TGQAPGFTYTDANK 1470.7 2+ 735.8 358.2 35 
 
TGPNLHGLFGR 1168.6 2+ 584.8 549.3 35 
 
EDLIAYLK 963.5 2+ 482.8 494.3 20 
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Table 5.5: Details of surrogate peptides, Q1, Q3 mass and specific collision energy for each target protein that was 
chemically treated. 
Protein   MRM transitions  
Protein Peptide Sequence Peptide mass Charge state Q1 Q3 Collision Energy 
BSA QTALVELLK 1014.6 2+ 507.8 785.5 25 
 
LVNELTEFAK 1163.6 2+ 582.3 951.5 25 
 
DAFLGSFLYEYSR 1567.7 3+ 523.3 717.3 25 
 
 
     
Transferrin YLGEEYVK 1000.5 2+ 500.8 724.3 25 
 
SVIPSDGPSVACVK 1415.7 2+ 708.4 558.8 35 
 
 
     
IgG-Kappa SGTASVVCLLNNFYPR 1797.9 2+ 899.0 435.3 35 
 
TVAAPSVFIFPPSDEQLK 1946.0 3+ 649.3 913.4 25 
 
VYACEVTHQGLSSPVTK 1875.9 3+ 626.0 807.3 25 
 
 
     
IgG1 FNWYVDGVEVHNAK 1677.8 3+ 559.9 708.8 25 
 
GPSVFPLAPSSK 1186.6 2+ 593.8 699.5 30 
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Figure 5-13: LC-MS/MS chromatogram corresponding to the MRM transitions associated with specific peptides for each 
targeted protein. 
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volume for digestion. All the assays were completed using the MRM methods 
developed previously.   
5.3.3.1 Plasma loading capacity of IMEPP tips 
The plasma loading experiment was designed to determine the maximum amount 
of plasma that can be used to yield the highest efficiency for digestion. This is 
particularly important since, if a lower amount of plasma sample is used, the 
sensitivity of detection will decrease; if too much plasma is used, it will block the 
tips and also decrease the tryptic digestion efficiency (due to the relative amount of 
protein present in the sample). This plasma loading experiment was also used to 
compare the sample capacity when liquid phase digestion and tip-based 
technology (i.e. MonoTip®  Trypsin and the IMEPP tip) were used. Figure 5-14 
shows one of the examples of plasma loading capacity for liquid phase digestion 
compared to the two different tip-based technologies. Liquid phase digestion 
always gives lower plasma capacity, in this case 5-10 µL of plasma, due to the 
limited amount of trypsin used for digestion in a bid to minimize auto-digestion 
that can potentially interfere with the sensitivity of detection. 
 Immobilized enzyme technology especially for tip-based methods, offers 
the advantages of high plasma loading capacity of up to 40 µL of plasma, fast 
digestion rate, and the ability to use a high concentration of enzyme for digestion 
without compromising the detection. This is consistent with all the other tested 
proteins. The present study also showed that the developed IMEPP tips based on a 
porous polymer monolith exhibited higher capacity and efficiency than the 
commercially available tryptic digest tips based on a silica monolith acting as 
enzyme support. Enzyme immobilization on a porous polymer monolith offers 
distinct advantages over the silica monolith in terms of flexibility of synthesis, 
greater biocompatibility over a wide pH range and also versatile functionality  
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Figure 5-14: Plasma loading capacity for liquid phase digestion, MonoTip® 
Trypsin and IMEPP tips for the digestion of cytochrome c spiked in different 
amount of rat plasma.  
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modification. The highly porous surface facilitates the flow-through of the sample 
solutions and moreover, the stability of the polymer support for trypsin 
immobilization means that polymer monolith will not shrink even with up to 40 
µL of plasma used for the digestion.    
5.3.3.2 Time course study 
A time course study was set up in order to investigate the efficiency of digestion 
for the IMEPP tip for different durations compared to the commercially available 
enzyme-tip and traditional in-solution digest. Figure 5-15 shows clear 
predominance of the newly developed IMEPP tips compared to the commercially 
available product and liquid phase digest over a 30 min digestion period. When 
compared to the in-solution digest analyses, the 30 min IMEPP tip digest yielded 
results similar to those of the 24 h solution digest.  
 
 
Figure 5-15: Digestion time course of cytochrome c with tip-based digestion (30 
min) compared to commercially available MonoTip® Trypsin and in-solution 
digestion (30 min, 1 h, 4 h and 24 h). 
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5.3.3.3 Sample clean-up and enrichment functionality assay 
Given the very small sizes of the samples handled in proteomics, miniature 
immobilized enzyme reactors placed in capillaries or microfluidic devices have 
been developed. However, the identification of proteins remains a challenge as the 
proteins are present in solutions at very low concentrations. The other significant 
challenge is that matrix interferences such as salts, buffers and detergents must be 
eliminated prior to the LC-MS/MS analyses. In order to obtain reliable analytical 
results using these techniques, sample pre-treatment and pre-concentration using 
solid-phase extraction (SPE) can be employed [18]. The compounds of interest are 
first absorbed onto the surface of porous materials and later released by elution 
with a strong solvent in a concentrated band. Custom-designed SPE devices have 
also been used to eliminate interfering compounds. A dual-function 
microanalytical device with the integration of SPE and enzymatic digestion for 
peptide mapping has been developed by Peterson et al. [13] . The samples were 
pre-concentrated in the first segment of the device, then eluted and digested in the 
second segment.  
The immobilized enzyme polymer monolith contains hydrophobic 
functionality which can be used for SPE. Therefore, the effects of sample 
enrichment functionality on IMEPP tips were further studied, as shown in Figure 
5-16. The recoveries rapidly decreased for the digestion in 100% aqueous buffer. In 
addition, the protein solution eluted from the aqueous digestion tip also showed a 
significant drop in recovery. Therefore, the sample enrichment functionality of the 
IMEPP tips was not very efficient. Digestion using buffer with 20% acetonitrile 
performed better than that obtained using an aqueous. The low recovery was 
possibly due to the properties of the monolith used. In this case a higher amount of 
cross-linking monomer was used to obtain a highly porous material. The 
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functional monomer was employed at a lower concentration of hydrophobic 
monomer, resulting in a loss of the hydrophobic functionality. It is recommended 
that a formulation should be used with a higher amount of functional monomer or 
cation-exchange monomer for future studies. However, as discussed in Section 
5.3.1, the tips still provide great potential for better sample clean-up and higher 
sensitivity of detection without the problem of enzyme autodigestion. 
 
 
 
Figure 5-16: Peak area of surrogate peptide of cytochrome c digested using 
MonoTip® Trypsin and IMEPP tips using  buffer/20% acetonitrile, aqueous and 
the eluted samples from the aqueous digestion-tips.  
 
Chapter 5 
 
158 
 
5.3.3.4 Volume test 
The volume test was employed to compare different dilutions for the same amount 
of plasma used for digestion to suit different purposes. For example, a volume just 
enough for a tip was used to have a fair comparison so that all the solution has the 
same residency digestion time on the stationary phase. If the total digestion 
volume used is 170 µL, it is expected to take 3-4 pipetting cycles for all solution to 
pass through the enzyme immobilized surface. Alternatively, we can pass all the 
solution through the immobilized bed if a smaller digestion volume of 70 µL used. 
One concern is that the concentration of plasma in solution might block the tip if a 
lower digestion volume used (also because of the lower dilution factor). 
Optimization steps will therefore be expected if different digestion volumes need 
to be used. In this case, 10 µL of plasma was used and diluted with 170 µL 
digestion buffer compared to 70 µL of digestion buffer for digestion in tips. Both of 
the sample solutions were then back-diluted to 200 µL using mobile phase A after 
digestion using IMEPP tips.  
Figure 5-17 shows the recoveries for the surrogate peptides of four different 
proteins after digestion using an IMEPP tip for digestion volumes of 170 µL and 70 
µL. It appears that the overall recoveries of surrogate peptides are higher using the 
70 µL digestion volume. The most significant results can be seen for surrogate 
peptides MELITTIN_A, RAT CGRP_B and CYTO_F (Figure 5-17). However, the 
recoveries for the peptides from myoglobin were relatively low. This is expected 
due to the presence of heme groups which are hard to digest. As discussed earlier, 
the higher digestion efficiency when using a lower digestion volume could be due 
to increased exposure of target proteins to the enzyme immobilized solid support. 
Therefore, a digestion volume for tip digestion of 70 µL was chosen for further 
studies. 
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Figure 5-17: Recoveries of surrogate peptides from four different proteins digested on IMEPP tips using different 
volumes for digestion. 
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5.3.4 Quantitative analysis of target proteins using LC-MS/MRM 
method after digestion using IMEPP tips  
To demonstrate the capability of the developed IMEPP tips to accurately quantify 
proteins and peptides in biological samples, quantitative MRM assays were 
specifically designed for tryptic digested peptides using IMEPP tips for seven 
targeted proteins spiked in rat plasma. MRM methods have been developed in 
order to study four simple proteins (i.e. melittin, rat CGRP, cytochrome c and 
myoglobin) and three larger proteins that had to be chemically reduced and 
alkylated [i.e. BSA, transferrin and hIgG components (Igg-1 and Igg-kappa)]. The 
two different groups of proteins were spiked into rat plasma at varying 
concentrations and digested using IMEPP tips. The multiplexing capability of LC-
QqQ-MS platforms for measuring peptides in complex digests is substantial, 
proving an opportunity to measure large panels of proteins accurately in each run. 
The protein levels were monitored to test the sensitivity and linearity of digested 
surrogate peptides using the IMEPP tips, as selected through the LC-MS/MRM 
method. Quantitative analysis information on six different proteins and the IgG 
components at six different concentration levels are reported in Table 5.6. Results 
show that the ratio of protein concentration and peak area correlation was linear at 
all concentration values studied, with correlation coefficient (R2) values of at least 
0.9884. Based on the results presented here, numerous targeted proteins ranging 
from low-molecular weight to those of high-molecular weight can be rapidly and 
efficiently digested and also quantitatively analyzed using peptide MRMs. It is also 
worth mentioning that the quantitative analysis of proteins digested using 
developed IMEPP tips demonstrates relatively good linearity over a wide range 
without the need for an additional internal standard to be used. 
Table 5.6: Quantitative information of the targeted proteins. 
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Proteins 
Plasma 
used (µL) 
Initial conc. 
(µg/mL) 
Analysis Conc. 
(ng/mL) 
Correlation 
coefficients (R2) 
Melittin 10 0.01-10 0.5 - 500 0.9993 
Rat CGRP 10 0.01-10 0.5 - 500 0.9970 
Cyto c 5 1.56 – 50 40 - 1250 0.9987 
Myoglobin 5 1.56 – 50 40 - 1250 0.9985 
BSA 1 1.56 – 50 8 - 250 0.9925 
Transferrin 1 1.56 – 50 8 - 250 0.9898 
Igg-1 1 1.56 – 50 8 - 250 0.9884 
Igg-kappa 1 1.56 – 50 8 - 250 0.9958 
 
5.3.5 Operational stability, storage stability and reusability 
The stability of the IMEPP tips was studied. Several identical IMEPP tips were 
prepared and tested for the digestion of denatured BSA. The IMEPP tip used for 
digestion of denatured BSA after 3 months storage gave a sequence coverage of 
over 80%. The IMEPP tip was also tested for reusability after digestion of the 
cytochrome c spiked in plasma. A sequence coverage of over 80% could be 
achieved. Figure 5-18 shows the SEM images of the morphology of the monolith 
after the photografting of reactive functional monomer, enzyme immobilization 
and protein digestion. A modified monolith with the desired functional groups 
was successfully prepared without altering the basic morphology of the monolith.  
However, the proteolytic activity of the IMEPP tip decreased after digestion of 
large proteins spiked in rat plasma. This might be due to non-specific protein 
adsorption which blocked the active sites on the monolith pores resulting in a loss 
of activity. Nevertheless, it is important to note that the reusability of pipette tips is 
not crucial in the present case since they were designed to be disposable. In 
addition, the reusability of tips may not be desirable in biological applications 
where it is important to avoid any possible chances of carry-over. 
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                                       (a)                                                                                                   (b) 
Figure 5-18: SEM images of porous polymer monoliths inside a PP tip after (a) VAL photografting, enzyme 
immobilization and used for protein digestion and (b) the magnified part. 
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5.4 Conclusions 
In this chapter, a miniaturized platform enzymatic reactor for application in 
bioanalysis is presented, based on a pipette tip format. The IMEPP tip showed high 
hydrolytic activity and long term stability for the digestion of low- and high-
molecular weight proteins. Sequence coverages obtained with the IMEPP tip in 20 
pipetting cycles, which is equivalent to a short total digestion time of 6 min, was 
comparable to those yielded by the conventional in-solution tryptic digestion for 24 
h. Furthermore, the IMEPP tip was also successfully applied to the digestion of 
proteins spiked in rat plasma, demonstrating its potential to be used in proteomic 
studies, as an alternative to commercially available tryptic digest tips. High plasma 
loading capacity and good calibration curve linearity of the tips were also 
demonstrated, thus indicating a wide dynamic range for quantitative analysis. 
These evaluations were conducted in an industrial bioanalytical laboratory (Pfizer 
Global Research and Development, Sandwich, UK) and demonstrated the 
possibilities of high-throughput sample preparation for pharmaceutical and 
pharmacokinetic studies, leading to faster and safer discovery of new drugs to treat 
diseases. The developed IMEPP tip is highly suited for MS-based proteomic and 
peptidomic analyses, for which the amount of sample is often limited.  
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C h a p t e r  6  
Optimization of Permeability and Format of 
IMEPP Tips for Proteomic Analysis 
6.1  Introduction 
In the pharmaceutical industry, the availability of highly developed tools for 
analytical procedures such as separation and detection instrumentation has led to 
an increase in the number of new drugs. With the advancement in analytical 
instrumentation, sample preparation has become a critical component in the 
analytical procedure but at the same time it has also become a bottleneck which 
limits high-throughput analysis. Because of this, much effort has been devoted to 
developing high-throughput sample preparation methods for toxicological and 
pharmacokinetic studies. An ideal sample preparation method should be easy to 
learn, environmental friendly, economical, and involve minimal manual handling 
steps. Furthermore, semi- or fully-automated analytical techniques are required to 
cope with the growing number of samples to be analyzed in the pharmaceutical 
industry [1]. Recent developments in sample handling techniques are directed 
towards miniaturization, automation and on-line coupling of sample preparation 
units and detection systems to speed up the whole analytical process. The more 
rapidly these measurements can be done, the faster is the progress of the drug 
toward regulatory approval and the more economically viable the drug becomes 
for the consumers [2].  
Tip-based technology has become increasingly popular in the development 
of high-throughput enzymatic digestion method for proteomic studies [3]. This 
miniaturized bioanalytical format is based on the stationary phase fixed inside a 
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pipette tip. The sample preparation is achieved by repeated aspirating and 
dispensing cycles using a manual micropipettor [4]. A 96-tip liquid handling 
robotic device has been introduced which allows 96 samples to be prepared 
simultaneously in only several minutes [5]. Compared with conventional liquid 
phase digestion, the tip-based digestion is easier, faster, and less expensive.  
There are several commercially available enzyme tips, including DigesTip®  
Trypsin from ProteoGen Bio (Pisa, Toscana, Italy) and MonoTip®  Trypsin from GL 
Sciences (Tokyo, Japan). More recently, a novel miniaturized SPE device, called 
microextraction by packed sorbent (MEPS) was introduced by Abdel-Rehim [6]. 
This MEPS device was demonstrated to be compatible with the majority of the 
commercially available autosamplers, as it allows sample purification, 
concentration and direct injection into GC or LC systems without modification of 
the chromatograph. Furthermore, this technique can be easily interfaced to GC- 
and LC-MS to provide a completely automated MEPS/LC-MS or MEPS/GC-MS 
system. The principles and application details of MEPS have been documented in a 
review by Abdel-Rehim [6]. This technique could be of interest in pharmaceutical 
and pharmacokinetic studies if the MEPS sorbent bed is immobilized with enzyme 
and integrated into a liquid handling syringe which allows protein digestion, 
sample clean-up and sample injection in a single step. 
Since the introduction of monolithic stationary phases in the 1990s by Svec 
and Tanaka, monolithic materials have been employed in enzyme immobilization 
to achieve fast digestion steps from several hours to a few minutes or even seconds 
[7,8]. At present, a wide variety of monomers are used for the preparation of 
polymeric monolithic stationary phases. The diversity of monomers provides the 
possibility of synthesizing customized polymer monolith with a desired porosity, 
selectivity, pore diameter and functionality, according to the needs of specific 
applications [9]. In the previous chapters, butyl methacrylate monoliths have been 
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prepared in situ in 75 µm i.d. fused-silica capillaries and used for the HPLC 
separation of -blockers and acidic compounds. The impact of different 
polymerization parameters (monomer content, porogenic solvent and cross-linker) 
on the porous properties, and hence on the separation selectivity for some acidic 
drugs and -blockers, was studied. Recent developments and applications of 
monolith-based immobilized enzyme reactors for proteome analysis have been 
summarized in a review by Ma et al. [10].  
This chapter describes the effects of the chaotropic agents, urea and 
guanidine hydrochloride (GdnHCl), disulfide bond reducing reagents 
dithiothreitol (DTT) and Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), as 
well as different buffer solutions containing calcium chloride in the protein-
containing solution used for digestion. The digestion efficiencies were evaluated 
using a Mascot database search of peptide fragment fingerprint (PFF) analysis. In 
addition, the IMEPP tip was prepared in different formats including an empty 
monotip and a specialized glass tube. Potentially, higher sample loading capacity 
and digestion efficiencies could be achieved. The influences of different polymer 
monolith formulations prepared in situ in PP tips on the permeability and 
digestion efficiencies were also investigated in detail.  
6.2 Experimental 
The general experimental details are described in Chapter 2.  Detailed conditions 
are elaborated in each of the figure captions. 
6.2.1 Comparison of protein digestion conditions 
A comparative study of protein digestion in different buffer solution (ammonium 
acetate and Tris-HCl) with and without acetonitrile and calcium chloride was 
performed with 0.1 mg/mL cytochrome c solution. The effects of the chaotropic 
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agents, urea and guanidine hydrochloride (GdnHCl), disulfide bond reducing 
reagents DTT and TCEP were evaluated with the digestion of 0.5 mg/mL BSA 
solution. The composition of the solutions and reagents for the digestion are listed 
in Table 6.1. The sample preparation details are summarized in Sections 5.2.1 and 
5.2.2. After the digestion of proteins using soluble trypsin and IMEPP tips, the 
digests were collected and analyzed via a LC-MS/MS method. 
6.2.2 Protein identification using public protein sequence database 
Peptide fragment fingerprints (PMFs) LC-MS/MS analyses for protein 
identification were performed with the Bruker Compass DataAnalysis 4.0 software 
using Mascot software (Matrix Science Ltd., UK, http://www.matrixscience.com 
website) and the public database SwissProt. Protein identification based on LC-ESI-
MS/MS experiments was achieved by conversion of raw data to mgf-files. The mgf-
files were searched using Mascot against SwissProt database with mammalia 
taxonomy. For proteins that were not chemically treated, such as cytochrome c, 
trypsin was selected as the digestion enzyme and 3 missed cleavage sites were 
allowed (precursor mass tolerance of 0.02 Da, fragment mass tolerance of 0.05 Da). 
The deaminated, Gln  pyro-Glu (N-term Q) and methionine oxidation were 
entered as variable modifications. Peptide charge was set to 1+. All peptide mass 
values were monoisotopic. Data format was set to Mascot generic and the 
instrument used was ESI-QUAD-TOF. A decoy setting was selected before the 
database search began. For proteins such as BSA that have already been treated 
with denaturants, all the parameters were the same except that carbamidomethyl 
cysteine was entered as a fixed modification and ammonia-loss, deaminated, Gln 
 pyro-Glu (N-term Q) and methionine oxidation were entered as variable 
modifications. 
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Table 6.1: Buffers and denaturants used for protein digestion. 
Protein buffer In Solution IMEPP tip
50 mM ammonium acetate + 20% ACN x
50 mM ammonium acetate + 10 mM calcium chloride + 20% ACN x
50 mM TRIS-HCl + 20% ACN x
50 mM TRIS-HCl + 10 mM calcium chloride + 20% ACN x
100 mM TRIS-HCl + 10 mM calcium chloride + 20% ACN x
Denaturant
Urea + DTT + IAA x x
GdnHCl + TCEP + IAA x x
Cytochrome c
BSA
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6.2.3 Preparation of highly permeable monoliths 
Surface modification in the pipette tip was done using single-step photografting 
according to the procedure described in Chapter 2. Nine different compositions of 
monoliths were prepared in situ in polypropylene pipette tips and all the 
compositions investigated are listed in Table 6.2. 
6.2.4 Manipulations of polymer monoliths in situ in polypropylene 
pipette tips 
Several types of IMEPP tips have been proposed, as shown in Figure 6-2. Tips (a) to 
(e) are Finntip-200 extended pipette tips and (f) is a Finntip-1000 purchased from 
Thermo Scientific. The tip (g) is called MonoTip empty tip 200 µL, purchased from 
GL Sciences (Tokyo, Japan).  A piece of capillary tubing was inserted into the filled 
tip as a template to create a main channel through the immobilized bed. After 
polymerization, it was removed to increase the permeability of the solid support. 
There were two models of through-channel pipette tips prepared, as shown in 
Figure 6-3. Both models of through-channel pipette tips were filled with 40 µL of 
polymerization mixture and exposed under UV. 
6.3  Results and discussion 
6.3.1 Optimization of protein digestion conditions 
Cytochrome c is a small protein (11.7 kDa) which is frequently used for evaluating 
enzymatic digestion efficiencies. Cytochrome c contains 105 amino acids and 21 
tryptic cleavage sites (i.e. Arg and Lys residues). The peptides resulted from the 
digestion can be easily identified using either direct infusion or LC-MS methods. In 
Chapter 4, it was described how cytochrome c was used to evaluate the optimum 
amount of VAL needed for immobilization and the effects of trypsin concentration 
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Table 6.2: Compositions of the polymerization mixtures (%, w/w) used for the preparation of polymer monoliths in situ 
in pipette tips. 
 
 
Polymerization mixtures 
Monomers / Initiator / Porogens (wt%) 
S2M 
S2M 
70% 
S2M 
75% 
S1 
70% 
S1 
75% 
Tetraglycol 
thermal 
Tetraglycol 
UV 
LP1 LPM1 
                  
Butyl methacrylate  16 12 10 18 15 19 19 15 10 
Ethylene glycol dimethacrylate 24 18 15 12 10 
  
10 15 
Tetra(ethylene glycol diacrylate)  
     
21 21 
  Vinylazlactone 
         1-Propanol  42 49 52.5 42 45 40 40 
  1,4-Butanediol 12 14 15 21 22.5 20 20 
  1-decanol 
         Water 6 7 7.5 7 7.5 
    Methanol 
       
52.5 52.5 
Hexane 
       
22.5 22.5 
2,2-dimethoxy-2-phenylacetophenone 1 1 1 1 1 
 
1 1 1 
Azobisisobutyronitrile 
     
1 
   
Median pore diameter, nm 1297 1514 1901 1231 1499   N/A   N/A 
 
N/A   N/A 
Porosity, % 62 72 77 70 78   N/A   N/A 
  
N/A   N/A 
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Figure 6-2: Several types of IMEPP tips were prepared. (a) Tip filled with 20 µL 
of polymerization mixture; (b) the tip filled with 20 µL of polymerization 
mixture and exposed under UV horizontally for 2.5 to 6 min and vertically from 
5 to 8 min; (c) the tip filled with 8 µL of polymerization mixture; (d) tip filled 
with 20 µL of polymerization mixture, and a larger “converter” was attached to it 
to allow the use of larger volume autopipette in order to give higher pipetting 
pressure; (e) top part of the tip filled with 20 µL of polymerization mixture (f) 1 
mL-tip filled with 20 µL of polymerization mixture; (g) MonoTip empty tip 200 
µL. All the polymerizations were conducted with the sharp end of the tip 
pointing downwards for 40 min and then with the sharp end up for 25 min, 
unless otherwise stated. 
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Figure 6-3: Two models of through-channel IMEPP tips: (a) monolithic bed in 
the middle section of the tip, (b) monolithic bed at the end of the tip. The tips 
were exposed horizontally under UV for 30 min.  
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on immobilization. It was also mentioned in Chapter 5 that cytochrome c was used 
to establish several tests in an industrial bioanalytical lab (Pfizer, UK) including 
plasma loading capacity, optimum volume for digestion, time course assay, sample 
clean-up and enrichment assay, and finally the qualitative and quantitative 
bioanalysis.  
There were two different protein digestion conditions that were used for 
qualitative and quantitative analysis in Chapters 4 and 5. The reagents used in the 
Pfizer Analytical Research Center (PARC, University of Tasmania, Australia) were 
described in the experimental work by Krenkova et al. [7]. The standard buffer 
used to make protein solution is 50 mM ammonium acetate at pH 8.75 containing 
20% acetonitrile. However, a different standard buffer was used in the Pfizer 
Bioanalytical Laboratory (Sandwich, United Kingdom). A 100 mM Tris-HCl buffer 
was used to prepare protein solution for digestion. Calcium chloride was also 
commonly added to the buffer solution because it has been reported that the 
calcium chloride can provide increased resistance to changes in conditions, such as 
pH or temperature [11]. The functions of calcium in stabilizing the enzyme 
conformation, reducing activation energy and maintaining the molecular folding of 
the denatured enzyme have also been reported [12]. As higher sequence coverage 
is normally achieved in the presence of an optimum amount of acetonitrile, 
acetonitrile was also added to all the protein solutions. 
The enzyme activity assays for different buffers were conducted in solution, 
and the assumption made that the data should be similar to that generated from 
the immobilized enzyme in pipette tips. The sequence coverage of in-solution 
digestion of cytochrome c using different buffers for the preparation of protein 
solutions are summarized in Table 6.3. There was no significant difference in the 
sequence coverage when different buffers were used. However, the ammonium 
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acetate buffer gave slightly higher sequence coverage in most cases than when 
Tris-HCl buffer was used. The addition of calcium chloride to the digestion buffer 
did not lead to any significant increase in enzyme activity (Table 6.3); instead, it 
resulted in the undesirable formation of a high salt peak on the chromatogram, 
which might cause ion suppression in the MS analysis and interfere with data 
analysis [Figure 6-4(b)]. Further, the high salt content of the Tris-HCl buffer led to a 
reduction in the intensity of most of the peptide peaks and as a result less peptides 
were identified [Figures 6-4 (a, c, d)]. It was interesting to discover that the use of 
Tris-HCl buffer resulted in much higher intensity of some of the peptide peaks 
(Figure 6-5) for the cytochrome c digest. This could be attributed to the fact that the 
Tris-HCl buffer could create some specific cleavage sites for trypsin. Therefore, the 
use of ammonium acetate buffer was preferred because it did not require desalting 
steps.  
For an optimum digestion of large and folded proteins, specific treatment 
prior to digestion was necessary to reduce the disulfide bonds. These proteins have 
to be treated by denaturing agents, such as urea or GdnHCl. Most enzymes used 
for proteomic studies have shown low tolerance against denaturants. However, 
immobilized enzyme has been shown to be more stable in the presence of a high 
concentration of denaturing agents [7]. In addition, the disulfide bridge was 
reduced using DTT or TCEP and the thiol group subsequently alkylated with 
iodoacetamide (IAA) to enhance exposure of sites of the protein previously 
inaccessible for proteolysis. Therefore, a comparative study was established to test 
the digestion efficiencies of various combinations of denaturing, reducing and 
alkylating agents.  
The results of digestion of BSA by soluble trypsin and the IMEPP tip are 
shown in Table 6.3. The sample pre-treated with a combination of urea, DTT and 
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Table 6.3: Results of the digestion of cytochrome c and BSA using different buffers and denaturants. 
In Solution IMEPP tip
buffer
50 mM ammonium acetate + 20% ACN 76
50 mM ammonium acetate + 10 mM calcium chloride + 20% ACN 75
50 mM TRIS-HCl + 20% ACN 70
50 mM TRIS-HCl + 10 mM calcium chloride + 20% CAN 70
100 mM TRIS-HCl + 10 mM calcium chloride + 20% ACN 68
Denaturant
Urea + DTT + IAA 75 66
GdnHCl + TCEP + IAA 71 52
Sequence coverage (%)
BSA
Cytochrome c
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Figure 6-4: Direct infusion mass spectra of cytochrome c digested in different buffer solutions. (a) 50 mM ammonium 
acetate + 20% acetonitrile, (b) 50 mM ammonium acetate + 10 mM calcium chloride + 20% acetonitrile, (c) 50 mM Tris-
HCl + 20% acetonitrile and (d) 100 mM Tris-HCl+ 10 mM calcium chloride + 20% acetonitrile.
(a) (b) 
(c) 
(d) 
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(a)                                                                  (b) 
Figure 6-5: Cytochrome c (0.1 mg/mL) after in-solution digestion in buffers (a) 50 
mM Tris-HCl +20% acetonitrile and (b) 50 mM ammonium acetate +20% 
acetonitrile. Top: base peak chromatograms. Middle: mass spectrometry (MS) 
survey scans. Bottom: tandem mass spectra (MS/MS) of the precursor ion at m/z 
585.1 corresponding to peptide TGPNLHGLFGRK, amino acids 29-39. 
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IAA yielded slightly higher sequence coverages for both in-solution digestion and 
the IMEPP tip.  
The present results are in agreement with the findings of Spross and Sinz 
who reported that urea was a better denaturant than GdnHCl when DTT was used 
as the reducing agent and IAA was used as the alkylating agent [9]. Although the 
use of GdnHCl as denaturant and TCEP as reducing agent resulted in a lower 
sequence coverage, it was found that the LC-chromatograms of the digestion gave 
a cleaner separation profile and resulted in higher intensities of some of the peptide 
peaks (Figure 6-6). Therefore, the combination of urea, DTT and IAA was probably 
better suited for qualitative analysis whereas GdnHCl, TCEP and IAA could be 
used for quantitative analysis of proteins. 
6.3.2 Development of a highly permeable IMEPP tip 
Despite the high loadability of the IMEPP tips for the protein digestion in rat 
plasma of up to 40 µL, they were limited by high backpressure caused by the large 
amount of sorbent used. Most of the pipetting tasks have to be performed by 
attaching the IMEPP tips to a curved syringe, as shown in Figure 2-4, to give a 
higher pipetting pressure. Therefore, different formulations of monolith and 
physical formats of the polymer monoliths in situ in polypropylene pipette tips 
were prepared in terms of the positions and the amount of polymerization mixture 
used, in order to give the monolith support to a higher permeability. 
6.3.2.1 Preparation of highly permeable monoliths 
There are many parameters that influence the porous properties of monoliths, 
including the type and concentration of the porogenic solvent(s), the 
polymerization temperature and time, and the percentage of cross-linker and 
initiator. Based on the preliminary experiments reported in chapter 3, monomer 
mixtures consisting of BMA and EDMA, and a porogenic solvent mixture 
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Figure 6-6: Separation of peptides resulting from BSA digestion (0.5 mg/mL) using the IMEPP tip and soluble enzyme by 
the combining different denaturants and reducing agents. Other conditions are the same as in Figure 5-4.
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containing 1-propanol and 1,4-butanediol, were used for the preparation of the 
IMEPP tips. Monolith formulations with the monomer Tetra(ethylene glycol) 
diacrylate were also investigated because they had been prepared in a capillary 
and reported with large pore sizes (~7 µm). Yu et al. reported that the 
polymerization mixture containing BMA and EDMA with a binary porogenic 
solvent of hexane and methanol yielded a monolith with large pore sizes (~8 µm)  
[13].  The porogenic solvent is the most important parameter for controlling the 
porous structure. Therefore, the ratio of monomer mixture to porogenic solvent in 
the polymerization mixture was slightly modified in order to increase the extent of 
through-pores and to facilitate low backpressure during enzyme digestion in the 
IMEPP tip. Compositions of the polymerization mixture are shown in Table 6.2. 
The monolith S2M, HEMA, tetraglycol thermal and tetraglycol UV were prepared 
from a polymerization mixture containing 40% (w/w) of the monomer mixture and 
60% (w/w) of porogenic solvent. To improve the through-pores, the composition of 
porogenic solvent in the polymerization mixture was increased from 60% (w/w) to 
70% (w/w) in S2M 70% and S1 70%, and increased from 60% (w/w) to 75% (w/w) in 
S2M 75% and S1 75%, respectively. The pore diameters and total porosities of the 
prepared monoliths were investigated through mercury porosimetry.  
From Table 6.2, it can be observed that the composition of had an influence 
on the porous properties and morphologies of the monolithic support. The pore 
diameters of the monoliths S2M, S2M 70% and S2M 75% increased slightly as the 
proportion of porogenic solvent in the polymerization mixture increased. In most 
cases, the total porosities also increased as the proportion of porogenic solvent 
increased (Table 6.2). Hence, increasing the porogen-to-monomer ratio is a 
straightforward method to increase the pore size and porosities, and consequently, 
to increase permeability during operations. However, this approach may also 
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decrease the rigidity of the macroporous polymer [14]. Figure 6-7 displays SEM 
images of the monolithic structures of the monoliths formed in the tips. Although 
the UV-initiated polymerization is usually performed within a short period 
compared to thermal initiation, the SEM images clearly showed the uniform 
porous structure across the monolithic support of the pipette tip. The difference in 
the pore diameters of S1 70% compared to S2M was not significant. The S1 75% 
and S2M 75% monoliths prepared within the pipette tips were very porous, but 
both monoliths collapsed after being washed with acetone. In addition, four of the 
monoliths studied, including tetraglycol thermal, tetraglycol UV, LP1 and LPM1 
formed an emulsion in the tip. Therefore, they were not further studied. The 
permeabilities of S2M and S2M 70% were further investigated by preparation in 
polypropylene pipette tips. 
6.3.2.2 Manipulation of IMEPP tip formats 
Different formats of macroscopic monoliths are commonly prepared, such as disks, 
rods (or columns) and polypropylene tips. They are often commercially available 
and produced by several companies such as BIA separations (Ljubljana, Slovenia) 
under the trade name CIM®  Disk, or as separation columns (ProSwiftTM, Dionex 
Corporation, USA). Monoliths in microscopic formats, such as capillary columns, 
silica steel tubing and microfluidic chips have also been widely developed [14].  
Based on the preliminary experiments studied in the pipette tip format, 
further adjustments were made in order to achieve more permeable tips that were 
compatible with autopipettes. Figure 6-8 shows different models of pipette tips 
prepared with the S2M monolith and Table 6.4 summarizes the physical properties 
of these tips. Tip model (b) was prepared by using a shorter UV exposure period. 
A 2.5 min exposure was not sufficient for the polymerization to occur. 
Consequently, the monolithic support collapsed when it was washed with acetone   
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                              S2M 60%                                         S2M 70%                                            S2M 75% 
 
           
                                                        S1 70%                                                 S1 75% 
Figure 6-7: SEM images of porous polymer monoliths inside the PP tips. 
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after polymerization. UV initiation for 3 min resulted in partial polymerization of 
the polymerization mixture, leaving a large void between pores and therefore the 
tip was only partially compatible with the autopipette. As soon as the 
polymerization exceeded 4 min, the monoliths were completely polymerized and 
required higher pipetting pressure (Table 6.4).  
The IMEPP tip that was prepared by polymerization using 8.5 min exposure 
was fully compatible with the autopipette (Table 6.4). Close examination of SEM 
images revealed that the polymer monolith was not completely attached to the tip 
wall. However, the polymer monolith was physically stable in the pipette during 
use (Figure 6-9). Meanwhile, the polymer monolith prepared in models (c, d, e, f) 
allowed only partial compatibility with autopipettes due to the limited 
backpressure experienced for suction operations (Table 6.4). The preparation of 
IMEPP tips in the different formats did not compromise the immobilized enzyme 
activities. At least 74% sequence coverage was achieved for the digestion of 
cytochrome c (0.1 mg/mL) using these different IMEPP tip formats. 
Tip model (e) was initially intended to simulate a commercially available 
enzyme tip, namely MonoTip®  Trypsin. This tip model yielded a larger internal 
i.d. of about 5 mm. A shorter monolith support prepared in the pipette tips could 
give higher permeability (Figure 6-10). The monoliths S2M and S2M 70% were 
further prepared in this tip model. The tip with monolith S2M only showed partial 
compatibility with the autopipette, similar to that prepared in the Finntip-200 
format. A highly permeable tip was achieved by filling 15 µL of S2M 70% into a 
MonoTip and polymerizing under UV for 20 min. This monolith provided a 
permeable through-pore size which could hold the polymer monolith in place 
while the solution was aspirated or expelled in and out using autopipette. 
Although this may also be achieved using 10 µL of S2M mixture in the MonoTip, a  
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Figure 6-8: Several models of IMEPP tips were prepared. The labels (a) to (f) are 
indicated in Figure 6-2, (g) through-channel IMEPP tips. 
 
 
(a) (b) (c) (d) (e) (f) (g) 
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Table 6.4: Physical properties of monoliths prepared in different formats. 
 
* Partial compatibility meant that the solution could be aspirated but not expelled in and out of the tips or vice versa. 
 
Tips 
model 
Amount of 
polymerization 
mixture (µL) 
Polymerization 
position 
Polymerizatio
n time (min) 
Stationary phase 
Compatibility 
with autopipette 
(200uL) 
1 (a) 20 vertical 30 ok no 
2 (b) 20 horizontal  2.5 collapsed NA 
3 (b) 20 horizontal  3 ok partial 
4 (b) 20 horizontal  4 ok no 
5 (b) 20 horizontal  5 ok no 
7 (b) 20 horizontal  6 ok no 
8 (b) 20 vertical 5 collapsed no 
9 (b) 20 vertical 6 collapsed no 
10 (b) 20 vertical 7 collapsed no 
11 (b) 20 vertical 8.5 ok yes 
12 (c) 5 vertical 30 ok Partial 
13 (c) 7 vertical 30 ok no 
14 (d) 20 vertical 30 ok Partial 
15 (e) 20 vertical 30 ok Partial 
16 (f) 20 vertical 30 ok Partial 
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Figure 6-9: SEM images of polymer monolith in pipette tip after the tip was 
exposed vertically for 8.5 min under UV.  
 
 
 
 
 
 
 
Figure 6-10: Photo of (a) MonoTip empty tip and (b) MonoTip with polymer 
monolith. 
 
 
(a)  (b)  
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larger monolith support in this case would be advantageous for enzyme 
immobilization. Sequence coverage of 80% was obtained using this S2M 70% 
MonoTip for the digestion of cytochrome c. 
A main channel was created through the immobilized bed by inserting a 
piece of capillary tubing into a tip filled with polymerization mixture and then 
removed after polymerization. This method of creating a flow channel in the 
monolith was first demonstrated by Hsu et al. to fabricate disposable plastic 
microtips, namely EasyTip, for SPE as an off-line sample preparation of biological 
samples [15]. Most importantly, the through-channel created within the 
immobilized bed did not affect the functionality of the EasyTip. The recovery 
percentage of the tryptic digest samples loaded onto the EasyTip was nearly 100% 
[15]. The same technique was in applied to the IMEPP tips. Up to 40 µL (~6 mg) of 
polymerization mixture was used in the through-channel IMEPP tips to increase 
the loadability since this system was not restricted by the pipetting backpressure 
[Figure 6-8 (g)]. Therefore, using this through-channel technique, the permeability 
problem was overcome easily. Figure 6-11 shows a SEM photograph of the 
monolithic structure with a through-channel. The monolith was attached to the tip 
wall and no cracks were observed. 
The monolithic support in the through-channel IMEPP tips was 
immobilized with trypsin and the digestion efficiencies were assessed using 
standard procedures. Figure 6-12 demonstrates the excellent digestion efficiency of 
the through-channel IMEPP tips since no significant difference in sequence 
coverage was observed compared to in-solution digestion as well as the IMEPP tip 
without through-channel (Table 6.5). However, additional peptide peaks were 
observed between the in-solution and in-tip digestion (Figure 6-12). To further 
confirm that these peptide peaks resulted from the digestion, two different  
Chapter 6 
 
189 
 
 
 
Figure 6-11: Through-channel in IMEPP tip created by inserting a piece of 
capillary tubing into the tip filled with polymerization mixture, and then 
removed after polymerization. 
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Figure 6-12: Separation of peptides resulting from cytochrome c digestion (0.1 mg/mL) using the soluble trypsin and 
through-channel IMEPP tips (a) and (b). Digestion and separation conditions are the same as in Figure 4-10.  
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Table 6.5: Results of the digestion of cytochrome c and BSA using soluble 
trypsin, IMEPP tip with and without through-channel. 
 
In Solution 
IMEPP tip without 
through-channel 
IMEPP tip with 
through-channel 
 
Sequence coverage (%) 
Cytochrome c 81 82 77 
BSA 75 66 67 
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surrogate peptides were extracted from the LC-MS chromatograms for        
comparison. Figure 6-13 shows two different surrogate peptides with amino acid 
sequences EETLMEYLENPK and TGQAPGFTYTDANK resulting from the tryptic 
digest of cytochrome c using in-solution digestion and through-channel tip 
digestion. The results clearly show that the intensity of surrogate peptides 
improved by 20 to 30 times for the through-channel mode. 
Protein identification by Mascot software showed that the additional 
peptide peaks from the through-channel IMEPP tips digest were mainly trypsin 
residues from the immobilization process (Figure 6-14). This could be due to the 
self-digestion of immobilized trypsin which was not completely washed out and 
was trapped or absorbed on the polymer monolith during immobilization. Thus, 
during the pipetting process, the digested trypsin was eluted into the sample 
solution, and caused the additional peptides on the LC-MS chromatograms.  
Therefore, the through-channel IMEPP tips were washed carefully with water and 
digestion buffer before used. Figure 6-15 shows that there were slightly fewer 
peptides observed for the LC-MS chromatogram of the protein digested using 
through-channel IMEPP tip after being washed with water and digestion buffer. 
However, a significant amount of additional peptides remained in comparison to 
the in-solution digestion. The separation by LC-MS/MS was very sensitive and 
even a small amount of trypsin leaching from the polymer monolith might result in 
significant additional peaks. However, even when the tip was washed with the 
water and buffer, the digestion efficiency was not compromised as the enzyme was 
immobilized strongly on the solid support with covalent bonds. Through-channel 
IMEPP tips exhibited high activity for digestion of high proteolytic resistivity 
proteins, such as BSA, with similar sequence coverage obtained using in-solution 
digestion (Figure 6-16). 
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(a) 
 
(b) 
Figure 6-13:  Extracted ion chromatograms of surrogate peptides with (a) amino 
acid sequences EETLMEYLENPK and (b) TGQAPGFTYTDANK resulting from 
the tryptic digest of cytochrome c using in-solution and through-channel tips 
digestion. 
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As mentioned earlier, the ideal monolith morphology in pipette format 
should contain larger amount of monolith plug for enzyme immobilization to 
achieve higher digestion capacity while still permeable enough for the protein to 
flow convectively through the interstices and interact with enzyme-immobilized 
surface. In this case, the design of Figure 6-3 is preferable because this design 
fulfills the requirement of allowing large amount of monolith support to be used 
while maintaining high permeability because of the through-channel. Most 
importantly, this design is compatible with the autopipette. The design from Figure 
6-3 does not significantly enhance sequence coverage of enzymatic digestion. 
However, preliminary results on showed that the intensity of surrogate peptides 
improved by 20 to 30 times digested using through-channel enzyme tip, which is 
extremely useful for quantitative bioanalysis (Figure 6-13). This result has to be 
confirmed using MRM quantitative method.     
 
 
 
Figure 6-14: Database searched using Mascot software against SwissProt 
database after cytochrome c digest was analyzed by LC-MS/MS and exported as 
mgf-files. 
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Figure 6-15: Comparison of LC-MS chromatogram for the digestion of cytochrome c using through-channel IMEPP tip (a) 
before and after being washed with water and digestion buffer. 
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6.3.3 Preparation of immobilized enzyme polymer monolith in glass  
tube for microdigestion 
MEPS is an automated version of SPE which was first developed by Abdel-Rehim 
in 2003. MEPS has been growing in popularity for the extraction and concentration 
of a wide range of analytes in different matrices (urine, plasma and blood) ever 
since it was made commercially available [6]. Most importantly, it has been used 
on-line with instruments for high-throughput sample preparation. One of the 
ultimate goals in this project is to develop miniaturization devices for protein 
digestion which meet the demands of automated high-throughput performance. 
Thus, the format of this device should be easily prepared, replaceable and easily 
integrated with the analysis without further modification.  
A special glass tube (~30 µL) with a needle insert was investigated as a 
potential format for a high-throughput sample preparation device (Figure 6-17). In 
order to anchor the monolithic structure to the glass tube wall through covalent 
bonding, the glass tube was surface-modified using the same procedure described 
in Section 2.3.3. Following this, the enzyme-immobilized polymer monolith (20 µL 
or 3 mg) was synthesized in the glass tube using the standard procedures for 
preparing polymer monolith, photografting of VAL functionality and enzyme 
immobilization. The glass tube was positioned between the syringe barrel and 
needle while the protein digestion took place on the immobilized bed (Figure 6-18).  
To evaluate the digestion efficiency of this new format, a protein solution 
containing 0.1 mg/mL of cytochrome c was used for the digestion and its 
performance was compared to that of a standard in-solution digestion. Protein 
solution was drawn through the immobilized bed within the glass tube and 
dispensed for about 20 cycles manually using the syringe attached. The sample 
was then analyzed directly with LC-MS/MS and identified by the Mascot software. 
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Figure 6-16: Separation of peptides resulting from BSA digestion (0.5 mg/mL) using the through-channel IMEPP tip and 
soluble enzyme. 
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Figure 6-17: Photograph of a glass tube with needle insert. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-18: Glass tube with immobilized bed and attached to a 3 mL syringe. 
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Sequence coverage of 74% was obtained for a 20 cycle digestion which required 
only five min for the whole digestion process. 
6.4 Conclusions 
In this chapter, the effects of using different buffer solutions for protein digestion 
were investigated. The combination of ammonium acetate and acetonitrile yielded 
better results compared to protein digestion in Tris-HCl buffer with the addition of 
calcium chloride. Also, the combination of urea (up to 8 M), DTT and IAA yielded 
better digestion efficiencies for the optimum digestion of large and folded proteins 
without damaging the trypsin activities. Butyl methacrylate-based monoliths were 
prepared using various compositions of the polymerization mixture in order to 
increase the through-pores of the immobilized bed. It was shown that increasing 
the porogen/monomer ratio led to increases in the pore sizes and total porosities of 
monoliths, and in turn this gave higher permeability for the suction operations. 
Several formats of IMEPP tips were also developed to work concurrently with an 
autopipette. It was found that an IMEPP tip prepared by polymerization of 8.5 min 
exposure under UV and the MonoTip prepared with S2M 70% were fully 
compatible with the autopipette. Both IMEPP tip formats gave higher permeability. 
An IMEPP tip with a through-channel was also used to demonstrate the potential 
of compatibility with an autopipette without compromising enzyme digestion 
efficiency. A new format for enzyme digestion that has been miniaturized to work 
with a syringe further expands the possibility for high-throughput sample 
preparation that can be performed either manually or in conjunction with an 
autosampler to allow protein digestion, sample clean-up and sample injection 
accomplished in a single step.  
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C h a p t e r  7  
General Conclusions 
 
The use of polymeric monolithic materials for bioanalysis has increased over the 
recent years. These materials have a number of desirable properties which include: 
1. Continuous structure of interlaced through-pores and skeleton that 
provides high permeability to enable chromatographic separations at 
extremely high flow-rates. 
2. Inexpensive, requiring no frits and easily prepared in situ in different 
formats by thermal-, UV- and γ-radiation. 
3. Porous properties can be controlled by varying the compositions of the 
polymerization mixture, tailored to suit separations of large and small 
molecules. 
4. Can be modified to feature almost any functionality; ion-exchange, affinity, 
chiral, mixed-mode, restricted access, hydrophobic and hydrophilic, in 
order to suit the stationary phases for specific analytes. 
5. Biocompatibility and high stability over a wide pH range, which is crucial 
when dealing with biological samples. 
 
Firstly, the SPMA-based monoliths were prepared both in bulk and inside 
Teflon® -coated UV transparent fused-silica capillaries using photoinitiated free 
radical polymerization. The relationship between the porogenic solvent 
composition and cross-linker with regard to morphologies, pore size distributions 
and separation performance were investigated. It was shown that the pore sizes 
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and separation properties of monoliths could be controlled by varying of the 
porogenic solvent ratio between 1,4-butanediol and 1-propanol. Increasing the 
percentage of 1-propanol relative to that of 1,4-butanediol in the polymerization 
mixture diminished the pore size in the prepared SPMA monoliths. Among the 
first set of columns (S1-S7) prepared using higher functional monomer/cross-linker 
ratio, the best separation of a mixture of target analytes was achieved with the 
porogen ratio 1,4-butanediol:1-propanol:water  30:60:10 (% w/w/w) for the S1 
column. This column exhibited good repeatability for run-to-run separation but 
showed non-robustness for column-to-column and batch-to-batch separations. In 
the second set of columns (S1M-S3M), the proportion of cross-linker (EDMA) in 
the monomer mixture was switched with that of the functional monomer (BMA), 
with the compositions BMA:SPMA:EDMA 16:0.4:23.6 (% w/w/w). The S2M column 
demonstrated the best separation performance with satisfactory column 
permeability suitable for an acceptable level of separation of acidic drugs and β-
blockers. The S2M column exhibited minimal column-to-column and batch-to-
batch differences in the majority of the investigated chromatographic parameters. 
Therefore, SPMA-based monolithic columns with a higher amount of cross-linker 
(SM-monoliths) exhibited better repeatability than those polymerized with less 
cross-linker (S-monoliths). Furthermore, the separation mechanism of the 
investigated compounds was shown to be based on a mixed-mode functionality of 
the SCX-RP monolith. The present work has demonstrated the high 
permeability (calculated using Darcy’s Law) of the developed monoliths. 
Although it was not thoroughly explored in this project, the developed 
monoliths could potentially be used for extremely high flow-rates separations. 
Thus, further studies are warranted. Moreover, as it has not been fully 
demonstrated in the current work that tailored monoliths could provide 
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separations of large and small molecules, future studies may focus on improving 
the developed materials for the efficient separations of large and small molecules. 
A novel trypsin-immobilized polypropylene pipette tip prepared with the 
newly optimized porous polymer monolith was developed. Disposable pipette tips 
were surface-modified before in situ synthesis of a plug of polymer monolith as an 
immobilized bed. A single photografting step using a stock solution of 
modification mixtures containing MMA:EDMA:BP resulted in better attachment of 
the polymer monolith on the polypropylene surface. A fluorescence assay 
indicated that UV light was capable of penetrating the polypropylene wall, 
enabling surface grafting of reactive functionalities (VAL) for trypsin 
immobilization. The concentrations of VAL in the grafting mixture as well as the 
grafting time were optimized, and the optimum trypsin concentration for 
immobilization was also determined. The first demonstration of proteolytic activity 
for the immobilized enzyme polypropylene pipette tips was carried out using a 
solution of cytochrome c. The preliminary results obtained were very promising as 
very high sequence coverage was achieved within a very short digest time of only 
a few minutes. 
The digestion performances of the IMEPP tips were further characterized 
and evaluated using MicrOTOF-Q quadrupole time-of-flight MS and a LC-MS/MS 
system including an AB SCIEX Triple Quadrupole™ 5500 mass spectrometer for 
the application of bioanalysis. The IMEPP tip showed a very good catalytic efficacy 
for different proteolytic resistivity proteins, ranging from 2.8 kDa to high 
molecular mass proteins, such as hIgG of 150 kDa. Direct comparison of the 
digestions achieved with IMEPP tips and soluble trypsin clearly demonstrated the 
advantages of the former as they afforded much higher digestion efficiencies 
within short periods of time. Further, IMEPP tips were also successfully applied to 
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biological sample preparation for qualitative and quantitative analysis in an 
industrial bioanalytical laboratory (Pfizer Inc., Sandwich). The developed IMEPP 
tips exhibited high plasma loading capacity of up to 40 µL of plasma, which could 
be used to yield the highest digestion efficiency. A time course assay demonstrated 
that the 30 min IMEPP tip digestion yielded similar results to the 24 h in-solution 
digestion. Although IMEPP tips did not possess significant sample clean-up and 
enrichment functionalities, nonetheless IMEPP tips eliminated the enzyme 
autodigestion which would have led to ion suppression in the MS analysis. 
Calibration curves were established for different target proteins and demonstrated 
relatively good linearity over a wide range from 40 ng/mL to 1000 ng/mL. IMEPP 
tips showed long-term stability and reproducibility. The results obtained were 
superior to those of commercially available tryptic digest tips.  
The author’s laboratory and the Pfizer bioanalytical laboratory used 
different digestion buffers and denaturants. Therefore, experiments were 
conducted to evaluate the digestion efficiencies of the two systems. Digestion 
buffer comprising 50 mM ammonium acetate, pH 8.75 containing 20% acetonitrile 
yielded better results compared to digestion in Tris-HCl buffer. In addition, the 
combination of urea, DTT and IAA gave better digestion of reduced and alkylated 
proteins. Additionally, the monolith plug in the pipette tip was varied to increase 
the extent of through-pores and to facilitate the suction operation during enzyme 
digestion in the IMEPP tip. A highly permeable tip was achieved by filling 15 µL of 
S2M 70% in empty MonoTip®  Trypsin, with polymerization under UV for 20 min. 
Newly developed through-channel IMEPP tips could also be used to overcome the 
permeability problem. Most importantly, these modified IMEPP tips allowed 
compatibility with autopipettes without compromising digestion performance. 
Trypsin-immobilized polymer monolith was also prepared within a syringe-
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compatible glass tube and the protein digestion efficiency was evaluated. 
Preliminary results showed that the enzyme on the immobilized bed maintained 
high proteolytic performance in this special format. 
Applications of the robust and repeatable monolithic columns and IMEPP 
tips developed in this work can be expected to be further expanded in the future. 
Further studies to achieve this goal would include: 
 Monolithic columns developed were prepared by copolymerization of 
BMA, EDMA and SPMA, with the sulfonate ions contributing to the cation-
exchange functionalities of the polymer chains. However, the cation-
exchange capacity was relatively low. One alternative approach is to 
introduce this functionality by post-photografting the monolithic support 
with a desired functional monomer. The mixed-mode monolith sorbent 
produced could be further tested for separation performance (e.g. HPLC, 
LC-MS) or used as the bulk material for solid-phase extraction of large and 
small molecules. 
 The tip-shape enzyme reactor has the advantage of easy applicability. With 
further development, this highly efficient enzyme reactor based on the 
pipette tip format can be adopted readily in the current setup of any 
laboratory for manual operation using an autopipette or by integrating it 
with an automated 96-tip robotic device for high-throughput sample 
preparation of bio-substances in pharmaceutical and pharmacokinetic 
studies, enabling faster and safer discovery of new drugs. 
 So far, the IMEPP tips have only been used in the digestion of standard 
proteins. These tips could be applied in a wider range of biological samples 
of pharmaceutical interest. 
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 Although this project has only demonstrated the immobilization of trypsin 
on polymer monoliths in pipette tips, immobilization of other enzymes (e.g. 
LysC and PNGase F) using these supports will also be feasible. It is also 
possible to prepare multiple enzyme reactors in a range of different formats 
with different parameters such as in situ in capillary, different internal 
diameter columns, microchips, syringe barrels, syringe filters and spin 
columns, leading to significant commercial potential. These designs also 
mean that they can be applicable to all types of bioanalytical problems. 
 It is also possible to prepare the immobilized bed in 96-well plates. The 
lower part of each well can be removed. The proteins samples are digested 
while eluting through the 96 wells and are subsequently injected for sample 
analysis (Figure 7-2).  
 A monolith in a glass tube could be fitted into a glass syringe and connected 
to an autosampler for on-line sample preparation prior to MS analysis. 
Further modification of the monolith functionalities may enable analysis of 
complex matrices, e.g. using two monolithic phases with different 
functionalities, thus providing the possibility of extraction, enrichment, 
digestion and injection in a single step for analysis (Figure 7-3). 
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Figure 7-2: 96-well plate with immobilized bed. 
 
 
 
 
 
 
Figure 7-3: Glass tube with two layers of monolithic phases fitted with gas tight 
syringe.  
Ion-exchange phase  
Immobilized enzyme bed  
